id	sid	tid	token	lemma	pos
iajs-3385	1	1	204	204	NUM
iajs-3385	1	2	©	©	PROPN
iajs-3385	1	3	2025	2025	NUM
iajs-3385	1	4	the	the	DET
iajs-3385	1	5	author(s	author(s	NOUN
iajs-3385	1	6	)	)	PUNCT
iajs-3385	1	7	.	.	PUNCT
iajs-3385	2	1	published	publish	VERB
iajs-3385	2	2	by	by	ADP
iajs-3385	2	3	college	college	NOUN
iajs-3385	2	4	of	of	ADP
iajs-3385	2	5	education	education	NOUN
iajs-3385	2	6	for	for	ADP
iajs-3385	2	7	pure	pure	ADJ
iajs-3385	2	8	science	science	NOUN
iajs-3385	2	9	(	(	PUNCT
iajs-3385	2	10	ibn	ibn	PROPN
iajs-3385	2	11	al	al	PROPN
iajs-3385	2	12	-	-	PUNCT
iajs-3385	2	13	haitham	haitham	PROPN
iajs-3385	2	14	)	)	PUNCT
iajs-3385	2	15	,	,	PUNCT
iajs-3385	2	16	university	university	NOUN
iajs-3385	2	17	of	of	ADP
iajs-3385	2	18	baghdad	baghdad	PROPN
iajs-3385	2	19	.	.	PUNCT
iajs-3385	3	1	this	this	PRON
iajs-3385	3	2	is	be	AUX
iajs-3385	3	3	an	an	DET
iajs-3385	3	4	open	open	ADJ
iajs-3385	3	5	-	-	PUNCT
iajs-3385	3	6	access	access	NOUN
iajs-3385	3	7	article	article	NOUN
iajs-3385	3	8	distributed	distribute	VERB
iajs-3385	3	9	under	under	ADP
iajs-3385	3	10	the	the	DET
iajs-3385	3	11	terms	term	NOUN
iajs-3385	3	12	of	of	ADP
iajs-3385	3	13	the	the	DET
iajs-3385	3	14	creative	creative	ADJ
iajs-3385	3	15	commons	common	NOUN
iajs-3385	3	16	attribution	attribution	NOUN
iajs-3385	3	17	4.0	4.0	NUM
iajs-3385	3	18	international	international	ADJ
iajs-3385	3	19	license	license	NOUN
iajs-3385	3	20	spectrophotometric	spectrophotometric	ADJ
iajs-3385	3	21	investigations	investigation	NOUN
iajs-3385	3	22	for	for	ADP
iajs-3385	3	23	simultaneous	simultaneous	ADJ
iajs-3385	3	24	analysis	analysis	NOUN
iajs-3385	3	25	of	of	ADP
iajs-3385	3	26	certain	certain	ADJ
iajs-3385	3	27	antibacterial	antibacterial	NOUN
iajs-3385	3	28	:	:	PUNCT
iajs-3385	3	29	a	a	DET
iajs-3385	3	30	brief	brief	ADJ
iajs-3385	3	31	review	review	NOUN
iajs-3385	3	32	farah	farah	PROPN
iajs-3385	3	33	nouri	nouri	PROPN
iajs-3385	3	34	jasim1	jasim1	PROPN
iajs-3385	3	35	and	and	CCONJ
iajs-3385	3	36	nahla	nahla	PROPN
iajs-3385	3	37	a.	a.	NOUN
iajs-3385	3	38	alassaf	alassaf	NOUN
iajs-3385	4	1	2	2	NUM
iajs-3385	4	2	*	*	SYM
iajs-3385	4	3	1,2department	1,2department	NUM
iajs-3385	4	4	of	of	ADP
iajs-3385	4	5	chemistry	chemistry	NOUN
iajs-3385	4	6	,	,	PUNCT
iajs-3385	4	7	college	college	NOUN
iajs-3385	4	8	of	of	ADP
iajs-3385	4	9	education	education	NOUN
iajs-3385	4	10	for	for	ADP
iajs-3385	4	11	pure	pure	ADJ
iajs-3385	4	12	science	science	NOUN
iajs-3385	4	13	(	(	PUNCT
iajs-3385	4	14	ibn	ibn	PROPN
iajs-3385	4	15	al	al	PROPN
iajs-3385	4	16	-	-	PUNCT
iajs-3385	4	17	haitham	haitham	PROPN
iajs-3385	4	18	)	)	PUNCT
iajs-3385	4	19	,	,	PUNCT
iajs-3385	4	20	university	university	NOUN
iajs-3385	4	21	of	of	ADP
iajs-3385	4	22	baghdad	baghdad	PROPN
iajs-3385	4	23	,	,	PUNCT
iajs-3385	4	24	baghdad	baghdad	PROPN
iajs-3385	4	25	,	,	PUNCT
iajs-3385	4	26	iraq	iraq	PROPN
iajs-3385	4	27	.	.	PUNCT
iajs-3385	5	1	*	*	PUNCT
iajs-3385	5	2	corresponding	correspond	VERB
iajs-3385	5	3	author	author	NOUN
iajs-3385	5	4	.	.	PUNCT
iajs-3385	6	1	received	receive	VERB
iajs-3385	6	2	:	:	PUNCT
iajs-3385	6	3	5	5	NUM
iajs-3385	6	4	april	april	PROPN
iajs-3385	6	5	2023	2023	NUM
iajs-3385	6	6	accepted	accept	VERB
iajs-3385	6	7	:	:	PUNCT
iajs-3385	6	8	25	25	NUM
iajs-3385	6	9	july	july	PROPN
iajs-3385	6	10	2023	2023	NUM
iajs-3385	6	11	published	publish	VERB
iajs-3385	6	12	:	:	PUNCT
iajs-3385	6	13	20	20	NUM
iajs-3385	6	14	april	april	PROPN
iajs-3385	6	15	2025	2025	NUM
iajs-3385	6	16	doi.org/10.30526/38.2.3385	doi.org/10.30526/38.2.3385	X
iajs-3385	6	17	abstract	abstract	ADJ
iajs-3385	6	18	antibacterial	antibacterial	ADJ
iajs-3385	6	19	substances	substance	NOUN
iajs-3385	6	20	belong	belong	VERB
iajs-3385	6	21	to	to	ADP
iajs-3385	6	22	a	a	DET
iajs-3385	6	23	group	group	NOUN
iajs-3385	6	24	of	of	ADP
iajs-3385	6	25	compounds	compound	NOUN
iajs-3385	6	26	that	that	PRON
iajs-3385	6	27	attack	attack	VERB
iajs-3385	6	28	dangerous	dangerous	ADJ
iajs-3385	6	29	microorganisms	microorganism	NOUN
iajs-3385	6	30	.	.	PUNCT
iajs-3385	7	1	therefore	therefore	ADV
iajs-3385	7	2	,	,	PUNCT
iajs-3385	7	3	killing	kill	VERB
iajs-3385	7	4	bacteria	bacteria	NOUN
iajs-3385	7	5	or	or	CCONJ
iajs-3385	7	6	reducing	reduce	VERB
iajs-3385	7	7	their	their	PRON
iajs-3385	7	8	metabolic	metabolic	NOUN
iajs-3385	7	9	activity	activity	NOUN
iajs-3385	7	10	will	will	AUX
iajs-3385	7	11	lessen	lessen	VERB
iajs-3385	7	12	their	their	PRON
iajs-3385	7	13	adverse	adverse	ADJ
iajs-3385	7	14	effects	effect	NOUN
iajs-3385	7	15	on	on	ADP
iajs-3385	7	16	a	a	DET
iajs-3385	7	17	biological	biological	ADJ
iajs-3385	7	18	system	system	NOUN
iajs-3385	7	19	.	.	PUNCT
iajs-3385	8	1	they	they	PRON
iajs-3385	8	2	originated	originate	VERB
iajs-3385	8	3	from	from	ADP
iajs-3385	8	4	either	either	CCONJ
iajs-3385	8	5	synthetic	synthetic	ADJ
iajs-3385	8	6	materials	material	NOUN
iajs-3385	8	7	,	,	PUNCT
iajs-3385	8	8	microbes	microbe	NOUN
iajs-3385	8	9	,	,	PUNCT
iajs-3385	8	10	or	or	CCONJ
iajs-3385	8	11	mold	mold	NOUN
iajs-3385	8	12	.	.	PUNCT
iajs-3385	9	1	many	many	ADJ
iajs-3385	9	2	of	of	ADP
iajs-3385	9	3	these	these	DET
iajs-3385	9	4	medications	medication	NOUN
iajs-3385	9	5	treat	treat	VERB
iajs-3385	9	6	the	the	DET
iajs-3385	9	7	gram	gram	NOUN
iajs-3385	9	8	-	-	PUNCT
iajs-3385	9	9	negative	negative	ADJ
iajs-3385	9	10	bacteria	bacteria	NOUN
iajs-3385	9	11	from	from	ADP
iajs-3385	9	12	the	the	DET
iajs-3385	9	13	critical	critical	ADJ
iajs-3385	9	14	precedence	precedence	NOUN
iajs-3385	9	15	group	group	NOUN
iajs-3385	9	16	,	,	PUNCT
iajs-3385	9	17	such	such	ADJ
iajs-3385	9	18	as	as	ADP
iajs-3385	9	19	pseudomonas	pseudomona	NOUN
iajs-3385	9	20	,	,	PUNCT
iajs-3385	9	21	carbapenem	carbapenem	NOUN
iajs-3385	9	22	-	-	PUNCT
iajs-3385	9	23	resistant	resistant	ADJ
iajs-3385	9	24	acinetobacter	acinetobacter	NOUN
iajs-3385	9	25	,	,	PUNCT
iajs-3385	9	26	and	and	CCONJ
iajs-3385	9	27	enterobacterales	enterobacterale	NOUN
iajs-3385	9	28	.	.	PUNCT
iajs-3385	10	1	this	this	DET
iajs-3385	10	2	study	study	NOUN
iajs-3385	10	3	aims	aim	VERB
iajs-3385	10	4	to	to	PART
iajs-3385	10	5	investigate	investigate	VERB
iajs-3385	10	6	the	the	DET
iajs-3385	10	7	simultaneous	simultaneous	ADJ
iajs-3385	10	8	analysis	analysis	NOUN
iajs-3385	10	9	of	of	ADP
iajs-3385	10	10	specific	specific	ADJ
iajs-3385	10	11	antibacterial	antibacterial	ADJ
iajs-3385	10	12	spectrophotometrically	spectrophotometrically	ADV
iajs-3385	10	13	.	.	PUNCT
iajs-3385	11	1	the	the	DET
iajs-3385	11	2	who	who	PRON
iajs-3385	11	3	maintains	maintain	VERB
iajs-3385	11	4	this	this	DET
iajs-3385	11	5	list	list	NOUN
iajs-3385	11	6	of	of	ADP
iajs-3385	11	7	priority	priority	NOUN
iajs-3385	11	8	infections	infection	NOUN
iajs-3385	11	9	with	with	ADP
iajs-3385	11	10	antibiotic	antibiotic	ADJ
iajs-3385	11	11	resistance	resistance	NOUN
iajs-3385	11	12	.	.	PUNCT
iajs-3385	11	13	drug	drug	NOUN
iajs-3385	11	14	combinations	combination	NOUN
iajs-3385	11	15	in	in	ADP
iajs-3385	11	16	single	single	ADJ
iajs-3385	11	17	dosage	dosage	NOUN
iajs-3385	11	18	forms	form	NOUN
iajs-3385	11	19	are	be	AUX
iajs-3385	11	20	becoming	become	VERB
iajs-3385	11	21	increasingly	increasingly	ADV
iajs-3385	11	22	popular	popular	ADJ
iajs-3385	11	23	in	in	ADP
iajs-3385	11	24	the	the	DET
iajs-3385	11	25	pharmaceutical	pharmaceutical	ADJ
iajs-3385	11	26	industry	industry	NOUN
iajs-3385	11	27	.	.	PUNCT
iajs-3385	12	1	this	this	PRON
iajs-3385	12	2	has	have	AUX
iajs-3385	12	3	created	create	VERB
iajs-3385	12	4	a	a	DET
iajs-3385	12	5	significant	significant	ADJ
iajs-3385	12	6	issue	issue	NOUN
iajs-3385	12	7	for	for	ADP
iajs-3385	12	8	pharmaceutical	pharmaceutical	ADJ
iajs-3385	12	9	administrators	administrator	NOUN
iajs-3385	12	10	,	,	PUNCT
iajs-3385	12	11	particularly	particularly	ADV
iajs-3385	12	12	in	in	ADP
iajs-3385	12	13	combating	combat	VERB
iajs-3385	12	14	fake	fake	ADJ
iajs-3385	12	15	medications	medication	NOUN
iajs-3385	12	16	and	and	CCONJ
iajs-3385	12	17	pharmaceutical	pharmaceutical	NOUN
iajs-3385	12	18	analysts	analyst	NOUN
iajs-3385	12	19	and	and	CCONJ
iajs-3385	12	20	developing	develop	VERB
iajs-3385	12	21	reliable	reliable	ADJ
iajs-3385	12	22	and	and	CCONJ
iajs-3385	12	23	accurate	accurate	ADJ
iajs-3385	12	24	methodologies	methodology	NOUN
iajs-3385	12	25	with	with	ADP
iajs-3385	12	26	minimal	minimal	ADJ
iajs-3385	12	27	overlapping	overlapping	ADJ
iajs-3385	12	28	effects	effect	NOUN
iajs-3385	12	29	on	on	ADP
iajs-3385	12	30	quantification	quantification	NOUN
iajs-3385	12	31	.	.	PUNCT
iajs-3385	13	1	the	the	DET
iajs-3385	13	2	basics	basic	NOUN
iajs-3385	13	3	of	of	ADP
iajs-3385	13	4	several	several	ADJ
iajs-3385	13	5	spectrophotometric	spectrophotometric	ADJ
iajs-3385	13	6	methods	method	NOUN
iajs-3385	13	7	utilized	utilize	VERB
iajs-3385	13	8	to	to	PART
iajs-3385	13	9	conduct	conduct	VERB
iajs-3385	13	10	multicomponent	multicomponent	NOUN
iajs-3385	13	11	analysis	analysis	NOUN
iajs-3385	13	12	are	be	AUX
iajs-3385	13	13	collected	collect	VERB
iajs-3385	13	14	in	in	ADP
iajs-3385	13	15	the	the	DET
iajs-3385	13	16	current	current	ADJ
iajs-3385	13	17	work	work	NOUN
iajs-3385	13	18	,	,	PUNCT
iajs-3385	13	19	and	and	CCONJ
iajs-3385	13	20	the	the	DET
iajs-3385	13	21	validation	validation	NOUN
iajs-3385	13	22	criteria	criterion	NOUN
iajs-3385	13	23	that	that	PRON
iajs-3385	13	24	are	be	AUX
iajs-3385	13	25	an	an	DET
iajs-3385	13	26	essential	essential	ADJ
iajs-3385	13	27	component	component	NOUN
iajs-3385	13	28	of	of	ADP
iajs-3385	13	29	the	the	DET
iajs-3385	13	30	approaches	approach	NOUN
iajs-3385	13	31	are	be	AUX
iajs-3385	13	32	also	also	ADV
iajs-3385	13	33	described	describe	VERB
iajs-3385	13	34	.	.	PUNCT
iajs-3385	14	1	numerous	numerous	ADJ
iajs-3385	14	2	analytical	analytical	ADJ
iajs-3385	14	3	techniques	technique	NOUN
iajs-3385	14	4	,	,	PUNCT
iajs-3385	14	5	including	include	VERB
iajs-3385	14	6	high	high	ADJ
iajs-3385	14	7	-	-	PUNCT
iajs-3385	14	8	performance	performance	NOUN
iajs-3385	14	9	liquid	liquid	ADJ
iajs-3385	14	10	chromatography	chromatography	NOUN
iajs-3385	14	11	,	,	PUNCT
iajs-3385	14	12	electrochemical	electrochemical	ADJ
iajs-3385	14	13	methods	method	NOUN
iajs-3385	14	14	,	,	PUNCT
iajs-3385	14	15	flow	flow	VERB
iajs-3385	14	16	injection	injection	NOUN
iajs-3385	14	17	techniques	technique	NOUN
iajs-3385	14	18	,	,	PUNCT
iajs-3385	14	19	gas	gas	NOUN
iajs-3385	14	20	chromatography	chromatography	NOUN
iajs-3385	14	21	,	,	PUNCT
iajs-3385	14	22	spectrofluorometric	spectrofluorometric	ADJ
iajs-3385	14	23	techniques	technique	NOUN
iajs-3385	14	24	,	,	PUNCT
iajs-3385	14	25	capillary	capillary	ADJ
iajs-3385	14	26	electrophoresis	electrophoresis	NOUN
iajs-3385	14	27	,	,	PUNCT
iajs-3385	14	28	and	and	CCONJ
iajs-3385	14	29	spectrophotometric	spectrophotometric	ADJ
iajs-3385	14	30	techniques	technique	NOUN
iajs-3385	14	31	,	,	PUNCT
iajs-3385	14	32	have	have	AUX
iajs-3385	14	33	been	be	AUX
iajs-3385	14	34	reported	report	VERB
iajs-3385	14	35	to	to	PART
iajs-3385	14	36	determine	determine	VERB
iajs-3385	14	37	antibacterials	antibacterial	NOUN
iajs-3385	14	38	.	.	PUNCT
iajs-3385	15	1	this	this	DET
iajs-3385	15	2	study	study	NOUN
iajs-3385	15	3	conducts	conduct	VERB
iajs-3385	15	4	a	a	DET
iajs-3385	15	5	concise	concise	ADJ
iajs-3385	15	6	narrative	narrative	NOUN
iajs-3385	15	7	evaluation	evaluation	NOUN
iajs-3385	15	8	of	of	ADP
iajs-3385	15	9	the	the	DET
iajs-3385	15	10	many	many	ADJ
iajs-3385	15	11	spectrophotometric	spectrophotometric	ADJ
iajs-3385	15	12	methods	method	NOUN
iajs-3385	15	13	that	that	PRON
iajs-3385	15	14	have	have	AUX
iajs-3385	15	15	been	be	AUX
iajs-3385	15	16	published	publish	VERB
iajs-3385	15	17	for	for	ADP
iajs-3385	15	18	the	the	DET
iajs-3385	15	19	simultaneous	simultaneous	ADJ
iajs-3385	15	20	investigation	investigation	NOUN
iajs-3385	15	21	of	of	ADP
iajs-3385	15	22	levofloxacin	levofloxacin	PROPN
iajs-3385	15	23	,	,	PUNCT
iajs-3385	15	24	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	15	25	,	,	PUNCT
iajs-3385	15	26	metronidazole	metronidazole	NOUN
iajs-3385	15	27	,	,	PUNCT
iajs-3385	15	28	and	and	CCONJ
iajs-3385	15	29	rifampicin	rifampicin	VERB
iajs-3385	15	30	in	in	ADP
iajs-3385	15	31	their	their	PRON
iajs-3385	15	32	pure	pure	ADJ
iajs-3385	15	33	forms	form	NOUN
iajs-3385	15	34	,	,	PUNCT
iajs-3385	15	35	pharmaceutical	pharmaceutical	ADJ
iajs-3385	15	36	dosage	dosage	NOUN
iajs-3385	15	37	forms	form	NOUN
iajs-3385	15	38	,	,	PUNCT
iajs-3385	15	39	and	and	CCONJ
iajs-3385	15	40	biological	biological	ADJ
iajs-3385	15	41	samples	sample	NOUN
iajs-3385	15	42	due	due	ADP
iajs-3385	15	43	to	to	ADP
iajs-3385	15	44	their	their	PRON
iajs-3385	15	45	sensitivity	sensitivity	NOUN
iajs-3385	15	46	,	,	PUNCT
iajs-3385	15	47	simplicity	simplicity	NOUN
iajs-3385	15	48	,	,	PUNCT
iajs-3385	15	49	and	and	CCONJ
iajs-3385	15	50	cost	cost	NOUN
iajs-3385	15	51	-	-	PUNCT
iajs-3385	15	52	effectiveness	effectiveness	NOUN
iajs-3385	15	53	.	.	PUNCT
iajs-3385	16	1	keywords	keyword	NOUN
iajs-3385	16	2	:	:	PUNCT
iajs-3385	16	3	antibacterial	antibacterial	ADJ
iajs-3385	16	4	agents	agent	NOUN
iajs-3385	16	5	,	,	PUNCT
iajs-3385	16	6	levofloxacin	levofloxacin	PROPN
iajs-3385	16	7	,	,	PUNCT
iajs-3385	16	8	metronidazole	metronidazole	NOUN
iajs-3385	16	9	,	,	PUNCT
iajs-3385	16	10	rifampicin	rifampicin	VERB
iajs-3385	16	11	,	,	PUNCT
iajs-3385	16	12	spectrophotometric	spectrophotometric	ADJ
iajs-3385	16	13	techniques	technique	NOUN
iajs-3385	16	14	,	,	PUNCT
iajs-3385	16	15	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	16	16	.	.	PUNCT
iajs-3385	17	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3385	17	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3385	17	3	https://orcid.org/0009-0003-9486-6365	https://orcid.org/0009-0003-9486-6365	VERB
iajs-3385	17	4	mailto:fnouri244@gmail.com	mailto:fnouri244@gmail.com	PROPN
iajs-3385	17	5	https://orcid.org/0000-0003-2803-8003	https://orcid.org/0000-0003-2803-8003	PROPN
iajs-3385	17	6	mailto:nahla.a.a@ihcoedu.uobaghdad.edu.iq	mailto:nahla.a.a@ihcoedu.uobaghdad.edu.iq	NOUN
iajs-3385	17	7	ihjpas	ihjpas	PROPN
iajs-3385	17	8	.	.	PUNCT
iajs-3385	18	1	2025	2025	NUM
iajs-3385	18	2	,	,	PUNCT
iajs-3385	18	3	38(2	38(2	NUM
iajs-3385	18	4	)	)	PUNCT
iajs-3385	18	5	205	205	NUM
iajs-3385	18	6	1	1	NUM
iajs-3385	18	7	.	.	PUNCT
iajs-3385	18	8	introduction	introduction	NOUN
iajs-3385	18	9	streptomycin	streptomycin	PROPN
iajs-3385	18	10	was	be	AUX
iajs-3385	18	11	discovered	discover	VERB
iajs-3385	18	12	in	in	ADP
iajs-3385	18	13	1943	1943	NUM
iajs-3385	18	14	by	by	ADP
iajs-3385	18	15	selman	selman	PROPN
iajs-3385	18	16	a.	a.	PROPN
iajs-3385	18	17	waksman	waksman	PROPN
iajs-3385	18	18	and	and	CCONJ
iajs-3385	18	19	albert	albert	PROPN
iajs-3385	18	20	schatz	schatz	PROPN
iajs-3385	18	21	.	.	PUNCT
iajs-3385	19	1	waksman	waksman	PROPN
iajs-3385	19	2	introduced	introduce	VERB
iajs-3385	19	3	the	the	DET
iajs-3385	19	4	term	term	NOUN
iajs-3385	19	5	"	"	PUNCT
iajs-3385	19	6	antibiotic	antibiotic	ADJ
iajs-3385	19	7	,	,	PUNCT
iajs-3385	19	8	"	"	PUNCT
iajs-3385	19	9	which	which	PRON
iajs-3385	19	10	refers	refer	VERB
iajs-3385	19	11	to	to	ADP
iajs-3385	19	12	a	a	DET
iajs-3385	19	13	substance	substance	NOUN
iajs-3385	19	14	created	create	VERB
iajs-3385	19	15	by	by	ADP
iajs-3385	19	16	an	an	DET
iajs-3385	19	17	organism	organism	NOUN
iajs-3385	19	18	to	to	PART
iajs-3385	19	19	eradicate	eradicate	VERB
iajs-3385	19	20	or	or	CCONJ
iajs-3385	19	21	stop	stop	VERB
iajs-3385	19	22	the	the	DET
iajs-3385	19	23	growth	growth	NOUN
iajs-3385	19	24	of	of	ADP
iajs-3385	19	25	other	other	ADJ
iajs-3385	19	26	species	specie	NOUN
iajs-3385	19	27	(	(	PUNCT
iajs-3385	19	28	1	1	NUM
iajs-3385	19	29	)	)	PUNCT
iajs-3385	19	30	.	.	PUNCT
iajs-3385	20	1	pathogenic	pathogenic	ADJ
iajs-3385	20	2	bacteria	bacteria	NOUN
iajs-3385	20	3	are	be	AUX
iajs-3385	20	4	those	those	PRON
iajs-3385	20	5	that	that	PRON
iajs-3385	20	6	cause	cause	VERB
iajs-3385	20	7	bacterial	bacterial	ADJ
iajs-3385	20	8	infections	infection	NOUN
iajs-3385	20	9	and	and	CCONJ
iajs-3385	20	10	sickness	sickness	NOUN
iajs-3385	20	11	.	.	PUNCT
iajs-3385	21	1	when	when	SCONJ
iajs-3385	21	2	they	they	PRON
iajs-3385	21	3	enter	enter	VERB
iajs-3385	21	4	the	the	DET
iajs-3385	21	5	body	body	NOUN
iajs-3385	21	6	,	,	PUNCT
iajs-3385	21	7	start	start	VERB
iajs-3385	21	8	reproducing	reproduce	VERB
iajs-3385	21	9	,	,	PUNCT
iajs-3385	21	10	displace	displace	VERB
iajs-3385	21	11	beneficial	beneficial	ADJ
iajs-3385	21	12	bacteria	bacteria	NOUN
iajs-3385	21	13	,	,	PUNCT
iajs-3385	21	14	or	or	CCONJ
iajs-3385	21	15	develop	develop	VERB
iajs-3385	21	16	into	into	ADP
iajs-3385	21	17	typically	typically	ADV
iajs-3385	21	18	sterile	sterile	ADJ
iajs-3385	21	19	tissues	tissue	NOUN
iajs-3385	21	20	,	,	PUNCT
iajs-3385	21	21	they	they	PRON
iajs-3385	21	22	cause	cause	VERB
iajs-3385	21	23	illnesses	illness	NOUN
iajs-3385	21	24	and	and	CCONJ
iajs-3385	21	25	ailments	ailment	NOUN
iajs-3385	21	26	.	.	PUNCT
iajs-3385	22	1	antibacterial	antibacterial	ADJ
iajs-3385	22	2	medications	medication	NOUN
iajs-3385	22	3	,	,	PUNCT
iajs-3385	22	4	considered	consider	VERB
iajs-3385	22	5	the	the	DET
iajs-3385	22	6	most	most	ADV
iajs-3385	22	7	promising	promising	ADJ
iajs-3385	22	8	chemotherapeutic	chemotherapeutic	ADJ
iajs-3385	22	9	agents	agent	NOUN
iajs-3385	22	10	,	,	PUNCT
iajs-3385	22	11	have	have	AUX
iajs-3385	22	12	been	be	AUX
iajs-3385	22	13	discovered	discover	VERB
iajs-3385	22	14	by	by	ADP
iajs-3385	22	15	researchers	researcher	NOUN
iajs-3385	22	16	to	to	PART
iajs-3385	22	17	treat	treat	VERB
iajs-3385	22	18	infectious	infectious	ADJ
iajs-3385	22	19	diseases	disease	NOUN
iajs-3385	22	20	(	(	PUNCT
iajs-3385	22	21	2	2	NUM
iajs-3385	22	22	)	)	PUNCT
iajs-3385	22	23	.	.	PUNCT
iajs-3385	23	1	although	although	SCONJ
iajs-3385	23	2	antibacterials	antibacterial	NOUN
iajs-3385	23	3	are	be	AUX
iajs-3385	23	4	life	life	NOUN
iajs-3385	23	5	-	-	PUNCT
iajs-3385	23	6	saving	save	VERB
iajs-3385	23	7	medications	medication	NOUN
iajs-3385	23	8	,	,	PUNCT
iajs-3385	23	9	improper	improper	ADJ
iajs-3385	23	10	use	use	NOUN
iajs-3385	23	11	can	can	AUX
iajs-3385	23	12	result	result	VERB
iajs-3385	23	13	in	in	ADP
iajs-3385	23	14	antibiotic	antibiotic	ADJ
iajs-3385	23	15	resistance	resistance	NOUN
iajs-3385	23	16	,	,	PUNCT
iajs-3385	23	17	a	a	DET
iajs-3385	23	18	significant	significant	ADJ
iajs-3385	23	19	public	public	ADJ
iajs-3385	23	20	health	health	NOUN
iajs-3385	23	21	risk	risk	NOUN
iajs-3385	23	22	.	.	PUNCT
iajs-3385	24	1	the	the	DET
iajs-3385	24	2	rise	rise	NOUN
iajs-3385	24	3	of	of	ADP
iajs-3385	24	4	antibiotic	antibiotic	ADJ
iajs-3385	24	5	-	-	PUNCT
iajs-3385	24	6	resistant	resistant	ADJ
iajs-3385	24	7	bacterial	bacterial	ADJ
iajs-3385	24	8	infections	infection	NOUN
iajs-3385	24	9	is	be	AUX
iajs-3385	24	10	one	one	NUM
iajs-3385	24	11	of	of	ADP
iajs-3385	24	12	the	the	DET
iajs-3385	24	13	major	major	ADJ
iajs-3385	24	14	factors	factor	NOUN
iajs-3385	24	15	contributing	contribute	VERB
iajs-3385	24	16	to	to	ADP
iajs-3385	24	17	increased	increase	VERB
iajs-3385	24	18	morbidity	morbidity	NOUN
iajs-3385	24	19	and	and	CCONJ
iajs-3385	24	20	mortality	mortality	NOUN
iajs-3385	24	21	,	,	PUNCT
iajs-3385	24	22	especially	especially	ADV
iajs-3385	24	23	in	in	ADP
iajs-3385	24	24	the	the	DET
iajs-3385	24	25	elderly	elderly	ADJ
iajs-3385	24	26	and	and	CCONJ
iajs-3385	24	27	individuals	individual	NOUN
iajs-3385	24	28	with	with	ADP
iajs-3385	24	29	medical	medical	ADJ
iajs-3385	24	30	conditions	condition	NOUN
iajs-3385	24	31	(	(	PUNCT
iajs-3385	24	32	3,4	3,4	NUM
iajs-3385	24	33	)	)	PUNCT
iajs-3385	24	34	.	.	PUNCT
iajs-3385	25	1	antibacterials	antibacterial	NOUN
iajs-3385	25	2	,	,	PUNCT
iajs-3385	25	3	a	a	DET
iajs-3385	25	4	subclass	subclass	NOUN
iajs-3385	25	5	of	of	ADP
iajs-3385	25	6	antibiotics	antibiotic	NOUN
iajs-3385	25	7	,	,	PUNCT
iajs-3385	25	8	have	have	AUX
iajs-3385	25	9	previously	previously	ADV
iajs-3385	25	10	been	be	AUX
iajs-3385	25	11	categorized	categorize	VERB
iajs-3385	25	12	in	in	ADP
iajs-3385	25	13	several	several	ADJ
iajs-3385	25	14	ways	way	NOUN
iajs-3385	25	15	;	;	PUNCT
iajs-3385	25	16	however	however	ADV
iajs-3385	25	17	,	,	PUNCT
iajs-3385	25	18	to	to	PART
iajs-3385	25	19	make	make	VERB
iajs-3385	25	20	it	it	PRON
iajs-3385	25	21	more	more	ADV
iajs-3385	25	22	straightforward	straightforward	ADJ
iajs-3385	25	23	,	,	PUNCT
iajs-3385	25	24	antibacterial	antibacterial	ADJ
iajs-3385	25	25	agents	agent	NOUN
iajs-3385	25	26	can	can	AUX
iajs-3385	25	27	be	be	AUX
iajs-3385	25	28	divided	divide	VERB
iajs-3385	25	29	into	into	ADP
iajs-3385	25	30	five	five	NUM
iajs-3385	25	31	categories	category	NOUN
iajs-3385	25	32	(	(	PUNCT
iajs-3385	25	33	5	5	NUM
iajs-3385	25	34	)	)	PUNCT
iajs-3385	25	35	.	.	PUNCT
iajs-3385	26	1	based	base	VERB
iajs-3385	26	2	on	on	ADP
iajs-3385	26	3	their	their	PRON
iajs-3385	26	4	mode	mode	NOUN
iajs-3385	26	5	of	of	ADP
iajs-3385	26	6	action	action	NOUN
iajs-3385	26	7	,	,	PUNCT
iajs-3385	26	8	antibacterials	antibacterial	NOUN
iajs-3385	26	9	can	can	AUX
iajs-3385	26	10	usually	usually	ADV
iajs-3385	26	11	be	be	AUX
iajs-3385	26	12	divided	divide	VERB
iajs-3385	26	13	into	into	ADP
iajs-3385	26	14	bacteriostatic	bacteriostatic	ADJ
iajs-3385	26	15	(	(	PUNCT
iajs-3385	26	16	like	like	ADP
iajs-3385	26	17	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	26	18	)	)	PUNCT
iajs-3385	26	19	and	and	CCONJ
iajs-3385	26	20	bactericidal	bactericidal	NOUN
iajs-3385	26	21	(	(	PUNCT
iajs-3385	26	22	i.e.	i.e.	X
iajs-3385	26	23	,	,	PUNCT
iajs-3385	26	24	levofloxacin	levofloxacin	PROPN
iajs-3385	26	25	,	,	PUNCT
iajs-3385	26	26	metronidazole	metronidazole	NOUN
iajs-3385	26	27	,	,	PUNCT
iajs-3385	26	28	and	and	CCONJ
iajs-3385	26	29	rifampicin	rifampicin	VERB
iajs-3385	26	30	)	)	PUNCT
iajs-3385	26	31	.	.	PUNCT
iajs-3385	27	1	while	while	SCONJ
iajs-3385	27	2	bactericidal	bactericidal	ADJ
iajs-3385	27	3	antibacterials	antibacterial	NOUN
iajs-3385	27	4	aim	aim	VERB
iajs-3385	27	5	to	to	PART
iajs-3385	27	6	kill	kill	VERB
iajs-3385	27	7	germs	germ	NOUN
iajs-3385	27	8	by	by	ADP
iajs-3385	27	9	attacking	attack	VERB
iajs-3385	27	10	their	their	PRON
iajs-3385	27	11	cell	cell	NOUN
iajs-3385	27	12	wall	wall	NOUN
iajs-3385	27	13	or	or	CCONJ
iajs-3385	27	14	membranes	membrane	NOUN
iajs-3385	27	15	,	,	PUNCT
iajs-3385	27	16	bacteriostatic	bacteriostatic	ADJ
iajs-3385	27	17	antibacterials	antibacterial	NOUN
iajs-3385	27	18	work	work	VERB
iajs-3385	27	19	to	to	PART
iajs-3385	27	20	slow	slow	VERB
iajs-3385	27	21	or	or	CCONJ
iajs-3385	27	22	prevent	prevent	VERB
iajs-3385	27	23	bacterial	bacterial	ADJ
iajs-3385	27	24	growth	growth	NOUN
iajs-3385	27	25	(	(	PUNCT
iajs-3385	27	26	6	6	NUM
iajs-3385	27	27	)	)	PUNCT
iajs-3385	27	28	.	.	PUNCT
iajs-3385	28	1	a	a	DET
iajs-3385	28	2	subclass	subclass	NOUN
iajs-3385	28	3	of	of	ADP
iajs-3385	28	4	antibiotics	antibiotic	NOUN
iajs-3385	28	5	known	know	VERB
iajs-3385	28	6	as	as	ADP
iajs-3385	28	7	antibacterials	antibacterial	NOUN
iajs-3385	28	8	can	can	AUX
iajs-3385	28	9	be	be	AUX
iajs-3385	28	10	produced	produce	VERB
iajs-3385	28	11	synthetically	synthetically	ADV
iajs-3385	28	12	,	,	PUNCT
iajs-3385	28	13	chemically	chemically	ADV
iajs-3385	28	14	altered	alter	VERB
iajs-3385	28	15	from	from	ADP
iajs-3385	28	16	naturally	naturally	ADV
iajs-3385	28	17	existing	exist	VERB
iajs-3385	28	18	substances	substance	NOUN
iajs-3385	28	19	,	,	PUNCT
iajs-3385	28	20	or	or	CCONJ
iajs-3385	28	21	spontaneously	spontaneously	ADV
iajs-3385	28	22	from	from	ADP
iajs-3385	28	23	fungal	fungal	ADJ
iajs-3385	28	24	sources	source	NOUN
iajs-3385	28	25	(	(	PUNCT
iajs-3385	28	26	7	7	NUM
iajs-3385	28	27	)	)	PUNCT
iajs-3385	28	28	.	.	PUNCT
iajs-3385	29	1	classification	classification	NOUN
iajs-3385	29	2	by	by	ADP
iajs-3385	29	3	activity	activity	NOUN
iajs-3385	29	4	spectrum	spectrum	NOUN
iajs-3385	29	5	is	be	AUX
iajs-3385	29	6	another	another	DET
iajs-3385	29	7	way	way	NOUN
iajs-3385	29	8	of	of	ADP
iajs-3385	29	9	classifying	classify	VERB
iajs-3385	29	10	antibiotics	antibiotic	NOUN
iajs-3385	29	11	or	or	CCONJ
iajs-3385	29	12	antimicrobials	antimicrobial	NOUN
iajs-3385	29	13	based	base	VERB
iajs-3385	29	14	on	on	ADP
iajs-3385	29	15	target	target	NOUN
iajs-3385	29	16	specification	specification	NOUN
iajs-3385	29	17	.	.	PUNCT
iajs-3385	30	1	in	in	ADP
iajs-3385	30	2	this	this	DET
iajs-3385	30	3	category	category	NOUN
iajs-3385	30	4	,	,	PUNCT
iajs-3385	30	5	antibiotics	antibiotic	NOUN
iajs-3385	30	6	are	be	AUX
iajs-3385	30	7	either	either	CCONJ
iajs-3385	30	8	narrow	narrow	ADJ
iajs-3385	30	9	-	-	PUNCT
iajs-3385	30	10	spectrum	spectrum	NOUN
iajs-3385	30	11	(	(	PUNCT
iajs-3385	30	12	metronidazole	metronidazole	NOUN
iajs-3385	30	13	)	)	PUNCT
iajs-3385	30	14	or	or	CCONJ
iajs-3385	30	15	broad	broad	ADJ
iajs-3385	30	16	-	-	PUNCT
iajs-3385	30	17	spectrum	spectrum	NOUN
iajs-3385	30	18	(	(	PUNCT
iajs-3385	30	19	levofloxacin	levofloxacin	PROPN
iajs-3385	30	20	,	,	PUNCT
iajs-3385	30	21	rifampicin	rifampicin	VERB
iajs-3385	30	22	,	,	PUNCT
iajs-3385	30	23	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	30	24	)	)	PUNCT
iajs-3385	30	25	.	.	PUNCT
iajs-3385	31	1	generally	generally	ADV
iajs-3385	31	2	,	,	PUNCT
iajs-3385	31	3	a	a	DET
iajs-3385	31	4	narrow	narrow	ADJ
iajs-3385	31	5	-	-	PUNCT
iajs-3385	31	6	spectrum	spectrum	NOUN
iajs-3385	31	7	antibiotic	antibiotic	NOUN
iajs-3385	31	8	is	be	AUX
iajs-3385	31	9	favored	favor	VERB
iajs-3385	31	10	over	over	ADP
iajs-3385	31	11	a	a	DET
iajs-3385	31	12	broad	broad	ADJ
iajs-3385	31	13	-	-	PUNCT
iajs-3385	31	14	spectrum	spectrum	NOUN
iajs-3385	31	15	antibiotic	antibiotic	NOUN
iajs-3385	31	16	,	,	PUNCT
iajs-3385	31	17	which	which	PRON
iajs-3385	31	18	is	be	AUX
iajs-3385	31	19	ideal	ideal	ADJ
iajs-3385	31	20	.	.	PUNCT
iajs-3385	32	1	this	this	PRON
iajs-3385	32	2	is	be	AUX
iajs-3385	32	3	because	because	SCONJ
iajs-3385	32	4	narrow	narrow	ADJ
iajs-3385	32	5	-	-	PUNCT
iajs-3385	32	6	spectrum	spectrum	NOUN
iajs-3385	32	7	antibiotics	antibiotic	NOUN
iajs-3385	32	8	are	be	AUX
iajs-3385	32	9	less	less	ADV
iajs-3385	32	10	likely	likely	ADJ
iajs-3385	32	11	to	to	PART
iajs-3385	32	12	result	result	VERB
iajs-3385	32	13	in	in	ADP
iajs-3385	32	14	superinfections	superinfection	NOUN
iajs-3385	32	15	than	than	ADP
iajs-3385	32	16	broadspectrum	broadspectrum	NOUN
iajs-3385	32	17	antibiotics	antibiotic	NOUN
iajs-3385	32	18	.	.	PUNCT
iajs-3385	33	1	after	after	ADV
iajs-3385	33	2	all	all	ADV
iajs-3385	33	3	,	,	PUNCT
iajs-3385	33	4	they	they	PRON
iajs-3385	33	5	do	do	AUX
iajs-3385	33	6	not	not	PART
iajs-3385	33	7	entirely	entirely	ADV
iajs-3385	33	8	eradicate	eradicate	VERB
iajs-3385	33	9	the	the	DET
iajs-3385	33	10	body	body	NOUN
iajs-3385	33	11	's	's	PART
iajs-3385	33	12	usual	usual	ADJ
iajs-3385	33	13	microbes	microbe	NOUN
iajs-3385	33	14	.	.	PUNCT
iajs-3385	34	1	bacteria	bacteria	NOUN
iajs-3385	34	2	become	become	VERB
iajs-3385	34	3	less	less	ADV
iajs-3385	34	4	immune	immune	ADJ
iajs-3385	34	5	as	as	ADP
iajs-3385	34	6	a	a	DET
iajs-3385	34	7	result	result	NOUN
iajs-3385	34	8	(	(	PUNCT
iajs-3385	34	9	8)	8)	NUM
iajs-3385	34	10	.	.	PUNCT
iajs-3385	35	1	a	a	DET
iajs-3385	35	2	variety	variety	NOUN
iajs-3385	35	3	of	of	ADP
iajs-3385	35	4	skeletal	skeletal	ADJ
iajs-3385	35	5	antibiotics	antibiotic	NOUN
iajs-3385	35	6	display	display	VERB
iajs-3385	35	7	various	various	ADJ
iajs-3385	35	8	curative	curative	ADJ
iajs-3385	35	9	behaviors	behavior	NOUN
iajs-3385	35	10	.	.	PUNCT
iajs-3385	36	1	as	as	ADP
iajs-3385	36	2	a	a	DET
iajs-3385	36	3	result	result	NOUN
iajs-3385	36	4	,	,	PUNCT
iajs-3385	36	5	it	it	PRON
iajs-3385	36	6	is	be	AUX
iajs-3385	36	7	crucial	crucial	ADJ
iajs-3385	36	8	to	to	PART
iajs-3385	36	9	categorize	categorize	VERB
iajs-3385	36	10	antibiotics	antibiotic	NOUN
iajs-3385	36	11	according	accord	VERB
iajs-3385	36	12	to	to	ADP
iajs-3385	36	13	their	their	PRON
iajs-3385	36	14	molecular	molecular	ADJ
iajs-3385	36	15	structure	structure	NOUN
iajs-3385	36	16	.	.	PUNCT
iajs-3385	37	1	this	this	DET
iajs-3385	37	2	classification	classification	NOUN
iajs-3385	37	3	is	be	AUX
iajs-3385	37	4	also	also	ADV
iajs-3385	37	5	vital	vital	ADJ
iajs-3385	37	6	because	because	SCONJ
iajs-3385	37	7	comparable	comparable	ADJ
iajs-3385	37	8	structural	structural	ADJ
iajs-3385	37	9	units	unit	NOUN
iajs-3385	37	10	share	share	VERB
iajs-3385	37	11	similar	similar	ADJ
iajs-3385	37	12	toxicity	toxicity	NOUN
iajs-3385	37	13	,	,	PUNCT
iajs-3385	37	14	potency	potency	NOUN
iajs-3385	37	15	,	,	PUNCT
iajs-3385	37	16	and	and	CCONJ
iajs-3385	37	17	other	other	ADJ
iajs-3385	37	18	related	related	ADJ
iajs-3385	37	19	properties	property	NOUN
iajs-3385	37	20	.	.	PUNCT
iajs-3385	38	1	antibiotics	antibiotic	NOUN
iajs-3385	38	2	are	be	AUX
iajs-3385	38	3	typically	typically	ADV
iajs-3385	38	4	split	split	VERB
iajs-3385	38	5	structurally	structurally	ADV
iajs-3385	38	6	into	into	ADP
iajs-3385	38	7	β	β	NOUN
iajs-3385	38	8	-	-	NOUN
iajs-3385	38	9	lactams	lactam	NOUN
iajs-3385	38	10	(	(	PUNCT
iajs-3385	38	11	group	group	NOUN
iajs-3385	38	12	a	a	NOUN
iajs-3385	38	13	)	)	PUNCT
iajs-3385	38	14	and	and	CCONJ
iajs-3385	38	15	aminoglycosides	aminoglycoside	NOUN
iajs-3385	38	16	(	(	PUNCT
iajs-3385	38	17	group	group	NOUN
iajs-3385	38	18	b	b	NOUN
iajs-3385	38	19	)	)	PUNCT
iajs-3385	38	20	.	.	PUNCT
iajs-3385	39	1	however	however	ADV
iajs-3385	39	2	,	,	PUNCT
iajs-3385	39	3	β	β	NOUN
iajs-3385	39	4	-	-	NOUN
iajs-3385	39	5	lactam	lactam	NOUN
iajs-3385	39	6	/	/	SYM
iajs-3385	39	7	β	β	NOUN
iajs-3385	39	8	-	-	NOUN
iajs-3385	39	9	lactamase	lactamase	ADJ
iajs-3385	39	10	,	,	PUNCT
iajs-3385	39	11	β	β	NOUN
iajs-3385	39	12	-	-	PUNCT
iajs-3385	39	13	lactams	lactam	NOUN
iajs-3385	39	14	inhibitor	inhibitor	NOUN
iajs-3385	39	15	mixtures	mixture	NOUN
iajs-3385	39	16	,	,	PUNCT
iajs-3385	39	17	amine	amine	ADJ
iajs-3385	39	18	glycosides	glycoside	NOUN
iajs-3385	39	19	,	,	PUNCT
iajs-3385	39	20	quinolones	quinolone	NOUN
iajs-3385	39	21	,	,	PUNCT
iajs-3385	39	22	macrolides	macrolide	NOUN
iajs-3385	39	23	,	,	PUNCT
iajs-3385	39	24	and	and	CCONJ
iajs-3385	39	25	fluoroquinolones	fluoroquinolone	NOUN
iajs-3385	39	26	are	be	AUX
iajs-3385	39	27	more	more	ADV
iajs-3385	39	28	specific	specific	ADJ
iajs-3385	39	29	antibiotic	antibiotic	ADJ
iajs-3385	39	30	categories	category	NOUN
iajs-3385	39	31	(	(	PUNCT
iajs-3385	39	32	5	5	NUM
iajs-3385	39	33	)	)	PUNCT
iajs-3385	39	34	.	.	PUNCT
iajs-3385	40	1	function	function	NOUN
iajs-3385	40	2	refers	refer	VERB
iajs-3385	40	3	to	to	ADP
iajs-3385	40	4	a	a	DET
iajs-3385	40	5	substance	substance	NOUN
iajs-3385	40	6	's	's	PART
iajs-3385	40	7	mode	mode	NOUN
iajs-3385	40	8	of	of	ADP
iajs-3385	40	9	operation	operation	NOUN
iajs-3385	40	10	or	or	CCONJ
iajs-3385	40	11	mode	mode	NOUN
iajs-3385	40	12	of	of	ADP
iajs-3385	40	13	activity	activity	NOUN
iajs-3385	40	14	.	.	PUNCT
iajs-3385	41	1	one	one	NUM
iajs-3385	41	2	of	of	ADP
iajs-3385	41	3	the	the	DET
iajs-3385	41	4	most	most	ADV
iajs-3385	41	5	crucial	crucial	ADJ
iajs-3385	41	6	aspects	aspect	NOUN
iajs-3385	41	7	of	of	ADP
iajs-3385	41	8	antimicrobial	antimicrobial	ADJ
iajs-3385	41	9	agents	agent	NOUN
iajs-3385	41	10	is	be	AUX
iajs-3385	41	11	this	this	PRON
iajs-3385	41	12	.	.	PUNCT
iajs-3385	42	1	cell	cell	NOUN
iajs-3385	42	2	membrane	membrane	NOUN
iajs-3385	42	3	function	function	NOUN
iajs-3385	42	4	,	,	PUNCT
iajs-3385	42	5	cell	cell	NOUN
iajs-3385	42	6	wall	wall	NOUN
iajs-3385	42	7	synthesis	synthesis	PROPN
iajs-3385	42	8	,	,	PUNCT
iajs-3385	42	9	nucleic	nucleic	ADJ
iajs-3385	42	10	acid	acid	NOUN
iajs-3385	42	11	synthesis	synthesis	NOUN
iajs-3385	42	12	,	,	PUNCT
iajs-3385	42	13	protein	protein	NOUN
iajs-3385	42	14	synthesis	synthesis	NOUN
iajs-3385	42	15	,	,	PUNCT
iajs-3385	42	16	etc	etc	X
iajs-3385	42	17	.	.	X
iajs-3385	42	18	,	,	PUNCT
iajs-3385	42	19	are	be	AUX
iajs-3385	42	20	the	the	DET
iajs-3385	42	21	primary	primary	ADJ
iajs-3385	42	22	processes	process	NOUN
iajs-3385	42	23	or	or	CCONJ
iajs-3385	42	24	activities	activity	NOUN
iajs-3385	42	25	in	in	ADP
iajs-3385	42	26	bacterial	bacterial	ADJ
iajs-3385	42	27	growth	growth	NOUN
iajs-3385	42	28	.	.	PUNCT
iajs-3385	43	1	antibiotics	antibiotic	NOUN
iajs-3385	43	2	can	can	AUX
iajs-3385	43	3	be	be	AUX
iajs-3385	43	4	used	use	VERB
iajs-3385	43	5	to	to	PART
iajs-3385	43	6	treat	treat	VERB
iajs-3385	43	7	any	any	DET
iajs-3385	43	8	one	one	NUM
iajs-3385	43	9	of	of	ADP
iajs-3385	43	10	these	these	DET
iajs-3385	43	11	mechanisms	mechanism	NOUN
iajs-3385	43	12	.	.	PUNCT
iajs-3385	44	1	antibiotics	antibiotic	NOUN
iajs-3385	44	2	can	can	AUX
iajs-3385	44	3	be	be	AUX
iajs-3385	44	4	divided	divide	VERB
iajs-3385	44	5	into	into	ADP
iajs-3385	44	6	four	four	NUM
iajs-3385	44	7	categories	category	NOUN
iajs-3385	44	8	based	base	VERB
iajs-3385	44	9	on	on	ADP
iajs-3385	44	10	how	how	SCONJ
iajs-3385	44	11	they	they	PRON
iajs-3385	44	12	interfere	interfere	VERB
iajs-3385	44	13	with	with	ADP
iajs-3385	44	14	or	or	CCONJ
iajs-3385	44	15	disrupt	disrupt	VERB
iajs-3385	44	16	these	these	DET
iajs-3385	44	17	processes	process	NOUN
iajs-3385	44	18	:	:	PUNCT
iajs-3385	44	19	inhibitors	inhibitor	NOUN
iajs-3385	44	20	of	of	ADP
iajs-3385	44	21	cell	cell	NOUN
iajs-3385	44	22	wall	wall	NOUN
iajs-3385	44	23	synthesis	synthesis	NOUN
iajs-3385	44	24	,	,	PUNCT
iajs-3385	44	25	protein	protein	NOUN
iajs-3385	44	26	synthesis	synthesis	NOUN
iajs-3385	44	27	inhibitors	inhibitor	NOUN
iajs-3385	44	28	(	(	PUNCT
iajs-3385	44	29	metronidazole	metronidazole	NOUN
iajs-3385	44	30	,	,	PUNCT
iajs-3385	44	31	etc	etc	X
iajs-3385	44	32	.	.	X
iajs-3385	44	33	)	)	PUNCT
iajs-3385	44	34	,	,	PUNCT
iajs-3385	44	35	membrane	membrane	NOUN
iajs-3385	44	36	function	function	NOUN
iajs-3385	44	37	inhibitors	inhibitor	NOUN
iajs-3385	44	38	,	,	PUNCT
iajs-3385	44	39	and	and	CCONJ
iajs-3385	44	40	nucleic	nucleic	ADJ
iajs-3385	44	41	acid	acid	NOUN
iajs-3385	44	42	synthesis	synthesis	NOUN
iajs-3385	44	43	inhibitors	inhibitor	NOUN
iajs-3385	44	44	(	(	PUNCT
iajs-3385	44	45	levofloxacin	levofloxacin	PROPN
iajs-3385	44	46	,	,	PUNCT
iajs-3385	44	47	rifampicin	rifampicin	VERB
iajs-3385	44	48	,	,	PUNCT
iajs-3385	44	49	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	44	50	,	,	PUNCT
iajs-3385	44	51	etc	etc	X
iajs-3385	44	52	.	.	X
iajs-3385	44	53	)	)	PUNCT
iajs-3385	45	1	(	(	PUNCT
iajs-3385	45	2	9	9	NUM
iajs-3385	45	3	)	)	PUNCT
iajs-3385	45	4	.	.	PUNCT
iajs-3385	46	1	this	this	DET
iajs-3385	46	2	study	study	NOUN
iajs-3385	46	3	aims	aim	VERB
iajs-3385	46	4	to	to	PART
iajs-3385	46	5	investigate	investigate	VERB
iajs-3385	46	6	the	the	DET
iajs-3385	46	7	simultaneous	simultaneous	ADJ
iajs-3385	46	8	analysis	analysis	NOUN
iajs-3385	46	9	of	of	ADP
iajs-3385	46	10	specific	specific	ADJ
iajs-3385	46	11	antibacterial	antibacterial	ADJ
iajs-3385	46	12	spectrophotometrically	spectrophotometrically	ADV
iajs-3385	46	13	.	.	PUNCT
iajs-3385	47	1	ihjpas	ihjpas	PROPN
iajs-3385	47	2	.	.	PUNCT
iajs-3385	48	1	2025	2025	NUM
iajs-3385	48	2	,	,	PUNCT
iajs-3385	48	3	38(2	38(2	NUM
iajs-3385	48	4	)	)	PUNCT
iajs-3385	48	5	206	206	NUM
iajs-3385	48	6	2	2	NUM
iajs-3385	48	7	.	.	PUNCT
iajs-3385	48	8	materials	material	NOUN
iajs-3385	48	9	and	and	CCONJ
iajs-3385	48	10	methods	method	NOUN
iajs-3385	48	11	2.1	2.1	NUM
iajs-3385	48	12	.	.	PUNCT
iajs-3385	49	1	levofloxacin	levofloxacin	PROPN
iajs-3385	49	2	levofloxacin	levofloxacin	PROPN
iajs-3385	49	3	(	(	PUNCT
iajs-3385	49	4	figure	figure	NOUN
iajs-3385	49	5	1a	1a	NOUN
iajs-3385	49	6	)	)	PUNCT
iajs-3385	49	7	,	,	PUNCT
iajs-3385	49	8	chemically	chemically	ADV
iajs-3385	49	9	is	be	AUX
iajs-3385	49	10	7h	7h	NUM
iajs-3385	49	11	-	-	PUNCT
iajs-3385	49	12	pyrido[1,2,3	pyrido[1,2,3	NOUN
iajs-3385	49	13	-	-	PUNCT
iajs-3385	49	14	de]-1,4	de]-1,4	ADV
iajs-3385	49	15	-	-	PUNCT
iajs-3385	49	16	benzoxazine-6	benzoxazine-6	VERB
iajs-3385	49	17	-	-	PUNCT
iajs-3385	49	18	carboxylic	carboxylic	ADJ
iajs-3385	49	19	acid	acid	NOUN
iajs-3385	49	20	,	,	PUNCT
iajs-3385	49	21	9	9	NUM
iajs-3385	49	22	-	-	PUNCT
iajs-3385	49	23	fluoro-2,3	fluoro-2,3	NOUN
iajs-3385	49	24	-	-	PUNCT
iajs-3385	49	25	dihydro-3	dihydro-3	VERB
iajs-3385	49	26	-	-	PUNCT
iajs-3385	49	27	methyl-10-(4	methyl-10-(4	NOUN
iajs-3385	49	28	-	-	PUNCT
iajs-3385	49	29	methyl-1	methyl-1	NOUN
iajs-3385	49	30	-	-	PUNCT
iajs-3385	49	31	piperazinyl)-7	piperazinyl)-7	NOUN
iajs-3385	49	32	-	-	PUNCT
iajs-3385	49	33	oxo	oxo	NOUN
iajs-3385	49	34	-	-	PUNCT
iajs-3385	49	35	hydrate	hydrate	NOUN
iajs-3385	49	36	(	(	PUNCT
iajs-3385	49	37	2:1	2:1	NUM
iajs-3385	49	38	)	)	PUNCT
iajs-3385	49	39	,	,	PUNCT
iajs-3385	49	40	(	(	PUNCT
iajs-3385	49	41	s)-	s)-	NOUN
iajs-3385	49	42	;	;	PUNCT
iajs-3385	49	43	(	(	PUNCT
iajs-3385	49	44	−)(s)-9	−)(s)-9	NOUN
iajs-3385	49	45	-	-	PUNCT
iajs-3385	49	46	fluoro-2,3	fluoro-2,3	NOUN
iajs-3385	49	47	-	-	PUNCT
iajs-3385	49	48	dihydro-3	dihydro-3	PROPN
iajs-3385	49	49	methyl-10(4	methyl-10(4	PROPN
iajs-3385	49	50	-	-	PUNCT
iajs-3385	49	51	methyl-1	methyl-1	NOUN
iajs-3385	49	52	-	-	PUNCT
iajs-3385	49	53	piperazinyl)7	piperazinyl)7	NOUN
iajs-3385	49	54	-	-	PUNCT
iajs-3385	49	55	oxo-7h	oxo-7h	NOUN
iajs-3385	49	56	-	-	PUNCT
iajs-3385	49	57	pyrido	pyrido	NOUN
iajs-3385	50	1	[	[	X
iajs-3385	50	2	1,2,3	1,2,3	NUM
iajs-3385	50	3	-	-	SYM
iajs-3385	50	4	de	de	X
iajs-3385	50	5	]	]	X
iajs-3385	50	6	1,4	1,4	NUM
iajs-3385	50	7	-	-	PUNCT
iajs-3385	50	8	benzoxazine-6	benzoxazine-6	VERB
iajs-3385	50	9	-	-	PUNCT
iajs-3385	50	10	carboxylic	carboxylic	ADJ
iajs-3385	50	11	acid	acid	NOUN
iajs-3385	50	12	,	,	PUNCT
iajs-3385	50	13	hemihydrate	hemihydrate	NOUN
iajs-3385	50	14	(	(	PUNCT
iajs-3385	50	15	10	10	NUM
iajs-3385	50	16	)	)	PUNCT
iajs-3385	50	17	.	.	PUNCT
iajs-3385	51	1	it	it	PRON
iajs-3385	51	2	is	be	AUX
iajs-3385	51	3	a	a	DET
iajs-3385	51	4	third	third	ADJ
iajs-3385	51	5	-	-	PUNCT
iajs-3385	51	6	generation	generation	NOUN
iajs-3385	51	7	broad	broad	ADJ
iajs-3385	51	8	-	-	PUNCT
iajs-3385	51	9	spectrum	spectrum	NOUN
iajs-3385	51	10	fluoroquinolone	fluoroquinolone	NOUN
iajs-3385	51	11	antibiotic	antibiotic	NOUN
iajs-3385	51	12	used	use	VERB
iajs-3385	51	13	to	to	PART
iajs-3385	51	14	treat	treat	VERB
iajs-3385	51	15	bacterial	bacterial	ADJ
iajs-3385	51	16	infections	infection	NOUN
iajs-3385	51	17	such	such	ADJ
iajs-3385	51	18	as	as	ADP
iajs-3385	51	19	acute	acute	ADJ
iajs-3385	51	20	bacterial	bacterial	ADJ
iajs-3385	51	21	sinusitis	sinusitis	NOUN
iajs-3385	51	22	,	,	PUNCT
iajs-3385	51	23	acute	acute	ADJ
iajs-3385	51	24	bacterial	bacterial	ADJ
iajs-3385	51	25	exacerbation	exacerbation	NOUN
iajs-3385	51	26	of	of	ADP
iajs-3385	51	27	chronic	chronic	ADJ
iajs-3385	51	28	bronchitis	bronchitis	NOUN
iajs-3385	51	29	,	,	PUNCT
iajs-3385	51	30	acute	acute	ADJ
iajs-3385	51	31	bacterial	bacterial	ADJ
iajs-3385	51	32	prostatitis	prostatitis	NOUN
iajs-3385	51	33	,	,	PUNCT
iajs-3385	51	34	and	and	CCONJ
iajs-3385	51	35	acute	acute	PROPN
iajs-3385	51	36	pyelonephritis	pyelonephritis	PROPN
iajs-3385	51	37	.	.	PUNCT
iajs-3385	52	1	levofloxacin	levofloxacin	PROPN
iajs-3385	52	2	was	be	AUX
iajs-3385	52	3	patented	patent	VERB
iajs-3385	52	4	in	in	ADP
iajs-3385	52	5	1987	1987	NUM
iajs-3385	52	6	and	and	CCONJ
iajs-3385	52	7	subsequently	subsequently	ADV
iajs-3385	52	8	in	in	ADP
iajs-3385	52	9	the	the	DET
iajs-3385	52	10	united	united	PROPN
iajs-3385	52	11	states	states	PROPN
iajs-3385	52	12	in	in	ADP
iajs-3385	52	13	1996	1996	NUM
iajs-3385	52	14	for	for	ADP
iajs-3385	52	15	treating	treat	VERB
iajs-3385	52	16	hospital	hospital	NOUN
iajs-3385	52	17	-	-	PUNCT
iajs-3385	52	18	acquired	acquire	VERB
iajs-3385	52	19	pneumonia	pneumonia	NOUN
iajs-3385	52	20	,	,	PUNCT
iajs-3385	52	21	community	community	NOUN
iajs-3385	52	22	-	-	PUNCT
iajs-3385	52	23	acquired	acquire	VERB
iajs-3385	52	24	pneumonia	pneumonia	NOUN
iajs-3385	52	25	,	,	PUNCT
iajs-3385	52	26	urinary	urinary	ADJ
iajs-3385	52	27	tract	tract	NOUN
iajs-3385	52	28	infections	infection	NOUN
iajs-3385	52	29	,	,	PUNCT
iajs-3385	52	30	and	and	CCONJ
iajs-3385	52	31	skin	skin	NOUN
iajs-3385	52	32	or	or	CCONJ
iajs-3385	52	33	skin	skin	NOUN
iajs-3385	52	34	structure	structure	NOUN
iajs-3385	52	35	infections	infection	NOUN
iajs-3385	52	36	.	.	PUNCT
iajs-3385	53	1	also	also	ADV
iajs-3385	53	2	,	,	PUNCT
iajs-3385	53	3	it	it	PRON
iajs-3385	53	4	is	be	AUX
iajs-3385	53	5	used	use	VERB
iajs-3385	53	6	to	to	PART
iajs-3385	53	7	prevent	prevent	VERB
iajs-3385	53	8	and	and	CCONJ
iajs-3385	53	9	treat	treat	VERB
iajs-3385	53	10	plaque	plaque	NOUN
iajs-3385	53	11	caused	cause	VERB
iajs-3385	53	12	by	by	ADP
iajs-3385	53	13	yersinia	yersinia	NOUN
iajs-3385	53	14	pasties	pasty	NOUN
iajs-3385	53	15	.	.	PUNCT
iajs-3385	54	1	levofloxacin	levofloxacin	PROPN
iajs-3385	54	2	was	be	AUX
iajs-3385	54	3	fda	fda	PROPN
iajs-3385	54	4	-	-	PUNCT
iajs-3385	54	5	approved	approve	VERB
iajs-3385	54	6	to	to	PART
iajs-3385	54	7	control	control	VERB
iajs-3385	54	8	the	the	DET
iajs-3385	54	9	progression	progression	NOUN
iajs-3385	54	10	of	of	ADP
iajs-3385	54	11	inhaled	inhaled	ADJ
iajs-3385	54	12	anthrax	anthrax	NOUN
iajs-3385	54	13	(	(	PUNCT
iajs-3385	54	14	11,12	11,12	NUM
iajs-3385	54	15	)	)	PUNCT
iajs-3385	54	16	.	.	PUNCT
iajs-3385	55	1	2.2	2.2	NUM
iajs-3385	55	2	.	.	PUNCT
iajs-3385	55	3	metronidazole	metronidazole	NOUN
iajs-3385	55	4	as	as	ADP
iajs-3385	55	5	an	an	DET
iajs-3385	55	6	antiprotozoal	antiprotozoal	NOUN
iajs-3385	55	7	,	,	PUNCT
iajs-3385	55	8	antiamebic	antiamebic	ADJ
iajs-3385	55	9	,	,	PUNCT
iajs-3385	55	10	and	and	CCONJ
iajs-3385	55	11	antibacterial	antibacterial	ADJ
iajs-3385	55	12	medication	medication	NOUN
iajs-3385	55	13	,	,	PUNCT
iajs-3385	55	14	metronidazole	metronidazole	NOUN
iajs-3385	55	15	with	with	ADP
iajs-3385	55	16	chemical	chemical	ADJ
iajs-3385	55	17	formula	formula	NOUN
iajs-3385	55	18	(	(	PUNCT
iajs-3385	55	19	2-(2	2-(2	NOUN
iajs-3385	55	20	-	-	PUNCT
iajs-3385	55	21	methyl-5	methyl-5	NOUN
iajs-3385	55	22	-	-	PUNCT
iajs-3385	55	23	nitro-1h	nitro-1h	NOUN
iajs-3385	55	24	-	-	PUNCT
iajs-3385	55	25	imidazol-1	imidazol-1	NOUN
iajs-3385	55	26	-	-	PUNCT
iajs-3385	55	27	yl	yl	NOUN
iajs-3385	55	28	)	)	PUNCT
iajs-3385	55	29	ethanol	ethanol	NOUN
iajs-3385	55	30	)	)	PUNCT
iajs-3385	55	31	(	(	PUNCT
iajs-3385	55	32	13	13	X
iajs-3385	55	33	)	)	PUNCT
iajs-3385	55	34	figure	figure	NOUN
iajs-3385	55	35	1b	1b	NUM
iajs-3385	55	36	,	,	PUNCT
iajs-3385	55	37	is	be	AUX
iajs-3385	55	38	a	a	DET
iajs-3385	55	39	bactericidal	bactericidal	ADJ
iajs-3385	55	40	synthetic	synthetic	ADJ
iajs-3385	55	41	derivative	derivative	NOUN
iajs-3385	55	42	of	of	ADP
iajs-3385	55	43	azomycin	azomycin	PROPN
iajs-3385	55	44	.	.	PUNCT
iajs-3385	56	1	due	due	ADP
iajs-3385	56	2	to	to	ADP
iajs-3385	56	3	its	its	PRON
iajs-3385	56	4	effectiveness	effectiveness	NOUN
iajs-3385	56	5	against	against	ADP
iajs-3385	56	6	anaerobic	anaerobic	ADJ
iajs-3385	56	7	bacteria	bacteria	NOUN
iajs-3385	56	8	and	and	CCONJ
iajs-3385	56	9	protozoa	protozoan	NOUN
iajs-3385	56	10	,	,	PUNCT
iajs-3385	56	11	it	it	PRON
iajs-3385	56	12	has	have	VERB
iajs-3385	56	13	a	a	DET
iajs-3385	56	14	wide	wide	ADJ
iajs-3385	56	15	range	range	NOUN
iajs-3385	56	16	of	of	ADP
iajs-3385	56	17	applications	application	NOUN
iajs-3385	56	18	.	.	PUNCT
iajs-3385	57	1	in	in	ADP
iajs-3385	57	2	the	the	DET
iajs-3385	57	3	human	human	ADJ
iajs-3385	57	4	liver	liver	NOUN
iajs-3385	57	5	,	,	PUNCT
iajs-3385	57	6	metronidazole	metronidazole	NOUN
iajs-3385	57	7	is	be	AUX
iajs-3385	57	8	converted	convert	VERB
iajs-3385	57	9	into	into	ADP
iajs-3385	57	10	more	more	ADJ
iajs-3385	57	11	polar	polar	ADJ
iajs-3385	57	12	metabolites	metabolite	NOUN
iajs-3385	57	13	.	.	PUNCT
iajs-3385	58	1	metronidazole	metronidazole	NOUN
iajs-3385	58	2	is	be	AUX
iajs-3385	58	3	the	the	DET
iajs-3385	58	4	best	good	ADJ
iajs-3385	58	5	option	option	NOUN
iajs-3385	58	6	for	for	ADP
iajs-3385	58	7	colitis	colitis	NOUN
iajs-3385	58	8	brought	bring	VERB
iajs-3385	58	9	on	on	ADP
iajs-3385	58	10	by	by	ADP
iajs-3385	58	11	clostridium	clostridium	NOUN
iajs-3385	58	12	difficile	difficile	NOUN
iajs-3385	58	13	(	(	PUNCT
iajs-3385	58	14	14–16	14–16	NUM
iajs-3385	58	15	)	)	PUNCT
iajs-3385	58	16	.	.	PUNCT
iajs-3385	59	1	2.3	2.3	NUM
iajs-3385	59	2	.	.	PUNCT
iajs-3385	59	3	rifampicin	rifampicin	VERB
iajs-3385	59	4	rifampicin	rifampicin	NOUN
iajs-3385	59	5	(	(	PUNCT
iajs-3385	59	6	figure	figure	NOUN
iajs-3385	59	7	1c	1c	NOUN
iajs-3385	59	8	)	)	PUNCT
iajs-3385	59	9	is	be	AUX
iajs-3385	59	10	a	a	DET
iajs-3385	59	11	semi	semi	ADJ
iajs-3385	59	12	-	-	ADJ
iajs-3385	59	13	synthetic	synthetic	ADJ
iajs-3385	59	14	antibiotic	antibiotic	ADJ
iajs-3385	59	15	derived	derive	VERB
iajs-3385	59	16	from	from	ADP
iajs-3385	59	17	rifamycin	rifamycin	PROPN
iajs-3385	59	18	sv	sv	PROPN
iajs-3385	59	19	and	and	CCONJ
iajs-3385	59	20	is	be	AUX
iajs-3385	59	21	chemically	chemically	ADV
iajs-3385	59	22	(	(	PUNCT
iajs-3385	59	23	(	(	PUNCT
iajs-3385	59	24	2s,12z,14e,16s,17s,18r,19r,20r,21s,22r,23s,24e)5,6,9,17,19	2s,12z,14e,16s,17s,18r,19r,20r,21s,22r,23s,24e)5,6,9,17,19	NUM
iajs-3385	59	25	-	-	ADJ
iajs-3385	59	26	pentahydroxy23	pentahydroxy23	ADJ
iajs-3385	59	27	-	-	PUNCT
iajs-3385	59	28	methoxy-2,4,12,16,18,20,22heptamethyl-8-[[(4	methoxy-2,4,12,16,18,20,22heptamethyl-8-[[(4	NOUN
iajs-3385	59	29	-	-	PUNCT
iajs-3385	59	30	methylpiperazin-1	methylpiperazin-1	NOUN
iajs-3385	59	31	-	-	PUNCT
iajs-3385	59	32	yl	yl	NOUN
iajs-3385	59	33	)	)	PUNCT
iajs-3385	59	34	imino	imino	NOUN
iajs-3385	59	35	]	]	PUNCT
iajs-3385	59	36	methyl]-1,11dioxo-1,2	methyl]-1,11dioxo-1,2	ADJ
iajs-3385	59	37	-	-	PUNCT
iajs-3385	59	38	dihydro-2,7-(epoxypentadeca	dihydro-2,7-(epoxypentadeca	NOUN
iajs-3385	59	39	{	{	PUNCT
iajs-3385	59	40	1,11,13	1,11,13	NUM
iajs-3385	59	41	}	}	PUNCT
iajs-3385	59	42	trieneimino	trieneimino	NOUN
iajs-3385	59	43	)	)	PUNCT
iajs-3385	59	44	naphtho[2,1	naphtho[2,1	PROPN
iajs-3385	59	45	-	-	PUNCT
iajs-3385	59	46	b	b	PROPN
iajs-3385	59	47	]	]	X
iajs-3385	59	48	furan-21	furan-21	PROPN
iajs-3385	59	49	-	-	PUNCT
iajs-3385	59	50	yl	yl	NOUN
iajs-3385	59	51	acetate	acetate	NOUN
iajs-3385	59	52	)	)	PUNCT
iajs-3385	59	53	)	)	PUNCT
iajs-3385	59	54	(	(	PUNCT
iajs-3385	59	55	13	13	X
iajs-3385	59	56	)	)	PUNCT
iajs-3385	59	57	active	active	ADJ
iajs-3385	59	58	in	in	ADP
iajs-3385	59	59	vitro	vitro	X
iajs-3385	59	60	against	against	ADP
iajs-3385	59	61	microbacteria	microbacteria	NOUN
iajs-3385	59	62	and	and	CCONJ
iajs-3385	59	63	gram	gram	NOUN
iajs-3385	59	64	-	-	PUNCT
iajs-3385	59	65	positive	positive	ADJ
iajs-3385	59	66	micro	micro	NOUN
iajs-3385	59	67	-	-	NOUN
iajs-3385	59	68	organisms	organism	NOUN
iajs-3385	59	69	.	.	PUNCT
iajs-3385	60	1	since	since	SCONJ
iajs-3385	60	2	its	its	PRON
iajs-3385	60	3	development	development	NOUN
iajs-3385	60	4	,	,	PUNCT
iajs-3385	60	5	it	it	PRON
iajs-3385	60	6	has	have	AUX
iajs-3385	60	7	been	be	AUX
iajs-3385	60	8	used	use	VERB
iajs-3385	60	9	in	in	ADP
iajs-3385	60	10	veterinary	veterinary	ADJ
iajs-3385	60	11	and	and	CCONJ
iajs-3385	60	12	human	human	ADJ
iajs-3385	60	13	medicine	medicine	NOUN
iajs-3385	60	14	to	to	PART
iajs-3385	60	15	treat	treat	VERB
iajs-3385	60	16	tuberculosis	tuberculosis	NOUN
iajs-3385	60	17	and	and	CCONJ
iajs-3385	60	18	other	other	ADJ
iajs-3385	60	19	mycobacterial	mycobacterial	ADJ
iajs-3385	60	20	infections	infection	NOUN
iajs-3385	60	21	(	(	PUNCT
iajs-3385	60	22	17,18	17,18	NUM
iajs-3385	60	23	)	)	PUNCT
iajs-3385	60	24	.	.	PUNCT
iajs-3385	61	1	2.4	2.4	NUM
iajs-3385	61	2	.	.	PUNCT
iajs-3385	61	3	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	61	4	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	61	5	is	be	AUX
iajs-3385	61	6	a	a	DET
iajs-3385	61	7	sulfonamide	sulfonamide	ADJ
iajs-3385	61	8	antibiotic	antibiotic	NOUN
iajs-3385	61	9	(	(	PUNCT
iajs-3385	61	10	figure	figure	NOUN
iajs-3385	61	11	1d	1d	NUM
iajs-3385	61	12	)	)	PUNCT
iajs-3385	61	13	with	with	ADP
iajs-3385	61	14	the	the	DET
iajs-3385	61	15	iupac	iupac	PROPN
iajs-3385	61	16	name	name	NOUN
iajs-3385	61	17	(	(	PUNCT
iajs-3385	61	18	4	4	NUM
iajs-3385	61	19	-	-	PUNCT
iajs-3385	61	20	amino	amino	NOUN
iajs-3385	61	21	-	-	PUNCT
iajs-3385	61	22	n(5methylisoxazol-3	n(5methylisoxazol-3	NOUN
iajs-3385	61	23	-	-	PUNCT
iajs-3385	61	24	yl)-benzenesulfonamide	yl)-benzenesulfonamide	NOUN
iajs-3385	61	25	)	)	PUNCT
iajs-3385	61	26	(	(	PUNCT
iajs-3385	61	27	13	13	NUM
iajs-3385	61	28	)	)	PUNCT
iajs-3385	61	29	.	.	PUNCT
iajs-3385	62	1	sulfamethoxazole	sulfamethoxazole	PROPN
iajs-3385	62	2	inhibits	inhibit	VERB
iajs-3385	62	3	bacterial	bacterial	ADJ
iajs-3385	62	4	dihydrofolate	dihydrofolate	ADJ
iajs-3385	62	5	synthesis	synthesis	NOUN
iajs-3385	62	6	due	due	ADP
iajs-3385	62	7	to	to	ADP
iajs-3385	62	8	its	its	PRON
iajs-3385	62	9	structural	structural	ADJ
iajs-3385	62	10	similarity	similarity	NOUN
iajs-3385	62	11	to	to	ADP
iajs-3385	62	12	para	para	NOUN
iajs-3385	62	13	-	-	PUNCT
iajs-3385	62	14	aminobenzoic	aminobenzoic	NOUN
iajs-3385	62	15	acid	acid	NOUN
iajs-3385	62	16	,	,	PUNCT
iajs-3385	62	17	an	an	DET
iajs-3385	62	18	endogenous	endogenous	ADJ
iajs-3385	62	19	substrate	substrate	NOUN
iajs-3385	62	20	that	that	PRON
iajs-3385	62	21	interferes	interfere	VERB
iajs-3385	62	22	with	with	ADP
iajs-3385	62	23	folate	folate	NOUN
iajs-3385	62	24	synthesis	synthesis	NOUN
iajs-3385	62	25	in	in	ADP
iajs-3385	62	26	susceptible	susceptible	ADJ
iajs-3385	62	27	bacteria	bacteria	NOUN
iajs-3385	62	28	(	(	PUNCT
iajs-3385	62	29	19	19	NUM
iajs-3385	62	30	)	)	PUNCT
iajs-3385	62	31	.	.	PUNCT
iajs-3385	63	1	the	the	DET
iajs-3385	63	2	emergence	emergence	NOUN
iajs-3385	63	3	of	of	ADP
iajs-3385	63	4	resistant	resistant	ADJ
iajs-3385	63	5	strains	strain	NOUN
iajs-3385	63	6	has	have	AUX
iajs-3385	63	7	limited	limit	VERB
iajs-3385	63	8	its	its	PRON
iajs-3385	63	9	use	use	NOUN
iajs-3385	63	10	,	,	PUNCT
iajs-3385	63	11	and	and	CCONJ
iajs-3385	63	12	it	it	PRON
iajs-3385	63	13	is	be	AUX
iajs-3385	63	14	now	now	ADV
iajs-3385	63	15	mainly	mainly	ADV
iajs-3385	63	16	used	use	VERB
iajs-3385	63	17	as	as	ADP
iajs-3385	63	18	a	a	DET
iajs-3385	63	19	mixture	mixture	NOUN
iajs-3385	63	20	with	with	ADP
iajs-3385	63	21	trimethoprim	trimethoprim	PROPN
iajs-3385	63	22	(	(	PUNCT
iajs-3385	63	23	20	20	NUM
iajs-3385	63	24	)	)	PUNCT
iajs-3385	63	25	.	.	PUNCT
iajs-3385	64	1	ihjpas	ihjpas	PROPN
iajs-3385	64	2	.	.	PUNCT
iajs-3385	65	1	2025	2025	NUM
iajs-3385	65	2	,	,	PUNCT
iajs-3385	65	3	38(2	38(2	NUM
iajs-3385	65	4	)	)	PUNCT
iajs-3385	65	5	207	207	NUM
iajs-3385	65	6	(	(	PUNCT
iajs-3385	65	7	a	a	NOUN
iajs-3385	65	8	)	)	PUNCT
iajs-3385	65	9	(	(	PUNCT
iajs-3385	65	10	b	b	X
iajs-3385	65	11	)	)	PUNCT
iajs-3385	65	12	(	(	PUNCT
iajs-3385	65	13	d	d	X
iajs-3385	65	14	)	)	PUNCT
iajs-3385	65	15	(	(	PUNCT
iajs-3385	65	16	c	c	X
iajs-3385	65	17	)	)	PUNCT
iajs-3385	65	18	figure	figure	NOUN
iajs-3385	65	19	1	1	NUM
iajs-3385	65	20	.	.	PUNCT
iajs-3385	65	21	structures	structure	NOUN
iajs-3385	65	22	formula	formula	NOUN
iajs-3385	65	23	of	of	ADP
iajs-3385	65	24	(	(	PUNCT
iajs-3385	65	25	a	a	PRON
iajs-3385	65	26	)	)	PUNCT
iajs-3385	65	27	levofloxacin	levofloxacin	PROPN
iajs-3385	65	28	,	,	PUNCT
iajs-3385	65	29	(	(	PUNCT
iajs-3385	65	30	b	b	NOUN
iajs-3385	65	31	)	)	PUNCT
iajs-3385	65	32	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	65	33	,	,	PUNCT
iajs-3385	65	34	(	(	PUNCT
iajs-3385	65	35	c	c	NOUN
iajs-3385	65	36	)	)	PUNCT
iajs-3385	65	37	metronidazole	metronidazole	NOUN
iajs-3385	65	38	and	and	CCONJ
iajs-3385	65	39	(	(	PUNCT
iajs-3385	65	40	d	d	NOUN
iajs-3385	65	41	)	)	PUNCT
iajs-3385	65	42	rifampicin	rifampicin	VERB
iajs-3385	65	43	.	.	PUNCT
iajs-3385	66	1	3	3	X
iajs-3385	66	2	.	.	NOUN
iajs-3385	66	3	results	result	NOUN
iajs-3385	66	4	and	and	CCONJ
iajs-3385	66	5	discussion	discussion	NOUN
iajs-3385	66	6	several	several	ADJ
iajs-3385	66	7	methods	method	NOUN
iajs-3385	66	8	have	have	AUX
iajs-3385	66	9	been	be	AUX
iajs-3385	66	10	introduced	introduce	VERB
iajs-3385	66	11	to	to	PART
iajs-3385	66	12	measure	measure	VERB
iajs-3385	66	13	levofloxacin	levofloxacin	NOUN
iajs-3385	66	14	,	,	PUNCT
iajs-3385	66	15	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	66	16	,	,	PUNCT
iajs-3385	66	17	metronidazole	metronidazole	NOUN
iajs-3385	66	18	,	,	PUNCT
iajs-3385	66	19	and	and	CCONJ
iajs-3385	66	20	rifampicin	rifampicin	VERB
iajs-3385	66	21	separately	separately	ADV
iajs-3385	66	22	or	or	CCONJ
iajs-3385	66	23	simultaneously	simultaneously	ADV
iajs-3385	66	24	.	.	PUNCT
iajs-3385	67	1	high	high	ADJ
iajs-3385	67	2	-	-	PUNCT
iajs-3385	67	3	performance	performance	NOUN
iajs-3385	67	4	liquid	liquid	ADJ
iajs-3385	67	5	chromatography	chromatography	NOUN
iajs-3385	67	6	,	,	PUNCT
iajs-3385	67	7	spectrophotometry	spectrophotometry	NOUN
iajs-3385	67	8	,	,	PUNCT
iajs-3385	67	9	capillary	capillary	ADJ
iajs-3385	67	10	electrophoresis	electrophoresis	NOUN
iajs-3385	67	11	,	,	PUNCT
iajs-3385	67	12	titration	titration	NOUN
iajs-3385	67	13	,	,	PUNCT
iajs-3385	67	14	spectrofluorometry	spectrofluorometry	NOUN
iajs-3385	67	15	,	,	PUNCT
iajs-3385	67	16	and	and	CCONJ
iajs-3385	67	17	voltammetry	voltammetry	NOUN
iajs-3385	67	18	are	be	AUX
iajs-3385	67	19	a	a	DET
iajs-3385	67	20	few	few	ADJ
iajs-3385	67	21	examples	example	NOUN
iajs-3385	67	22	.	.	PUNCT
iajs-3385	68	1	simultaneous	simultaneous	ADJ
iajs-3385	68	2	spectrophotometry	spectrophotometry	NOUN
iajs-3385	68	3	is	be	AUX
iajs-3385	68	4	the	the	DET
iajs-3385	68	5	most	most	ADV
iajs-3385	68	6	widely	widely	ADV
iajs-3385	68	7	used	use	VERB
iajs-3385	68	8	due	due	ADP
iajs-3385	68	9	to	to	ADP
iajs-3385	68	10	its	its	PRON
iajs-3385	68	11	simplicity	simplicity	NOUN
iajs-3385	68	12	,	,	PUNCT
iajs-3385	68	13	sensitivity	sensitivity	NOUN
iajs-3385	68	14	,	,	PUNCT
iajs-3385	68	15	and	and	CCONJ
iajs-3385	68	16	cost	cost	NOUN
iajs-3385	68	17	-	-	PUNCT
iajs-3385	68	18	effectiveness	effectiveness	NOUN
iajs-3385	68	19	(	(	PUNCT
iajs-3385	68	20	21–23	21–23	NUM
iajs-3385	68	21	)	)	PUNCT
iajs-3385	68	22	.	.	PUNCT
iajs-3385	69	1	the	the	DET
iajs-3385	69	2	primary	primary	ADJ
iajs-3385	69	3	application	application	NOUN
iajs-3385	69	4	of	of	ADP
iajs-3385	69	5	uv	uv	NOUN
iajs-3385	69	6	spectrophotometry	spectrophotometry	NOUN
iajs-3385	69	7	techniques	technique	NOUN
iajs-3385	69	8	is	be	AUX
iajs-3385	69	9	multicomponent	multicomponent	ADJ
iajs-3385	69	10	analysis	analysis	NOUN
iajs-3385	69	11	,	,	PUNCT
iajs-3385	69	12	which	which	PRON
iajs-3385	69	13	minimizes	minimize	VERB
iajs-3385	69	14	the	the	DET
iajs-3385	69	15	laborious	laborious	ADJ
iajs-3385	69	16	process	process	NOUN
iajs-3385	69	17	of	of	ADP
iajs-3385	69	18	isolating	isolate	VERB
iajs-3385	69	19	interferences	interference	NOUN
iajs-3385	69	20	,	,	PUNCT
iajs-3385	69	21	shortens	shorten	VERB
iajs-3385	69	22	analysis	analysis	NOUN
iajs-3385	69	23	time	time	NOUN
iajs-3385	69	24	and	and	CCONJ
iajs-3385	69	25	expenses	expense	NOUN
iajs-3385	69	26	,	,	PUNCT
iajs-3385	69	27	and	and	CCONJ
iajs-3385	69	28	enables	enable	VERB
iajs-3385	69	29	the	the	DET
iajs-3385	69	30	measurement	measurement	NOUN
iajs-3385	69	31	of	of	ADP
iajs-3385	69	32	more	more	ADJ
iajs-3385	69	33	analytes	analyte	NOUN
iajs-3385	69	34	(	(	PUNCT
iajs-3385	69	35	24	24	NUM
iajs-3385	69	36	)	)	PUNCT
iajs-3385	69	37	.	.	PUNCT
iajs-3385	70	1	the	the	DET
iajs-3385	70	2	foundation	foundation	NOUN
iajs-3385	70	3	of	of	ADP
iajs-3385	70	4	multicomponent	multicomponent	NOUN
iajs-3385	70	5	uv	uv	NOUN
iajs-3385	70	6	spectrophotometry	spectrophotometry	NOUN
iajs-3385	70	7	is	be	AUX
iajs-3385	70	8	the	the	DET
iajs-3385	70	9	documentation	documentation	NOUN
iajs-3385	70	10	of	of	ADP
iajs-3385	70	11	standard	standard	ADJ
iajs-3385	70	12	absorption	absorption	NOUN
iajs-3385	70	13	spectra	spectra	NOUN
iajs-3385	70	14	and	and	CCONJ
iajs-3385	70	15	its	its	PRON
iajs-3385	70	16	mathematical	mathematical	ADJ
iajs-3385	70	17	analysis	analysis	NOUN
iajs-3385	70	18	.	.	PUNCT
iajs-3385	71	1	the	the	DET
iajs-3385	71	2	benefits	benefit	NOUN
iajs-3385	71	3	of	of	ADP
iajs-3385	71	4	spectrophotometry	spectrophotometry	NOUN
iajs-3385	71	5	are	be	AUX
iajs-3385	71	6	as	as	SCONJ
iajs-3385	71	7	follows	follow	VERB
iajs-3385	71	8	:	:	PUNCT
iajs-3385	71	9	it	it	PRON
iajs-3385	71	10	is	be	AUX
iajs-3385	71	11	broadly	broadly	ADV
iajs-3385	71	12	applicable	applicable	ADJ
iajs-3385	71	13	to	to	ADP
iajs-3385	71	14	both	both	CCONJ
iajs-3385	71	15	organic	organic	ADJ
iajs-3385	71	16	and	and	CCONJ
iajs-3385	71	17	inorganic	inorganic	ADJ
iajs-3385	71	18	systems	system	NOUN
iajs-3385	71	19	while	while	SCONJ
iajs-3385	71	20	avoiding	avoid	VERB
iajs-3385	71	21	traditional	traditional	ADJ
iajs-3385	71	22	separation	separation	NOUN
iajs-3385	71	23	methods	method	NOUN
iajs-3385	71	24	,	,	PUNCT
iajs-3385	71	25	such	such	ADJ
iajs-3385	71	26	as	as	ADP
iajs-3385	71	27	extraction	extraction	NOUN
iajs-3385	71	28	,	,	PUNCT
iajs-3385	71	29	occupant	occupant	ADJ
iajs-3385	71	30	enrichment	enrichment	NOUN
iajs-3385	71	31	,	,	PUNCT
iajs-3385	71	32	and	and	CCONJ
iajs-3385	71	33	potentially	potentially	ADV
iajs-3385	71	34	essential	essential	ADJ
iajs-3385	71	35	purification	purification	NOUN
iajs-3385	71	36	steps	step	NOUN
iajs-3385	71	37	;	;	PUNCT
iajs-3385	71	38	spectral	spectral	ADJ
iajs-3385	71	39	data	datum	NOUN
iajs-3385	71	40	acquisition	acquisition	NOUN
iajs-3385	71	41	is	be	AUX
iajs-3385	71	42	easy	easy	ADJ
iajs-3385	71	43	to	to	PART
iajs-3385	71	44	acquire	acquire	VERB
iajs-3385	71	45	;	;	PUNCT
iajs-3385	71	46	detection	detection	NOUN
iajs-3385	71	47	limits	limit	NOUN
iajs-3385	71	48	typically	typically	ADV
iajs-3385	71	49	of	of	ADP
iajs-3385	71	50	10	10	NUM
iajs-3385	71	51	-	-	SYM
iajs-3385	71	52	4	4	NUM
iajs-3385	71	53	-	-	PUNCT
iajs-3385	71	54	10	10	NUM
iajs-3385	71	55	-	-	SYM
iajs-3385	71	56	5	5	NUM
iajs-3385	71	57	m	m	NOUN
iajs-3385	71	58	;	;	PUNCT
iajs-3385	71	59	reasonable	reasonable	ADJ
iajs-3385	71	60	to	to	ADP
iajs-3385	71	61	high	high	ADJ
iajs-3385	71	62	selectivity	selectivity	NOUN
iajs-3385	71	63	and	and	CCONJ
iajs-3385	71	64	good	good	ADJ
iajs-3385	71	65	accuracy	accuracy	NOUN
iajs-3385	71	66	(	(	PUNCT
iajs-3385	71	67	25	25	NUM
iajs-3385	71	68	)	)	PUNCT
iajs-3385	71	69	.	.	PUNCT
iajs-3385	72	1	diverse	diverse	ADJ
iajs-3385	72	2	spectrophotometry	spectrophotometry	NOUN
iajs-3385	72	3	,	,	PUNCT
iajs-3385	72	4	vierodt	vierodt	PROPN
iajs-3385	72	5	’s	’s	PART
iajs-3385	72	6	method	method	NOUN
iajs-3385	72	7	,	,	PUNCT
iajs-3385	72	8	derivative	derivative	ADJ
iajs-3385	72	9	spectrophotometry	spectrophotometry	NOUN
iajs-3385	72	10	,	,	PUNCT
iajs-3385	72	11	dual	dual	ADJ
iajs-3385	72	12	wavelength	wavelength	NOUN
iajs-3385	72	13	method	method	NOUN
iajs-3385	72	14	,	,	PUNCT
iajs-3385	72	15	absorbance	absorbance	NOUN
iajs-3385	72	16	ratio	ratio	NOUN
iajs-3385	72	17	spectral	spectral	ADJ
iajs-3385	72	18	method	method	NOUN
iajs-3385	72	19	,	,	PUNCT
iajs-3385	72	20	differential	differential	ADJ
iajs-3385	72	21	ratio	ratio	NOUN
iajs-3385	72	22	spectral	spectral	ADJ
iajs-3385	72	23	method	method	NOUN
iajs-3385	72	24	,	,	PUNCT
iajs-3385	72	25	absorption	absorption	NOUN
iajs-3385	72	26	coefficient	coefficient	NOUN
iajs-3385	72	27	method	method	NOUN
iajs-3385	72	28	,	,	PUNCT
iajs-3385	72	29	continuous	continuous	ADJ
iajs-3385	72	30	ratio	ratio	NOUN
iajs-3385	72	31	differential	differential	ADJ
iajs-3385	72	32	spectral	spectral	ADJ
iajs-3385	72	33	method	method	NOUN
iajs-3385	72	34	,	,	PUNCT
iajs-3385	72	35	q	q	ADJ
iajs-3385	72	36	-	-	PUNCT
iajs-3385	72	37	absorption	absorption	NOUN
iajs-3385	72	38	ratio	ratio	NOUN
iajs-3385	72	39	method	method	NOUN
iajs-3385	72	40	,	,	PUNCT
iajs-3385	72	41	isosbestic	isosbestic	ADJ
iajs-3385	72	42	points	point	NOUN
iajs-3385	72	43	method	method	NOUN
iajs-3385	72	44	,	,	PUNCT
iajs-3385	72	45	and	and	CCONJ
iajs-3385	72	46	other	other	ADJ
iajs-3385	72	47	techniques	technique	NOUN
iajs-3385	72	48	are	be	AUX
iajs-3385	72	49	all	all	PRON
iajs-3385	72	50	examples	example	NOUN
iajs-3385	72	51	of	of	ADP
iajs-3385	72	52	multicomponent	multicomponent	NOUN
iajs-3385	72	53	spectrophotometry	spectrophotometry	NOUN
iajs-3385	72	54	.	.	PUNCT
iajs-3385	73	1	in	in	ADP
iajs-3385	73	2	addition	addition	NOUN
iajs-3385	73	3	,	,	PUNCT
iajs-3385	73	4	chemometric	chemometric	ADJ
iajs-3385	73	5	methods	method	NOUN
iajs-3385	73	6	have	have	AUX
iajs-3385	73	7	been	be	AUX
iajs-3385	73	8	used	use	VERB
iajs-3385	73	9	for	for	ADP
iajs-3385	73	10	multicomponent	multicomponent	NOUN
iajs-3385	73	11	analysis	analysis	NOUN
iajs-3385	73	12	,	,	PUNCT
iajs-3385	73	13	including	include	VERB
iajs-3385	73	14	multivariate	multivariate	NOUN
iajs-3385	73	15	regression	regression	NOUN
iajs-3385	73	16	models	model	NOUN
iajs-3385	73	17	,	,	PUNCT
iajs-3385	73	18	principal	principal	ADJ
iajs-3385	73	19	component	component	NOUN
iajs-3385	73	20	analysis	analysis	NOUN
iajs-3385	73	21	,	,	PUNCT
iajs-3385	73	22	partial	partial	ADJ
iajs-3385	73	23	least	least	ADJ
iajs-3385	73	24	squares	square	NOUN
iajs-3385	73	25	,	,	PUNCT
iajs-3385	73	26	parallel	parallel	ADJ
iajs-3385	73	27	factor	factor	NOUN
iajs-3385	73	28	analysis	analysis	NOUN
iajs-3385	73	29	,	,	PUNCT
iajs-3385	73	30	and	and	CCONJ
iajs-3385	73	31	artificial	artificial	ADJ
iajs-3385	73	32	neural	neural	ADJ
iajs-3385	73	33	networks	network	NOUN
iajs-3385	73	34	(	(	PUNCT
iajs-3385	73	35	26	26	NUM
iajs-3385	73	36	)	)	PUNCT
iajs-3385	73	37	.	.	PUNCT
iajs-3385	74	1	table	table	NOUN
iajs-3385	74	2	1	1	NUM
iajs-3385	74	3	illustrates	illustrate	VERB
iajs-3385	74	4	a	a	DET
iajs-3385	74	5	brief	brief	ADJ
iajs-3385	74	6	discussion	discussion	NOUN
iajs-3385	74	7	of	of	ADP
iajs-3385	74	8	each	each	DET
iajs-3385	74	9	method	method	NOUN
iajs-3385	74	10	,	,	PUNCT
iajs-3385	74	11	including	include	VERB
iajs-3385	74	12	the	the	DET
iajs-3385	74	13	combined	combine	VERB
iajs-3385	74	14	drug(s	drug(s	NOUN
iajs-3385	74	15	)	)	PUNCT
iajs-3385	74	16	,	,	PUNCT
iajs-3385	74	17	method(s	method(s	PROPN
iajs-3385	74	18	)	)	PUNCT
iajs-3385	74	19	,	,	PUNCT
iajs-3385	74	20	analytical	analytical	ADJ
iajs-3385	74	21	results	result	NOUN
iajs-3385	74	22	,	,	PUNCT
iajs-3385	74	23	and	and	CCONJ
iajs-3385	74	24	application	application	NOUN
iajs-3385	74	25	remark	remark	NOUN
iajs-3385	74	26	.	.	PUNCT
iajs-3385	75	1	ihjpas	ihjpas	PROPN
iajs-3385	75	2	.	.	PUNCT
iajs-3385	76	1	2025	2025	NUM
iajs-3385	76	2	,	,	PUNCT
iajs-3385	76	3	38(2	38(2	NUM
iajs-3385	76	4	)	)	PUNCT
iajs-3385	76	5	208	208	NUM
iajs-3385	76	6	table	table	NOUN
iajs-3385	76	7	1	1	NUM
iajs-3385	76	8	.	.	PUNCT
iajs-3385	76	9	spectrophotometric	spectrophotometric	ADJ
iajs-3385	76	10	methods	method	NOUN
iajs-3385	76	11	for	for	ADP
iajs-3385	76	12	simultaneous	simultaneous	ADJ
iajs-3385	76	13	determination	determination	NOUN
iajs-3385	76	14	of	of	ADP
iajs-3385	76	15	levofloxacin	levofloxacin	NOUN
iajs-3385	76	16	,	,	PUNCT
iajs-3385	76	17	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	76	18	,	,	PUNCT
iajs-3385	76	19	metronidazole	metronidazole	NOUN
iajs-3385	76	20	and	and	CCONJ
iajs-3385	76	21	rifampicin	rifampicin	VERB
iajs-3385	76	22	.	.	PUNCT
iajs-3385	77	1	drug	drug	NOUN
iajs-3385	77	2	method(s	method(s	PROPN
iajs-3385	77	3	)	)	PUNCT
iajs-3385	77	4	analytical	analytical	ADJ
iajs-3385	77	5	results	result	NOUN
iajs-3385	77	6	application	application	NOUN
iajs-3385	77	7	remark	remark	NOUN
iajs-3385	77	8	year	year	NOUN
iajs-3385	77	9	ref	ref	NOUN
iajs-3385	77	10	target	target	NOUN
iajs-3385	77	11	combined(s	combined(s	NOUN
iajs-3385	77	12	)	)	PUNCT
iajs-3385	77	13	l	l	NOUN
iajs-3385	77	14	ev	ev	INTJ
iajs-3385	77	15	o	o	INTJ
iajs-3385	78	1	fl	fl	NUM
iajs-3385	78	2	o	o	NOUN
iajs-3385	78	3	x	x	X
iajs-3385	78	4	a	a	DET
iajs-3385	78	5	ci	ci	NOUN
iajs-3385	78	6	n	n	PRON
iajs-3385	78	7	azithromycin	azithromycin	NOUN
iajs-3385	78	8	area	area	NOUN
iajs-3385	78	9	under	under	ADP
iajs-3385	78	10	curve	curve	NOUN
iajs-3385	78	11	method	method	NOUN
iajs-3385	78	12	using	use	VERB
iajs-3385	78	13	ddq	ddq	PROPN
iajs-3385	78	14	and	and	CCONJ
iajs-3385	78	15	p	p	X
iajs-3385	78	16	-	-	PUNCT
iajs-3385	78	17	ca	ca	NOUN
iajs-3385	78	18	λ=	λ=	X
iajs-3385	78	19	(	(	PUNCT
iajs-3385	78	20	390	390	NUM
iajs-3385	78	21	-	-	SYM
iajs-3385	78	22	650	650	NUM
iajs-3385	78	23	)	)	PUNCT
iajs-3385	78	24	nm	nm	NOUN
iajs-3385	78	25	and	and	CCONJ
iajs-3385	78	26	(	(	PUNCT
iajs-3385	78	27	400700	400700	NUM
iajs-3385	78	28	)	)	PUNCT
iajs-3385	79	1	nm	nm	PROPN
iajs-3385	79	2	,	,	PUNCT
iajs-3385	79	3	linearity	linearity	NOUN
iajs-3385	79	4	range	range	NOUN
iajs-3385	79	5	:	:	PUNCT
iajs-3385	79	6	14.0	14.0	NUM
iajs-3385	79	7	-	-	SYM
iajs-3385	79	8	140.0	140.0	NUM
iajs-3385	79	9	μg	μg	NOUN
iajs-3385	79	10	/	/	SYM
iajs-3385	79	11	ml	ml	PROPN
iajs-3385	79	12	and	and	CCONJ
iajs-3385	79	13	30300.0μg	30300.0μg	NUM
iajs-3385	79	14	/	/	SYM
iajs-3385	79	15	ml	ml	PROPN
iajs-3385	79	16	,	,	PUNCT
iajs-3385	79	17	r2	r2	NOUN
iajs-3385	79	18	0.999	0.999	NUM
iajs-3385	79	19	for	for	ADP
iajs-3385	79	20	both	both	PRON
iajs-3385	79	21	,	,	PUNCT
iajs-3385	79	22	recovery	recovery	NOUN
iajs-3385	79	23	99.71102.64	99.71102.64	NUM
iajs-3385	79	24	%	%	NOUN
iajs-3385	79	25	and	and	CCONJ
iajs-3385	79	26	99.38	99.38	NUM
iajs-3385	79	27	-	-	SYM
iajs-3385	79	28	101.76	101.76	NUM
iajs-3385	79	29	%	%	NOUN
iajs-3385	79	30	,	,	PUNCT
iajs-3385	79	31	lod	lod	PROPN
iajs-3385	79	32	1.40	1.40	NUM
iajs-3385	79	33	μg	μg	NOUN
iajs-3385	79	34	/	/	SYM
iajs-3385	79	35	ml	ml	PROPN
iajs-3385	79	36	and	and	CCONJ
iajs-3385	79	37	3.00	3.00	NUM
iajs-3385	79	38	μg	μg	NOUN
iajs-3385	79	39	/	/	SYM
iajs-3385	79	40	ml	ml	X
iajs-3385	79	41	pure	pure	ADJ
iajs-3385	79	42	mixture	mixture	NOUN
iajs-3385	79	43	,	,	PUNCT
iajs-3385	79	44	pharmaceutical	pharmaceutical	ADJ
iajs-3385	79	45	binary	binary	ADJ
iajs-3385	79	46	dosage	dosage	NOUN
iajs-3385	79	47	forms	form	VERB
iajs-3385	79	48	2019	2019	NUM
iajs-3385	79	49	(	(	PUNCT
iajs-3385	79	50	27	27	NUM
iajs-3385	79	51	)	)	PUNCT
iajs-3385	79	52	azithromycin	azithromycin	NOUN
iajs-3385	79	53	direct	direct	ADJ
iajs-3385	79	54	measurement	measurement	NOUN
iajs-3385	79	55	of	of	ADP
iajs-3385	79	56	abs	ab	NOUN
iajs-3385	79	57	in	in	ADP
iajs-3385	79	58	perchloric	perchloric	ADJ
iajs-3385	79	59	acid	acid	NOUN
iajs-3385	79	60	methanolic	methanolic	NOUN
iajs-3385	79	61	solution	solution	NOUN
iajs-3385	79	62	λ=	λ=	VERB
iajs-3385	79	63	224	224	NUM
iajs-3385	79	64	nm	nm	NOUN
iajs-3385	79	65	,	,	PUNCT
iajs-3385	79	66	linearity	linearity	NOUN
iajs-3385	79	67	range	range	NOUN
iajs-3385	79	68	:	:	PUNCT
iajs-3385	79	69	2.5	2.5	NUM
iajs-3385	79	70	-	-	SYM
iajs-3385	79	71	20.0	20.0	NUM
iajs-3385	79	72	μg	μg	PROPN
iajs-3385	79	73	/	/	SYM
iajs-3385	79	74	ml	ml	PROPN
iajs-3385	79	75	,	,	PUNCT
iajs-3385	79	76	r2	r2	PROPN
iajs-3385	79	77	0.9991	0.9991	NUM
iajs-3385	79	78	,	,	PUNCT
iajs-3385	79	79	recovery100.95	recovery100.95	NOUN
iajs-3385	79	80	%	%	NOUN
iajs-3385	79	81	,	,	PUNCT
iajs-3385	79	82	lod	lod	PROPN
iajs-3385	79	83	0.80	0.80	NUM
iajs-3385	79	84	μg	μg	PROPN
iajs-3385	79	85	/	/	SYM
iajs-3385	79	86	ml	ml	NOUN
iajs-3385	79	87	bulk	bulk	ADJ
iajs-3385	79	88	powder	powder	NOUN
iajs-3385	79	89	,	,	PUNCT
iajs-3385	79	90	laboratoryprepared	laboratoryprepare	VERB
iajs-3385	79	91	tablets	tablet	NOUN
iajs-3385	79	92	2020	2020	NUM
iajs-3385	79	93	(	(	PUNCT
iajs-3385	79	94	28	28	NUM
iajs-3385	79	95	)	)	PUNCT
iajs-3385	79	96	first	first	ADJ
iajs-3385	79	97	derivative	derivative	ADJ
iajs-3385	79	98	peak	peak	NOUN
iajs-3385	79	99	-	-	PUNCT
iajs-3385	79	100	to	to	ADP
iajs-3385	79	101	-	-	PUNCT
iajs-3385	79	102	peak	peak	NOUN
iajs-3385	79	103	amplitudes	amplitude	NOUN
iajs-3385	79	104	λ=	λ=	VERB
iajs-3385	79	105	280–253	280–253	NUM
iajs-3385	79	106	nm	nm	NOUN
iajs-3385	79	107	,	,	PUNCT
iajs-3385	79	108	linearity	linearity	NOUN
iajs-3385	79	109	range	range	NOUN
iajs-3385	79	110	:	:	PUNCT
iajs-3385	79	111	5.0	5.0	NUM
iajs-3385	79	112	-	-	SYM
iajs-3385	79	113	40.0	40.0	NUM
iajs-3385	79	114	μg	μg	PROPN
iajs-3385	79	115	/	/	SYM
iajs-3385	79	116	ml	ml	PROPN
iajs-3385	79	117	,	,	PUNCT
iajs-3385	79	118	r2	r2	PROPN
iajs-3385	79	119	0.9992	0.9992	NUM
iajs-3385	79	120	,	,	PUNCT
iajs-3385	79	121	recovery100.53	recovery100.53	PROPN
iajs-3385	79	122	%	%	NOUN
iajs-3385	79	123	,	,	PUNCT
iajs-3385	79	124	lod	lod	PROPN
iajs-3385	79	125	1.50	1.50	NUM
iajs-3385	79	126	μg	μg	PROPN
iajs-3385	79	127	/	/	SYM
iajs-3385	79	128	ml	ml	X
iajs-3385	79	129	atenolol	atenolol	PROPN
iajs-3385	79	130	,	,	PUNCT
iajs-3385	79	131	paracetamol	paracetamol	PROPN
iajs-3385	79	132	,	,	PUNCT
iajs-3385	79	133	and	and	CCONJ
iajs-3385	79	134	hydrochlorot	hydrochlorot	PROPN
iajs-3385	79	135	hiazide	hiazide	VERB
iajs-3385	79	136	extended	extend	VERB
iajs-3385	79	137	derivative	derivative	ADJ
iajs-3385	79	138	ratio	ratio	NOUN
iajs-3385	79	139	λ=	λ=	VERB
iajs-3385	79	140	282.8	282.8	NUM
iajs-3385	79	141	nm	nm	NOUN
iajs-3385	79	142	,	,	PUNCT
iajs-3385	79	143	linearity	linearity	NOUN
iajs-3385	79	144	range	range	NOUN
iajs-3385	79	145	:	:	PUNCT
iajs-3385	79	146	1.0	1.0	NUM
iajs-3385	79	147	-	-	SYM
iajs-3385	79	148	15.0	15.0	NUM
iajs-3385	79	149	μg	μg	NOUN
iajs-3385	79	150	/	/	SYM
iajs-3385	79	151	ml	ml	PROPN
iajs-3385	79	152	,	,	PUNCT
iajs-3385	79	153	r2	r2	PROPN
iajs-3385	79	154	0.9996	0.9996	NUM
iajs-3385	79	155	,	,	PUNCT
iajs-3385	79	156	recovery	recovery	NOUN
iajs-3385	79	157	100.15	100.15	NUM
iajs-3385	79	158	%	%	NOUN
iajs-3385	79	159	lod	lod	PROPN
iajs-3385	79	160	0.25	0.25	NUM
iajs-3385	79	161	μg	μg	NOUN
iajs-3385	79	162	/	/	SYM
iajs-3385	79	163	ml	ml	NOUN
iajs-3385	79	164	dosage	dosage	NOUN
iajs-3385	79	165	forms	form	NOUN
iajs-3385	79	166	,	,	PUNCT
iajs-3385	79	167	human	human	ADJ
iajs-3385	79	168	urine	urine	NOUN
iajs-3385	79	169	2020	2020	NUM
iajs-3385	79	170	(	(	PUNCT
iajs-3385	79	171	29	29	NUM
iajs-3385	79	172	)	)	PUNCT
iajs-3385	79	173	multivariate	multivariate	NOUN
iajs-3385	79	174	curve	curve	NOUN
iajs-3385	79	175	resolution	resolution	NOUN
iajs-3385	79	176	alternating	alternate	VERB
iajs-3385	79	177	least	least	ADJ
iajs-3385	79	178	squares	square	NOUN
iajs-3385	79	179	λ=	λ=	NOUN
iajs-3385	79	180	(	(	PUNCT
iajs-3385	79	181	220.0	220.0	NUM
iajs-3385	79	182	-	-	SYM
iajs-3385	79	183	290.0	290.0	NUM
iajs-3385	79	184	)	)	PUNCT
iajs-3385	79	185	nm	nm	PROPN
iajs-3385	79	186	,	,	PUNCT
iajs-3385	79	187	linearity	linearity	NOUN
iajs-3385	79	188	range	range	NOUN
iajs-3385	79	189	:	:	PUNCT
iajs-3385	79	190	1.0	1.0	NUM
iajs-3385	79	191	-	-	SYM
iajs-3385	79	192	7.0	7.0	NUM
iajs-3385	79	193	μg	μg	PROPN
iajs-3385	79	194	/	/	SYM
iajs-3385	79	195	ml	ml	PROPN
iajs-3385	79	196	,	,	PUNCT
iajs-3385	79	197	r2	r2	PROPN
iajs-3385	79	198	0.9999	0.9999	NUM
iajs-3385	79	199	,	,	PUNCT
iajs-3385	79	200	recovery	recovery	NOUN
iajs-3385	79	201	99.56	99.56	NUM
iajs-3385	79	202	%	%	NOUN
iajs-3385	79	203	ambroxol	ambroxol	NOUN
iajs-3385	79	204	absorbance	absorbance	NOUN
iajs-3385	79	205	ratio	ratio	NOUN
iajs-3385	79	206	method	method	NOUN
iajs-3385	79	207	λ=	λ=	NOUN
iajs-3385	79	208	(	(	PUNCT
iajs-3385	79	209	244.6	244.6	NUM
iajs-3385	79	210	,	,	PUNCT
iajs-3385	79	211	218,6)nm	218,6)nm	NUM
iajs-3385	79	212	,	,	PUNCT
iajs-3385	79	213	linearity	linearity	NOUN
iajs-3385	79	214	range	range	NOUN
iajs-3385	79	215	:	:	PUNCT
iajs-3385	79	216	3.0	3.0	NUM
iajs-3385	79	217	-	-	SYM
iajs-3385	79	218	7.0	7.0	NUM
iajs-3385	79	219	μg	μg	NOUN
iajs-3385	79	220	/	/	SYM
iajs-3385	79	221	ml	ml	PROPN
iajs-3385	79	222	,	,	PUNCT
iajs-3385	79	223	r2	r2	PROPN
iajs-3385	79	224	0.9999	0.9999	NUM
iajs-3385	79	225	,	,	PUNCT
iajs-3385	79	226	recovery	recovery	NOUN
iajs-3385	79	227	99.0100.0	99.0100.0	NUM
iajs-3385	79	228	%	%	NOUN
iajs-3385	79	229	,	,	PUNCT
iajs-3385	79	230	lod	lod	PROPN
iajs-3385	79	231	0.18	0.18	NUM
iajs-3385	79	232	μg	μg	PROPN
iajs-3385	79	233	/	/	SYM
iajs-3385	79	234	ml	ml	VERB
iajs-3385	79	235	tablets	tablet	NOUN
iajs-3385	79	236	2021	2021	NUM
iajs-3385	79	237	(	(	PUNCT
iajs-3385	79	238	30	30	NUM
iajs-3385	79	239	)	)	PUNCT
iajs-3385	79	240	doxycycline	doxycycline	NOUN
iajs-3385	79	241	absorbance	absorbance	NOUN
iajs-3385	79	242	ratio	ratio	NOUN
iajs-3385	79	243	method	method	NOUN
iajs-3385	79	244	,	,	PUNCT
iajs-3385	79	245	simultaneous	simultaneous	ADJ
iajs-3385	79	246	equation	equation	NOUN
iajs-3385	79	247	method	method	NOUN
iajs-3385	79	248	λ=	λ=	VERB
iajs-3385	79	249	287	287	NUM
iajs-3385	79	250	nm	nm	NOUN
iajs-3385	79	251	,	,	PUNCT
iajs-3385	79	252	linearity	linearity	NOUN
iajs-3385	79	253	range	range	NOUN
iajs-3385	79	254	:	:	PUNCT
iajs-3385	79	255	220	220	NUM
iajs-3385	79	256	μg	μg	NOUN
iajs-3385	79	257	/	/	SYM
iajs-3385	79	258	ml	ml	PROPN
iajs-3385	79	259	,	,	PUNCT
iajs-3385	79	260	r2	r2	PROPN
iajs-3385	79	261	0.9998	0.9998	NUM
iajs-3385	79	262	,	,	PUNCT
iajs-3385	79	263	recovery	recovery	NOUN
iajs-3385	79	264	99.66	99.66	NUM
iajs-3385	79	265	%	%	NOUN
iajs-3385	79	266	,	,	PUNCT
iajs-3385	79	267	lod	lod	PROPN
iajs-3385	79	268	0.63	0.63	NUM
iajs-3385	79	269	μg	μg	PROPN
iajs-3385	79	270	/	/	SYM
iajs-3385	79	271	ml	ml	NOUN
iajs-3385	79	272	synthetic	synthetic	ADJ
iajs-3385	79	273	mixture	mixture	NOUN
iajs-3385	79	274	,	,	PUNCT
iajs-3385	79	275	combined	combine	VERB
iajs-3385	79	276	pharmaceutical	pharmaceutical	NOUN
iajs-3385	79	277	dosage	dosage	NOUN
iajs-3385	79	278	forms	form	VERB
iajs-3385	79	279	2022	2022	NUM
iajs-3385	79	280	(	(	PUNCT
iajs-3385	79	281	31	31	NUM
iajs-3385	79	282	)	)	PUNCT
iajs-3385	79	283	ornidazole	ornidazole	ADJ
iajs-3385	79	284	area	area	NOUN
iajs-3385	79	285	under	under	ADP
iajs-3385	79	286	curve	curve	NOUN
iajs-3385	79	287	method	method	NOUN
iajs-3385	79	288	using	use	VERB
iajs-3385	79	289	ddq	ddq	PROPN
iajs-3385	79	290	and	and	CCONJ
iajs-3385	79	291	p	p	X
iajs-3385	79	292	-	-	PUNCT
iajs-3385	79	293	ca	ca	NOUN
iajs-3385	79	294	λ=(390	λ=(390	PROPN
iajs-3385	79	295	-	-	PROPN
iajs-3385	79	296	690)nm	690)nm	PROPN
iajs-3385	79	297	and	and	CCONJ
iajs-3385	79	298	(	(	PUNCT
iajs-3385	79	299	400	400	NUM
iajs-3385	79	300	-	-	SYM
iajs-3385	79	301	700	700	NUM
iajs-3385	79	302	)	)	PUNCT
iajs-3385	79	303	nm	nm	PROPN
iajs-3385	79	304	,	,	PUNCT
iajs-3385	79	305	linearity	linearity	NOUN
iajs-3385	79	306	range	range	NOUN
iajs-3385	79	307	:	:	PUNCT
iajs-3385	79	308	10.0200.0	10.0200.0	NUM
iajs-3385	79	309	μg	μg	NOUN
iajs-3385	79	310	/	/	SYM
iajs-3385	79	311	ml	ml	PROPN
iajs-3385	79	312	and	and	CCONJ
iajs-3385	79	313	30	30	NUM
iajs-3385	79	314	-	-	SYM
iajs-3385	79	315	600.0	600.0	NUM
iajs-3385	79	316	μg	μg	NOUN
iajs-3385	79	317	/	/	SYM
iajs-3385	79	318	ml	ml	PROPN
iajs-3385	79	319	,	,	PUNCT
iajs-3385	79	320	r2	r2	PROPN
iajs-3385	79	321	0.998	0.998	NUM
iajs-3385	79	322	and	and	CCONJ
iajs-3385	79	323	0.999	0.999	NUM
iajs-3385	79	324	,	,	PUNCT
iajs-3385	79	325	recovery	recovery	NOUN
iajs-3385	79	326	98.81	98.81	NUM
iajs-3385	79	327	-	-	SYM
iajs-3385	79	328	101.55	101.55	NUM
iajs-3385	79	329	%	%	NOUN
iajs-3385	79	330	and	and	CCONJ
iajs-3385	79	331	98.8	98.8	NUM
iajs-3385	79	332	-	-	SYM
iajs-3385	79	333	100.86	100.86	NUM
iajs-3385	79	334	%	%	NOUN
iajs-3385	79	335	,	,	PUNCT
iajs-3385	79	336	lod	lod	PROPN
iajs-3385	79	337	3.3	3.3	NUM
iajs-3385	79	338	μg	μg	PROPN
iajs-3385	79	339	/	/	SYM
iajs-3385	79	340	ml	ml	PROPN
iajs-3385	79	341	and	and	CCONJ
iajs-3385	79	342	9.9μg	9.9μg	NUM
iajs-3385	79	343	/	/	SYM
iajs-3385	79	344	ml	ml	ADV
iajs-3385	79	345	pure	pure	ADJ
iajs-3385	79	346	mixture	mixture	NOUN
iajs-3385	79	347	,	,	PUNCT
iajs-3385	79	348	pharmaceutical	pharmaceutical	ADJ
iajs-3385	79	349	binary	binary	ADJ
iajs-3385	79	350	dosage	dosage	NOUN
iajs-3385	79	351	forms	form	VERB
iajs-3385	79	352	2022	2022	NUM
iajs-3385	79	353	(	(	PUNCT
iajs-3385	79	354	32	32	NUM
iajs-3385	79	355	)	)	PUNCT
iajs-3385	79	356	m	m	VERB
iajs-3385	79	357	et	et	NOUN
iajs-3385	79	358	ro	ro	NOUN
iajs-3385	79	359	n	n	PROPN
iajs-3385	80	1	i	i	PROPN
iajs-3385	80	2	d	d	PROPN
iajs-3385	80	3	a	a	DET
iajs-3385	80	4	zo	zo	PROPN
iajs-3385	80	5	le	le	X
iajs-3385	80	6	spiramycin	spiramycin	PROPN
iajs-3385	80	7	direct	direct	ADJ
iajs-3385	80	8	uvspectrophotometry	uvspectrophotometry	NOUN
iajs-3385	80	9	λmax=	λmax=	PROPN
iajs-3385	80	10	311	311	NUM
iajs-3385	80	11	nm	nm	NOUN
iajs-3385	80	12	.	.	PROPN
iajs-3385	80	13	,	,	PUNCT
iajs-3385	80	14	linearity	linearity	PROPN
iajs-3385	80	15	range	range	NOUN
iajs-3385	80	16	:	:	PUNCT
iajs-3385	80	17	5–25	5–25	PROPN
iajs-3385	80	18	μg	μg	PROPN
iajs-3385	80	19	/	/	SYM
iajs-3385	80	20	ml	ml	PROPN
iajs-3385	80	21	,	,	PUNCT
iajs-3385	80	22	r2	r2	PROPN
iajs-3385	80	23	0.9997	0.9997	NUM
iajs-3385	80	24	,	,	PUNCT
iajs-3385	80	25	recovery	recovery	NOUN
iajs-3385	80	26	100.16	100.16	NUM
iajs-3385	80	27	%	%	NOUN
iajs-3385	80	28	,	,	PUNCT
iajs-3385	80	29	lod	lod	PROPN
iajs-3385	80	30	0.3938μg	0.3938μg	NUM
iajs-3385	80	31	/	/	SYM
iajs-3385	80	32	ml	ml	X
iajs-3385	80	33	pure	pure	ADJ
iajs-3385	80	34	form	form	NOUN
iajs-3385	80	35	,	,	PUNCT
iajs-3385	80	36	tablets	tablet	NOUN
iajs-3385	80	37	2010	2010	NUM
iajs-3385	80	38	(	(	PUNCT
iajs-3385	80	39	33	33	NUM
iajs-3385	80	40	)	)	PUNCT
iajs-3385	80	41	ihjpas	ihjpa	NOUN
iajs-3385	80	42	.	.	PUNCT
iajs-3385	81	1	2025	2025	NUM
iajs-3385	81	2	,	,	PUNCT
iajs-3385	81	3	38(2	38(2	NUM
iajs-3385	81	4	)	)	PUNCT
iajs-3385	81	5	209	209	NUM
iajs-3385	81	6	drug	drug	NOUN
iajs-3385	81	7	method(s	method(	VERB
iajs-3385	81	8	)	)	PUNCT
iajs-3385	81	9	analytical	analytical	ADJ
iajs-3385	81	10	results	result	NOUN
iajs-3385	81	11	application	application	NOUN
iajs-3385	81	12	remark	remark	NOUN
iajs-3385	81	13	year	year	NOUN
iajs-3385	81	14	ref	ref	NOUN
iajs-3385	81	15	target	target	NOUN
iajs-3385	81	16	combined(s	combined(s	NOUN
iajs-3385	81	17	)	)	PUNCT
iajs-3385	81	18	ratio	ratio	NOUN
iajs-3385	81	19	derivative	derivative	ADJ
iajs-3385	81	20	spectrophotometry	spectrophotometry	NOUN
iajs-3385	81	21	(	(	PUNCT
iajs-3385	81	22	1dd	1dd	ADJ
iajs-3385	81	23	)	)	PUNCT
iajs-3385	81	24	λmax=	λmax=	NUM
iajs-3385	81	25	311	311	NUM
iajs-3385	81	26	nm	nm	NOUN
iajs-3385	81	27	,	,	PUNCT
iajs-3385	81	28	linearity	linearity	NOUN
iajs-3385	81	29	range	range	NOUN
iajs-3385	81	30	:	:	PUNCT
iajs-3385	81	31	5–25	5–25	PROPN
iajs-3385	81	32	μg	μg	PROPN
iajs-3385	81	33	/	/	SYM
iajs-3385	81	34	ml	ml	PROPN
iajs-3385	81	35	,	,	PUNCT
iajs-3385	81	36	r2	r2	PROPN
iajs-3385	81	37	0.9997	0.9997	NUM
iajs-3385	81	38	,	,	PUNCT
iajs-3385	81	39	recovery	recovery	NOUN
iajs-3385	81	40	100.16	100.16	NUM
iajs-3385	81	41	%	%	NOUN
iajs-3385	81	42	,	,	PUNCT
iajs-3385	81	43	lod	lod	PROPN
iajs-3385	81	44	0.3938μg	0.3938μg	NUM
iajs-3385	81	45	/	/	SYM
iajs-3385	81	46	ml	ml	NOUN
iajs-3385	81	47	mean	mean	VERB
iajs-3385	81	48	centring	centring	NOUN
iajs-3385	81	49	of	of	ADP
iajs-3385	81	50	the	the	DET
iajs-3385	81	51	ratio	ratio	NOUN
iajs-3385	81	52	spectra	spectra	PROPN
iajs-3385	81	53	(	(	PUNCT
iajs-3385	81	54	mcr	mcr	PROPN
iajs-3385	81	55	)	)	PUNCT
iajs-3385	81	56	λ=	λ=	NOUN
iajs-3385	81	57	(	(	PUNCT
iajs-3385	81	58	200	200	NUM
iajs-3385	81	59	-	-	SYM
iajs-3385	81	60	400)nm	400)nm	NUM
iajs-3385	81	61	,	,	PUNCT
iajs-3385	81	62	linearity	linearity	NOUN
iajs-3385	81	63	range	range	NOUN
iajs-3385	81	64	:	:	PUNCT
iajs-3385	81	65	5–25	5–25	PROPN
iajs-3385	81	66	μg	μg	PROPN
iajs-3385	81	67	/	/	SYM
iajs-3385	81	68	ml	ml	PROPN
iajs-3385	81	69	,	,	PUNCT
iajs-3385	81	70	r2	r2	PROPN
iajs-3385	81	71	1.0000	1.0000	NUM
iajs-3385	81	72	,	,	PUNCT
iajs-3385	81	73	recovery	recovery	NOUN
iajs-3385	81	74	101.1	101.1	NUM
iajs-3385	81	75	%	%	NOUN
iajs-3385	81	76	,	,	PUNCT
iajs-3385	81	77	lod	lod	PROPN
iajs-3385	81	78	0.4967μg	0.4967μg	PRON
iajs-3385	81	79	/	/	SYM
iajs-3385	81	80	ml	ml	NOUN
iajs-3385	81	81	ciprofloxacin	ciprofloxacin	NOUN
iajs-3385	81	82	hydrochloride	hydrochloride	NOUN
iajs-3385	81	83	second	second	ADJ
iajs-3385	81	84	derivative	derivative	ADJ
iajs-3385	81	85	ratio	ratio	NOUN
iajs-3385	81	86	spectrophotometry	spectrophotometry	NOUN
iajs-3385	81	87	technique	technique	NOUN
iajs-3385	81	88	(	(	PUNCT
iajs-3385	81	89	2dd	2dd	NOUN
iajs-3385	81	90	)	)	PUNCT
iajs-3385	81	91	λ=	λ=	VERB
iajs-3385	81	92	301	301	NUM
iajs-3385	81	93	nm	nm	NOUN
iajs-3385	81	94	,	,	PUNCT
iajs-3385	81	95	linearity	linearity	NOUN
iajs-3385	81	96	range	range	NOUN
iajs-3385	81	97	:	:	PUNCT
iajs-3385	81	98	4	4	NUM
iajs-3385	81	99	–	–	PUNCT
iajs-3385	81	100	16	16	NUM
iajs-3385	81	101	μg	μg	NOUN
iajs-3385	81	102	/	/	SYM
iajs-3385	81	103	ml	ml	PROPN
iajs-3385	81	104	,	,	PUNCT
iajs-3385	81	105	r2	r2	PROPN
iajs-3385	81	106	0.9992	0.9992	NUM
iajs-3385	81	107	,	,	PUNCT
iajs-3385	81	108	recovery	recovery	NOUN
iajs-3385	81	109	100.21	100.21	NUM
iajs-3385	81	110	%	%	NOUN
iajs-3385	81	111	,	,	PUNCT
iajs-3385	81	112	lod	lod	PROPN
iajs-3385	81	113	0.4900μg	0.4900μg	X
iajs-3385	81	114	/	/	SYM
iajs-3385	81	115	ml	ml	ADV
iajs-3385	81	116	pure	pure	ADJ
iajs-3385	81	117	form	form	NOUN
iajs-3385	81	118	,	,	PUNCT
iajs-3385	81	119	tablets	tablet	NOUN
iajs-3385	81	120	2012	2012	NUM
iajs-3385	81	121	(	(	PUNCT
iajs-3385	81	122	34	34	NUM
iajs-3385	81	123	)	)	PUNCT
iajs-3385	81	124	moxifloxacin	moxifloxacin	NOUN
iajs-3385	81	125	partial	partial	ADJ
iajs-3385	81	126	least	least	ADJ
iajs-3385	81	127	squares	square	NOUN
iajs-3385	81	128	regression	regression	NOUN
iajs-3385	81	129	(	(	PUNCT
iajs-3385	81	130	pls	pls	INTJ
iajs-3385	81	131	)	)	PUNCT
iajs-3385	81	132	,	,	PUNCT
iajs-3385	81	133	principal	principal	ADJ
iajs-3385	81	134	component	component	NOUN
iajs-3385	81	135	regression	regression	NOUN
iajs-3385	81	136	(	(	PUNCT
iajs-3385	81	137	pcr	pcr	NOUN
iajs-3385	81	138	)	)	PUNCT
iajs-3385	81	139	λ=	λ=	VERB
iajs-3385	81	140	200	200	NUM
iajs-3385	81	141	-	-	SYM
iajs-3385	81	142	500	500	NUM
iajs-3385	81	143	nm	nm	NOUN
iajs-3385	81	144	,	,	PUNCT
iajs-3385	81	145	standard	standard	ADJ
iajs-3385	81	146	error	error	NOUN
iajs-3385	81	147	of	of	ADP
iajs-3385	81	148	prediction	prediction	NOUN
iajs-3385	81	149	(	(	PUNCT
iajs-3385	81	150	sep	sep	PROPN
iajs-3385	81	151	):	):	PUNCT
iajs-3385	81	152	0.036	0.036	NUM
iajs-3385	81	153	(	(	PUNCT
iajs-3385	81	154	pls	pls	INTJ
iajs-3385	81	155	)	)	PUNCT
iajs-3385	81	156	,	,	PUNCT
iajs-3385	81	157	0.043	0.043	NUM
iajs-3385	81	158	(	(	PUNCT
iajs-3385	81	159	pcr	pcr	NOUN
iajs-3385	81	160	)	)	PUNCT
iajs-3385	81	161	prediction	prediction	NOUN
iajs-3385	81	162	residual	residual	ADJ
iajs-3385	81	163	error	error	NOUN
iajs-3385	81	164	sumof	sumof	NOUN
iajs-3385	81	165	squares	square	NOUN
iajs-3385	81	166	(	(	PUNCT
iajs-3385	81	167	press	press	NOUN
iajs-3385	81	168	):	):	PUNCT
iajs-3385	81	169	0.052	0.052	NUM
iajs-3385	81	170	(	(	PUNCT
iajs-3385	81	171	pls	pls	INTJ
iajs-3385	81	172	)	)	PUNCT
iajs-3385	81	173	,	,	PUNCT
iajs-3385	81	174	0.064	0.064	NUM
iajs-3385	81	175	(	(	PUNCT
iajs-3385	81	176	pcr	pcr	PROPN
iajs-3385	81	177	)	)	PUNCT
iajs-3385	81	178	,	,	PUNCT
iajs-3385	81	179	recovery:99.4%(pls	recovery:99.4%(pls	NOUN
iajs-3385	81	180	)	)	PUNCT
iajs-3385	81	181	,	,	PUNCT
iajs-3385	81	182	99.43	99.43	NUM
iajs-3385	81	183	%	%	NOUN
iajs-3385	81	184	(	(	PUNCT
iajs-3385	81	185	pcr	pcr	NOUN
iajs-3385	81	186	)	)	PUNCT
iajs-3385	81	187	pharmaceutical	pharmaceutical	NOUN
iajs-3385	81	188	tablets	tablet	NOUN
iajs-3385	81	189	2017	2017	NUM
iajs-3385	81	190	(	(	PUNCT
iajs-3385	81	191	35	35	NUM
iajs-3385	81	192	)	)	PUNCT
iajs-3385	81	193	metronidazole	metronidazole	NOUN
iajs-3385	81	194	benzoate	benzoate	NOUN
iajs-3385	81	195	1st	1st	PROPN
iajs-3385	81	196	and	and	CCONJ
iajs-3385	81	197	2nd	2nd	ADJ
iajs-3385	81	198	derivative	derivative	ADJ
iajs-3385	81	199	spectrophotometry	spectrophotometry	NOUN
iajs-3385	81	200	λ=	λ=	VERB
iajs-3385	81	201	200	200	NUM
iajs-3385	81	202	-	-	SYM
iajs-3385	81	203	350	350	NUM
iajs-3385	81	204	nm	nm	NOUN
iajs-3385	81	205	,	,	PUNCT
iajs-3385	81	206	linearity	linearity	NOUN
iajs-3385	81	207	range	range	NOUN
iajs-3385	81	208	:	:	PUNCT
iajs-3385	81	209	1–25	1–25	PROPN
iajs-3385	81	210	μg	μg	PROPN
iajs-3385	81	211	/	/	SYM
iajs-3385	81	212	ml	ml	PROPN
iajs-3385	81	213	,	,	PUNCT
iajs-3385	81	214	r2	r2	PROPN
iajs-3385	81	215	0.9999	0.9999	NUM
iajs-3385	81	216	,	,	PUNCT
iajs-3385	81	217	recovery	recovery	NOUN
iajs-3385	81	218	99.75%101.25	99.75%101.25	NUM
iajs-3385	81	219	%	%	NOUN
iajs-3385	81	220	pharmaceutical	pharmaceutical	ADJ
iajs-3385	81	221	preparations	preparation	NOUN
iajs-3385	81	222	2017	2017	NUM
iajs-3385	81	223	(	(	PUNCT
iajs-3385	81	224	36	36	NUM
iajs-3385	81	225	)	)	PUNCT
iajs-3385	81	226	amoxicillin	amoxicillin	NOUN
iajs-3385	81	227	trihydrate	trihydrate	NOUN
iajs-3385	81	228	,	,	PUNCT
iajs-3385	81	229	pantoprazole	pantoprazole	PROPN
iajs-3385	81	230	artificial	artificial	ADJ
iajs-3385	81	231	neural	neural	ADJ
iajs-3385	81	232	networks	network	NOUN
iajs-3385	81	233	λ=	λ=	VERB
iajs-3385	81	234	200	200	NUM
iajs-3385	81	235	-	-	SYM
iajs-3385	81	236	400	400	NUM
iajs-3385	81	237	nm	nm	NOUN
iajs-3385	81	238	,	,	PUNCT
iajs-3385	81	239	3	3	NUM
iajs-3385	81	240	layers	layer	NOUN
iajs-3385	81	241	feedforward	feedforward	VERB
iajs-3385	81	242	neural	neural	ADJ
iajs-3385	81	243	networks	network	NOUN
iajs-3385	81	244	with	with	ADP
iajs-3385	81	245	the	the	DET
iajs-3385	81	246	lower	low	ADJ
iajs-3385	81	247	backward	backward	ADV
iajs-3385	81	248	-	-	PUNCT
iajs-3385	81	249	spread	spread	VERB
iajs-3385	81	250	set	set	NOUN
iajs-3385	81	251	of	of	ADP
iajs-3385	81	252	rules	rule	NOUN
iajs-3385	81	253	,	,	PUNCT
iajs-3385	81	254	rmse	rmse	NOUN
iajs-3385	81	255	:	:	PUNCT
iajs-3385	81	256	0.34	0.34	NUM
iajs-3385	81	257	tablets	tablet	NOUN
iajs-3385	81	258	2022	2022	NUM
iajs-3385	81	259	(	(	PUNCT
iajs-3385	81	260	37	37	NUM
iajs-3385	81	261	)	)	PUNCT
iajs-3385	81	262	r	r	NOUN
iajs-3385	81	263	if	if	SCONJ
iajs-3385	81	264	a	a	PRON
iajs-3385	81	265	m	m	VERB
iajs-3385	81	266	p	p	NOUN
iajs-3385	81	267	ic	ic	PROPN
iajs-3385	81	268	in	in	ADP
iajs-3385	81	269	piperine	piperine	NOUN
iajs-3385	81	270	q	q	ADJ
iajs-3385	81	271	-	-	PUNCT
iajs-3385	81	272	absorbance	absorbance	NOUN
iajs-3385	81	273	method	method	NOUN
iajs-3385	81	274	λ=	λ=	VERB
iajs-3385	81	275	387	387	NUM
iajs-3385	81	276	nm	nm	NOUN
iajs-3385	81	277	,	,	PUNCT
iajs-3385	81	278	337	337	NUM
iajs-3385	81	279	nm	nm	NOUN
iajs-3385	81	280	,	,	PUNCT
iajs-3385	81	281	linearity	linearity	NOUN
iajs-3385	81	282	range	range	NOUN
iajs-3385	81	283	:	:	PUNCT
iajs-3385	81	284	5–40	5–40	NUM
iajs-3385	81	285	μg	μg	PROPN
iajs-3385	81	286	/	/	SYM
iajs-3385	81	287	ml	ml	PROPN
iajs-3385	81	288	,	,	PUNCT
iajs-3385	81	289	r2	r2	NOUN
iajs-3385	81	290	0.999	0.999	NUM
iajs-3385	81	291	,	,	PUNCT
iajs-3385	81	292	recovery	recovery	NOUN
iajs-3385	81	293	98.36	98.36	NUM
iajs-3385	81	294	-	-	SYM
iajs-3385	81	295	99.53	99.53	NUM
iajs-3385	81	296	%	%	NOUN
iajs-3385	81	297	,	,	PUNCT
iajs-3385	81	298	lod	lod	PROPN
iajs-3385	81	299	1.51μg	1.51μg	NUM
iajs-3385	81	300	/	/	SYM
iajs-3385	81	301	ml	ml	VERB
iajs-3385	81	302	combined	combine	VERB
iajs-3385	81	303	capsule	capsule	NOUN
iajs-3385	81	304	2012	2012	NUM
iajs-3385	81	305	(	(	PUNCT
iajs-3385	81	306	38	38	NUM
iajs-3385	81	307	)	)	PUNCT
iajs-3385	81	308	isoniazid	isoniazid	NOUN
iajs-3385	81	309	partial	partial	ADJ
iajs-3385	81	310	least	least	ADJ
iajs-3385	81	311	squares	square	NOUN
iajs-3385	81	312	regression	regression	NOUN
iajs-3385	81	313	(	(	PUNCT
iajs-3385	81	314	plsr	plsr	PROPN
iajs-3385	81	315	)	)	PUNCT
iajs-3385	81	316	λ=	λ=	VERB
iajs-3385	81	317	449	449	NUM
iajs-3385	81	318	nm	nm	NOUN
iajs-3385	81	319	,	,	PUNCT
iajs-3385	81	320	linearity	linearity	NOUN
iajs-3385	81	321	range	range	NOUN
iajs-3385	81	322	:	:	PUNCT
iajs-3385	81	323	8	8	NUM
iajs-3385	81	324	-57	-57	PROPN
iajs-3385	81	325	μg	μg	PROPN
iajs-3385	81	326	/	/	SYM
iajs-3385	81	327	ml	ml	PROPN
iajs-3385	81	328	,	,	PUNCT
iajs-3385	81	329	recovery	recovery	NOUN
iajs-3385	81	330	92	92	NUM
iajs-3385	81	331	119	119	NUM
iajs-3385	81	332	%	%	NOUN
iajs-3385	81	333	,	,	PUNCT
iajs-3385	81	334	rmsep3lvs1.64	rmsep3lvs1.64	PROPN
iajs-3385	81	335	μg	μg	PROPN
iajs-3385	81	336	/	/	SYM
iajs-3385	81	337	ml	ml	X
iajs-3385	81	338	urine	urine	NOUN
iajs-3385	81	339	,	,	PUNCT
iajs-3385	81	340	pharmaceutical	pharmaceutical	NOUN
iajs-3385	81	341	formulations	formulation	NOUN
iajs-3385	81	342	2013	2013	NUM
iajs-3385	81	343	(	(	PUNCT
iajs-3385	81	344	39	39	NUM
iajs-3385	81	345	)	)	PUNCT
iajs-3385	81	346	isoniazid	isoniazid	VERB
iajs-3385	81	347	simultaneous	simultaneous	ADJ
iajs-3385	81	348	equation	equation	NOUN
iajs-3385	81	349	λ=	λ=	VERB
iajs-3385	81	350	338	338	NUM
iajs-3385	81	351	nm	nm	NOUN
iajs-3385	81	352	,	,	PUNCT
iajs-3385	81	353	linearity	linearity	NOUN
iajs-3385	81	354	range	range	NOUN
iajs-3385	81	355	:	:	PUNCT
iajs-3385	81	356	5	5	NUM
iajs-3385	81	357	-50	-50	PUNCT
iajs-3385	81	358	μg	μg	PROPN
iajs-3385	81	359	/	/	SYM
iajs-3385	81	360	ml	ml	PROPN
iajs-3385	81	361	,	,	PUNCT
iajs-3385	81	362	r2	r2	PROPN
iajs-3385	81	363	0.992	0.992	NUM
iajs-3385	81	364	,	,	PUNCT
iajs-3385	81	365	recovery	recovery	NOUN
iajs-3385	81	366	98.12	98.12	NUM
iajs-3385	81	367	-	-	SYM
iajs-3385	81	368	98.32	98.32	NUM
iajs-3385	81	369	%	%	NOUN
iajs-3385	81	370	,	,	PUNCT
iajs-3385	81	371	lod	lod	PROPN
iajs-3385	81	372	3.50	3.50	NUM
iajs-3385	81	373	μg	μg	PROPN
iajs-3385	81	374	/	/	SYM
iajs-3385	81	375	ml	ml	X
iajs-3385	81	376	co	co	ADJ
iajs-3385	81	377	-	-	ADJ
iajs-3385	81	378	formulated	formulate	VERB
iajs-3385	81	379	tablets	tablet	NOUN
iajs-3385	81	380	2017	2017	NUM
iajs-3385	81	381	(	(	PUNCT
iajs-3385	81	382	40	40	NUM
iajs-3385	81	383	)	)	PUNCT
iajs-3385	81	384	first	first	ADJ
iajs-3385	81	385	-	-	PUNCT
iajs-3385	81	386	derivative	derivative	NOUN
iajs-3385	81	387	spectrophotometry	spectrophotometry	NOUN
iajs-3385	81	388	λ=	λ=	VERB
iajs-3385	81	389	263	263	NUM
iajs-3385	81	390	nm	nm	NOUN
iajs-3385	81	391	,	,	PUNCT
iajs-3385	81	392	linearity	linearity	NOUN
iajs-3385	81	393	range	range	NOUN
iajs-3385	81	394	:	:	PUNCT
iajs-3385	81	395	550	550	NUM
iajs-3385	81	396	μg	μg	NOUN
iajs-3385	81	397	/	/	SYM
iajs-3385	81	398	ml	ml	PROPN
iajs-3385	81	399	,	,	PUNCT
iajs-3385	81	400	r2	r2	PROPN
iajs-3385	81	401	0.996	0.996	NUM
iajs-3385	81	402	,	,	PUNCT
iajs-3385	81	403	recovery	recovery	NOUN
iajs-3385	81	404	98.80	98.80	NUM
iajs-3385	81	405	-	-	SYM
iajs-3385	81	406	99.15%,lod2.30	99.15%,lod2.30	NUM
iajs-3385	81	407	μg	μg	PROPN
iajs-3385	81	408	/	/	SYM
iajs-3385	81	409	ml	ml	NOUN
iajs-3385	81	410	ihjpas	ihjpas	PROPN
iajs-3385	81	411	.	.	PUNCT
iajs-3385	82	1	2025	2025	NUM
iajs-3385	82	2	,	,	PUNCT
iajs-3385	82	3	38(2	38(2	NUM
iajs-3385	82	4	)	)	PUNCT
iajs-3385	82	5	210	210	NUM
iajs-3385	82	6	drug	drug	NOUN
iajs-3385	82	7	method(s	method(	VERB
iajs-3385	82	8	)	)	PUNCT
iajs-3385	82	9	analytical	analytical	ADJ
iajs-3385	82	10	results	result	NOUN
iajs-3385	82	11	application	application	NOUN
iajs-3385	82	12	remark	remark	NOUN
iajs-3385	82	13	year	year	NOUN
iajs-3385	82	14	ref	ref	NOUN
iajs-3385	82	15	target	target	NOUN
iajs-3385	82	16	combined(s	combined(s	NOUN
iajs-3385	82	17	)	)	PUNCT
iajs-3385	82	18	isoniazid	isoniazid	NOUN
iajs-3385	82	19	,	,	PUNCT
iajs-3385	82	20	pyrazinamide	pyrazinamide	VERB
iajs-3385	82	21	first	first	ADJ
iajs-3385	82	22	order	order	NOUN
iajs-3385	82	23	derivative	derivative	ADJ
iajs-3385	82	24	spectrophotometry	spectrophotometry	NOUN
iajs-3385	82	25	λ=	λ=	VERB
iajs-3385	82	26	322	322	NUM
iajs-3385	82	27	nm	nm	NOUN
iajs-3385	82	28	,	,	PUNCT
iajs-3385	82	29	linearity	linearity	NOUN
iajs-3385	82	30	range	range	NOUN
iajs-3385	82	31	:	:	PUNCT
iajs-3385	82	32	1.5	1.5	NUM
iajs-3385	82	33	-	-	SYM
iajs-3385	82	34	7.5	7.5	NUM
iajs-3385	82	35	μg	μg	NOUN
iajs-3385	82	36	/	/	SYM
iajs-3385	82	37	ml	ml	PROPN
iajs-3385	82	38	,	,	PUNCT
iajs-3385	82	39	r2	r2	PROPN
iajs-3385	82	40	0.9927	0.9927	NUM
iajs-3385	82	41	,	,	PUNCT
iajs-3385	82	42	recovery	recovery	NOUN
iajs-3385	82	43	100.80	100.80	NUM
iajs-3385	82	44	%	%	NOUN
iajs-3385	82	45	,	,	PUNCT
iajs-3385	82	46	lod	lod	PROPN
iajs-3385	82	47	0.03μg	0.03μg	PROPN
iajs-3385	82	48	/	/	SYM
iajs-3385	82	49	ml	ml	NOUN
iajs-3385	82	50	bulk	bulk	ADJ
iajs-3385	82	51	form	form	NOUN
iajs-3385	82	52	,	,	PUNCT
iajs-3385	82	53	pharmaceutical	pharmaceutical	ADJ
iajs-3385	82	54	dosage	dosage	NOUN
iajs-3385	82	55	form	form	NOUN
iajs-3385	82	56	2020	2020	NUM
iajs-3385	82	57	(	(	PUNCT
iajs-3385	82	58	41	41	NUM
iajs-3385	82	59	)	)	PUNCT
iajs-3385	82	60	isoniazid	isoniazid	NOUN
iajs-3385	82	61	vierordt	vierordt	NOUN
iajs-3385	82	62	's	's	PART
iajs-3385	82	63	method	method	NOUN
iajs-3385	82	64	λ=	λ=	VERB
iajs-3385	82	65	335	335	NUM
iajs-3385	82	66	nm	nm	NOUN
iajs-3385	82	67	,	,	PUNCT
iajs-3385	82	68	linearity	linearity	NOUN
iajs-3385	82	69	range	range	NOUN
iajs-3385	82	70	:	:	PUNCT
iajs-3385	82	71	6	6	NUM
iajs-3385	82	72	-	-	SYM
iajs-3385	82	73	36	36	NUM
iajs-3385	82	74	μg	μg	NOUN
iajs-3385	82	75	/	/	SYM
iajs-3385	82	76	ml	ml	ADP
iajs-3385	82	77	simulated	simulate	VERB
iajs-3385	82	78	lungs	lung	NOUN
iajs-3385	82	79	alveolar	alveolar	ADJ
iajs-3385	82	80	macrophages	macrophage	NOUN
iajs-3385	82	81	fluid	fluid	ADJ
iajs-3385	82	82	2022	2022	NUM
iajs-3385	82	83	(	(	PUNCT
iajs-3385	82	84	42	42	NUM
iajs-3385	82	85	)	)	PUNCT
iajs-3385	82	86	s	s	PART
iajs-3385	82	87	u	u	NOUN
iajs-3385	82	88	lf	lf	ADP
iajs-3385	82	89	a	a	DET
iajs-3385	82	90	m	m	NOUN
iajs-3385	82	91	et	et	NOUN
iajs-3385	82	92	h	h	NOUN
iajs-3385	82	93	o	o	NOUN
iajs-3385	82	94	x	x	X
iajs-3385	82	95	a	a	DET
iajs-3385	82	96	zo	zo	PROPN
iajs-3385	82	97	le	le	X
iajs-3385	82	98	trimethoprim	trimethoprim	NOUN
iajs-3385	82	99	first	first	ADJ
iajs-3385	82	100	derivative	derivative	ADJ
iajs-3385	82	101	method	method	NOUN
iajs-3385	82	102	λ=	λ=	VERB
iajs-3385	82	103	288	288	NUM
iajs-3385	82	104	nm	nm	NOUN
iajs-3385	82	105	,	,	PUNCT
iajs-3385	82	106	linearity	linearity	NOUN
iajs-3385	82	107	range	range	NOUN
iajs-3385	82	108	:	:	PUNCT
iajs-3385	82	109	420	420	NUM
iajs-3385	82	110	μg	μg	PROPN
iajs-3385	82	111	/	/	SYM
iajs-3385	82	112	ml	ml	PROPN
iajs-3385	82	113	,	,	PUNCT
iajs-3385	82	114	r2	r2	PROPN
iajs-3385	82	115	0.9999	0.9999	NUM
iajs-3385	82	116	,	,	PUNCT
iajs-3385	82	117	recovery	recovery	NOUN
iajs-3385	82	118	108.64	108.64	NUM
iajs-3385	82	119	%	%	NOUN
iajs-3385	82	120	tablets	tablet	NOUN
iajs-3385	82	121	,	,	PUNCT
iajs-3385	82	122	syrups	syrup	NOUN
iajs-3385	82	123	1997	1997	NUM
iajs-3385	82	124	(	(	PUNCT
iajs-3385	82	125	43	43	NUM
iajs-3385	82	126	)	)	PUNCT
iajs-3385	82	127	classical	classical	ADJ
iajs-3385	82	128	least	least	ADJ
iajs-3385	82	129	squares	square	NOUN
iajs-3385	82	130	(	(	PUNCT
iajs-3385	82	131	cls	cls	NOUN
iajs-3385	82	132	)	)	PUNCT
iajs-3385	82	133	method	method	NOUN
iajs-3385	82	134	λ=	λ=	VERB
iajs-3385	82	135	200	200	NUM
iajs-3385	82	136	-	-	SYM
iajs-3385	82	137	350	350	NUM
iajs-3385	82	138	nm	nm	NOUN
iajs-3385	82	139	,	,	PUNCT
iajs-3385	82	140	linearity	linearity	NOUN
iajs-3385	82	141	range	range	NOUN
iajs-3385	82	142	:	:	PUNCT
iajs-3385	82	143	4	4	NUM
iajs-3385	82	144	-	-	SYM
iajs-3385	82	145	20	20	NUM
iajs-3385	82	146	μg	μg	NOUN
iajs-3385	82	147	/	/	SYM
iajs-3385	82	148	ml	ml	PROPN
iajs-3385	82	149	,	,	PUNCT
iajs-3385	82	150	recovery	recovery	NOUN
iajs-3385	82	151	100.00	100.00	NUM
iajs-3385	82	152	%	%	NOUN
iajs-3385	82	153	sulfacetamide	sulfacetamide	ADJ
iajs-3385	82	154	1st	1st	PROPN
iajs-3385	82	155	derivative	derivative	NOUN
iajs-3385	82	156	:	:	PUNCT
iajs-3385	82	157	peak	peak	NOUN
iajs-3385	82	158	to	to	PART
iajs-3385	82	159	baseline	baseline	VERB
iajs-3385	82	160	,	,	PUNCT
iajs-3385	82	161	peak	peak	NOUN
iajs-3385	82	162	to	to	PART
iajs-3385	82	163	peak	peak	VERB
iajs-3385	82	164	,	,	PUNCT
iajs-3385	82	165	and	and	CCONJ
iajs-3385	82	166	peak	peak	NOUN
iajs-3385	82	167	area	area	NOUN
iajs-3385	82	168	λ=	λ=	VERB
iajs-3385	82	169	219.75	219.75	NUM
iajs-3385	82	170	nm	nm	NOUN
iajs-3385	82	171	,	,	PUNCT
iajs-3385	82	172	(	(	PUNCT
iajs-3385	82	173	219.0	219.0	NUM
iajs-3385	82	174	,	,	PUNCT
iajs-3385	82	175	253.0	253.0	NUM
iajs-3385	82	176	)	)	PUNCT
iajs-3385	82	177	nm	nm	NOUN
iajs-3385	82	178	,	,	PUNCT
iajs-3385	82	179	and	and	CCONJ
iajs-3385	82	180	(	(	PUNCT
iajs-3385	82	181	270.2	270.2	NUM
iajs-3385	82	182	-	-	PUNCT
iajs-3385	82	183	322.5)nm	322.5)nm	NUM
iajs-3385	82	184	,	,	PUNCT
iajs-3385	82	185	linearity	linearity	NOUN
iajs-3385	82	186	range	range	NOUN
iajs-3385	82	187	:	:	PUNCT
iajs-3385	82	188	1–8μg	1–8μg	NUM
iajs-3385	82	189	/	/	SYM
iajs-3385	82	190	ml	ml	NOUN
iajs-3385	82	191	,	,	PUNCT
iajs-3385	82	192	recovery	recovery	NOUN
iajs-3385	82	193	98.9	98.9	NUM
iajs-3385	82	194	-	-	SYM
iajs-3385	82	195	101.4	101.4	NUM
iajs-3385	82	196	%	%	NOUN
iajs-3385	82	197	synthetic	synthetic	ADJ
iajs-3385	82	198	sample	sample	NOUN
iajs-3385	82	199	and	and	CCONJ
iajs-3385	82	200	urine	urine	NOUN
iajs-3385	82	201	2014	2014	NUM
iajs-3385	82	202	(	(	PUNCT
iajs-3385	82	203	44	44	NUM
iajs-3385	82	204	)	)	PUNCT
iajs-3385	82	205	2nd	2nd	NOUN
iajs-3385	82	206	derivative	derivative	NOUN
iajs-3385	82	207	:	:	PUNCT
iajs-3385	82	208	peak	peak	NOUN
iajs-3385	82	209	to	to	PART
iajs-3385	82	210	baseline	baseline	VERB
iajs-3385	82	211	,	,	PUNCT
iajs-3385	82	212	peak	peak	NOUN
iajs-3385	82	213	to	to	PART
iajs-3385	82	214	peak	peak	VERB
iajs-3385	82	215	,	,	PUNCT
iajs-3385	82	216	and	and	CCONJ
iajs-3385	82	217	peak	peak	NOUN
iajs-3385	82	218	area	area	NOUN
iajs-3385	82	219	λ=	λ=	VERB
iajs-3385	82	220	275.0	275.0	NUM
iajs-3385	82	221	nm	nm	NOUN
iajs-3385	82	222	,	,	PUNCT
iajs-3385	82	223	(	(	PUNCT
iajs-3385	82	224	232.0	232.0	NUM
iajs-3385	82	225	,	,	PUNCT
iajs-3385	82	226	275.0	275.0	NUM
iajs-3385	82	227	)	)	PUNCT
iajs-3385	82	228	nm	nm	NOUN
iajs-3385	82	229	,	,	PUNCT
iajs-3385	82	230	and	and	CCONJ
iajs-3385	82	231	(	(	PUNCT
iajs-3385	82	232	215.2	215.2	NUM
iajs-3385	82	233	-	-	PUNCT
iajs-3385	82	234	227.4)nm	227.4)nm	NUM
iajs-3385	82	235	,	,	PUNCT
iajs-3385	82	236	linearity	linearity	NOUN
iajs-3385	82	237	range	range	NOUN
iajs-3385	82	238	:	:	PUNCT
iajs-3385	82	239	1–8μg	1–8μg	NUM
iajs-3385	82	240	/	/	SYM
iajs-3385	82	241	ml	ml	NOUN
iajs-3385	82	242	,	,	PUNCT
iajs-3385	82	243	recovery	recovery	NOUN
iajs-3385	82	244	98.1	98.1	NUM
iajs-3385	82	245	-	-	SYM
iajs-3385	82	246	102.3	102.3	NUM
iajs-3385	82	247	%	%	NOUN
iajs-3385	82	248	pls1	pls1	NOUN
iajs-3385	82	249	,	,	PUNCT
iajs-3385	82	250	pls2	pls2	PROPN
iajs-3385	82	251	λ=190	λ=190	PROPN
iajs-3385	82	252	-	-	PUNCT
iajs-3385	82	253	350	350	NUM
iajs-3385	82	254	nm	nm	NOUN
iajs-3385	82	255	,	,	PUNCT
iajs-3385	82	256	linearity	linearity	NOUN
iajs-3385	82	257	range:1–8μg	range:1–8μg	NOUN
iajs-3385	82	258	/	/	SYM
iajs-3385	82	259	ml	ml	NOUN
iajs-3385	82	260	,	,	PUNCT
iajs-3385	82	261	recovery100.72	recovery100.72	NOUN
iajs-3385	82	262	%	%	NOUN
iajs-3385	82	263	,	,	PUNCT
iajs-3385	82	264	01.16	01.16	NUM
iajs-3385	82	265	%	%	NOUN
iajs-3385	82	266	trimethoprim	trimethoprim	ADJ
iajs-3385	82	267	partial	partial	ADJ
iajs-3385	82	268	least	least	ADV
iajs-3385	82	269	square	square	ADJ
iajs-3385	82	270	(	(	PUNCT
iajs-3385	82	271	pls	pls	INTJ
iajs-3385	82	272	)	)	PUNCT
iajs-3385	82	273	regression	regression	NOUN
iajs-3385	82	274	λ=	λ=	VERB
iajs-3385	82	275	200	200	NUM
iajs-3385	82	276	-	-	SYM
iajs-3385	82	277	400	400	NUM
iajs-3385	82	278	nm	nm	NOUN
iajs-3385	82	279	,	,	PUNCT
iajs-3385	82	280	linearity	linearity	NOUN
iajs-3385	82	281	range	range	NOUN
iajs-3385	82	282	:	:	PUNCT
iajs-3385	82	283	1–16μg	1–16μg	NUM
iajs-3385	82	284	/	/	SYM
iajs-3385	82	285	ml	ml	NOUN
iajs-3385	82	286	,	,	PUNCT
iajs-3385	82	287	r2	r2	PROPN
iajs-3385	82	288	0.99	0.99	NUM
iajs-3385	83	1	rmsec	rmsec	PROPN
iajs-3385	83	2	0.167	0.167	NUM
iajs-3385	83	3	%	%	NOUN
iajs-3385	83	4	,	,	PUNCT
iajs-3385	83	5	recovery	recovery	NOUN
iajs-3385	83	6	100.72	100.72	NUM
iajs-3385	83	7	%	%	NOUN
iajs-3385	83	8	,	,	PUNCT
iajs-3385	83	9	101.16	101.16	NUM
iajs-3385	83	10	%	%	NOUN
iajs-3385	83	11	combined	combine	VERB
iajs-3385	83	12	tablets	tablet	NOUN
iajs-3385	83	13	2015	2015	NUM
iajs-3385	83	14	(	(	PUNCT
iajs-3385	83	15	45	45	NUM
iajs-3385	83	16	)	)	PUNCT
iajs-3385	83	17	trimethoprim	trimethoprim	NOUN
iajs-3385	83	18	mean	mean	VERB
iajs-3385	83	19	centering	centering	NOUN
iajs-3385	83	20	of	of	ADP
iajs-3385	83	21	ratio	ratio	NOUN
iajs-3385	83	22	spectra	spectra	PROPN
iajs-3385	83	23	(	(	PUNCT
iajs-3385	83	24	mcr	mcr	PROPN
iajs-3385	83	25	)	)	PUNCT
iajs-3385	83	26	λ=	λ=	VERB
iajs-3385	83	27	200	200	NUM
iajs-3385	83	28	-	-	SYM
iajs-3385	83	29	400	400	NUM
iajs-3385	83	30	nm	nm	NOUN
iajs-3385	83	31	,	,	PUNCT
iajs-3385	83	32	linearity	linearity	NOUN
iajs-3385	83	33	range:3.5–9.5μg	range:3.5–9.5μg	NOUN
iajs-3385	83	34	/	/	SYM
iajs-3385	83	35	ml	ml	NOUN
iajs-3385	83	36	,	,	PUNCT
iajs-3385	83	37	recovery	recovery	NOUN
iajs-3385	83	38	103.31±0.34	103.31±0.34	NOUN
iajs-3385	83	39	%	%	NOUN
iajs-3385	83	40	tablets	tablet	NOUN
iajs-3385	83	41	2018	2018	NUM
iajs-3385	83	42	(	(	PUNCT
iajs-3385	83	43	46	46	NUM
iajs-3385	83	44	)	)	PUNCT
iajs-3385	83	45	trimethoprim	trimethoprim	PROPN
iajs-3385	83	46	aea	aea	PROPN
iajs-3385	83	47	under	under	ADP
iajs-3385	83	48	peak	peak	NOUN
iajs-3385	83	49	of	of	ADP
iajs-3385	83	50	sia	sia	PROPN
iajs-3385	83	51	λ=	λ=	VERB
iajs-3385	83	52	540	540	NUM
iajs-3385	83	53	nm	nm	NOUN
iajs-3385	83	54	and	and	CCONJ
iajs-3385	83	55	264	264	NUM
iajs-3385	83	56	nm	nm	NOUN
iajs-3385	83	57	,	,	PUNCT
iajs-3385	83	58	linearity	linearity	NOUN
iajs-3385	83	59	range	range	NOUN
iajs-3385	83	60	:	:	PUNCT
iajs-3385	83	61	0.1	0.1	NUM
iajs-3385	83	62	-	-	SYM
iajs-3385	83	63	10	10	NUM
iajs-3385	83	64	μg	μg	NOUN
iajs-3385	83	65	/	/	SYM
iajs-3385	83	66	ml	ml	PROPN
iajs-3385	83	67	and	and	CCONJ
iajs-3385	83	68	0.03	0.03	NUM
iajs-3385	83	69	-	-	SYM
iajs-3385	83	70	5	5	NUM
iajs-3385	83	71	μg	μg	NOUN
iajs-3385	83	72	/	/	SYM
iajs-3385	83	73	ml	ml	PROPN
iajs-3385	83	74	,	,	PUNCT
iajs-3385	83	75	r2	r2	PROPN
iajs-3385	83	76	0.9797	0.9797	NUM
iajs-3385	83	77	and	and	CCONJ
iajs-3385	83	78	0.9928	0.9928	NUM
iajs-3385	83	79	,	,	PUNCT
iajs-3385	83	80	lod	lod	PROPN
iajs-3385	83	81	0.01	0.01	NUM
iajs-3385	83	82	and	and	CCONJ
iajs-3385	83	83	0.03	0.03	NUM
iajs-3385	83	84	μg	μg	NOUN
iajs-3385	83	85	/	/	SYM
iajs-3385	83	86	ml	ml	VERB
iajs-3385	83	87	tablets	tablet	NOUN
iajs-3385	83	88	2020	2020	NUM
iajs-3385	83	89	(	(	PUNCT
iajs-3385	83	90	47	47	NUM
iajs-3385	83	91	)	)	PUNCT
iajs-3385	83	92	4	4	NUM
iajs-3385	84	1	.	.	X
iajs-3385	84	2	conclusion	conclusion	NOUN
iajs-3385	84	3	due	due	ADP
iajs-3385	84	4	to	to	ADP
iajs-3385	84	5	numerous	numerous	ADJ
iajs-3385	84	6	benefits	benefit	NOUN
iajs-3385	84	7	such	such	ADJ
iajs-3385	84	8	patient	patient	ADJ
iajs-3385	84	9	compliance	compliance	NOUN
iajs-3385	84	10	,	,	PUNCT
iajs-3385	84	11	timely	timely	ADJ
iajs-3385	84	12	dose	dose	NOUN
iajs-3385	84	13	administration	administration	NOUN
iajs-3385	84	14	,	,	PUNCT
iajs-3385	84	15	and	and	CCONJ
iajs-3385	84	16	fewer	few	ADJ
iajs-3385	84	17	doses	dose	NOUN
iajs-3385	84	18	,	,	PUNCT
iajs-3385	84	19	multi	multi	ADJ
iajs-3385	84	20	-	-	ADJ
iajs-3385	84	21	drug	drug	ADJ
iajs-3385	84	22	therapies	therapy	NOUN
iajs-3385	84	23	and	and	CCONJ
iajs-3385	84	24	formulations	formulation	NOUN
iajs-3385	84	25	are	be	AUX
iajs-3385	84	26	becoming	become	VERB
iajs-3385	84	27	increasingly	increasingly	ADV
iajs-3385	84	28	important	important	ADJ
iajs-3385	84	29	.	.	PUNCT
iajs-3385	85	1	analytical	analytical	ADJ
iajs-3385	85	2	chemists	chemist	NOUN
iajs-3385	85	3	must	must	AUX
iajs-3385	85	4	pursue	pursue	VERB
iajs-3385	85	5	new	new	ADJ
iajs-3385	85	6	directions	direction	NOUN
iajs-3385	85	7	and	and	CCONJ
iajs-3385	85	8	develop	develop	VERB
iajs-3385	85	9	new	new	ADJ
iajs-3385	85	10	,	,	PUNCT
iajs-3385	85	11	accurate	accurate	ADJ
iajs-3385	85	12	,	,	PUNCT
iajs-3385	85	13	precise	precise	ADJ
iajs-3385	85	14	,	,	PUNCT
iajs-3385	85	15	cost	cost	NOUN
iajs-3385	85	16	-	-	PUNCT
iajs-3385	85	17	effective	effective	ADJ
iajs-3385	85	18	,	,	PUNCT
iajs-3385	85	19	timeeffective	timeeffective	NOUN
iajs-3385	85	20	,	,	PUNCT
iajs-3385	85	21	and	and	CCONJ
iajs-3385	85	22	simple	simple	ADJ
iajs-3385	85	23	methodologies	methodology	NOUN
iajs-3385	85	24	to	to	PART
iajs-3385	85	25	estimate	estimate	VERB
iajs-3385	85	26	pharmaceuticals	pharmaceutical	NOUN
iajs-3385	85	27	in	in	ADP
iajs-3385	85	28	a	a	DET
iajs-3385	85	29	multi	multi	ADJ
iajs-3385	85	30	-	-	ADJ
iajs-3385	85	31	component	component	ADJ
iajs-3385	85	32	system	system	NOUN
iajs-3385	85	33	.	.	PUNCT
iajs-3385	86	1	due	due	ADP
iajs-3385	86	2	to	to	ADP
iajs-3385	86	3	their	their	PRON
iajs-3385	86	4	inherent	inherent	ADJ
iajs-3385	86	5	advantages	advantage	NOUN
iajs-3385	86	6	,	,	PUNCT
iajs-3385	86	7	simultaneous	simultaneous	ADJ
iajs-3385	86	8	analysis	analysis	NOUN
iajs-3385	86	9	procedures	procedure	NOUN
iajs-3385	86	10	are	be	AUX
iajs-3385	86	11	used	use	VERB
iajs-3385	86	12	more	more	ADV
iajs-3385	86	13	frequently	frequently	ADV
iajs-3385	86	14	for	for	ADP
iajs-3385	86	15	ihjpas	ihjpa	NOUN
iajs-3385	86	16	.	.	PUNCT
iajs-3385	87	1	2025	2025	NUM
iajs-3385	87	2	,	,	PUNCT
iajs-3385	87	3	38(2	38(2	NUM
iajs-3385	87	4	)	)	PUNCT
iajs-3385	87	5	211	211	NUM
iajs-3385	87	6	drug	drug	NOUN
iajs-3385	87	7	estimation	estimation	NOUN
iajs-3385	87	8	in	in	ADP
iajs-3385	87	9	multi	multi	ADJ
iajs-3385	87	10	-	-	ADJ
iajs-3385	87	11	component	component	ADJ
iajs-3385	87	12	pharmaceutical	pharmaceutical	NOUN
iajs-3385	87	13	formulations	formulation	NOUN
iajs-3385	87	14	.	.	PUNCT
iajs-3385	88	1	these	these	DET
iajs-3385	88	2	advantages	advantage	NOUN
iajs-3385	88	3	include	include	VERB
iajs-3385	88	4	avoiding	avoid	VERB
iajs-3385	88	5	time	time	NOUN
iajs-3385	88	6	-	-	PUNCT
iajs-3385	88	7	consuming	consume	VERB
iajs-3385	88	8	extraction	extraction	NOUN
iajs-3385	88	9	and	and	CCONJ
iajs-3385	88	10	separation	separation	NOUN
iajs-3385	88	11	,	,	PUNCT
iajs-3385	88	12	being	be	AUX
iajs-3385	88	13	economical	economical	ADJ
iajs-3385	88	14	by	by	ADP
iajs-3385	88	15	using	use	VERB
iajs-3385	88	16	fewer	few	ADJ
iajs-3385	88	17	expensive	expensive	ADJ
iajs-3385	88	18	regents	regent	NOUN
iajs-3385	88	19	,	,	PUNCT
iajs-3385	88	20	and	and	CCONJ
iajs-3385	88	21	being	be	AUX
iajs-3385	88	22	equally	equally	ADV
iajs-3385	88	23	accurate	accurate	ADJ
iajs-3385	88	24	and	and	CCONJ
iajs-3385	88	25	precise	precise	ADJ
iajs-3385	88	26	.	.	PUNCT
iajs-3385	89	1	according	accord	VERB
iajs-3385	89	2	to	to	ADP
iajs-3385	89	3	the	the	DET
iajs-3385	89	4	international	international	ADJ
iajs-3385	89	5	conference	conference	NOUN
iajs-3385	89	6	on	on	ADP
iajs-3385	89	7	harmonization	harmonization	NOUN
iajs-3385	89	8	recommendations	recommendation	NOUN
iajs-3385	89	9	,	,	PUNCT
iajs-3385	89	10	techniques	technique	NOUN
iajs-3385	89	11	must	must	AUX
iajs-3385	89	12	be	be	AUX
iajs-3385	89	13	validated	validate	VERB
iajs-3385	89	14	using	use	VERB
iajs-3385	89	15	the	the	DET
iajs-3385	89	16	same	same	ADJ
iajs-3385	89	17	parameters	parameter	NOUN
iajs-3385	89	18	.	.	PUNCT
iajs-3385	90	1	acknowledgment	acknowledgment	NOUN
iajs-3385	90	2	this	this	DET
iajs-3385	90	3	work	work	NOUN
iajs-3385	90	4	was	be	AUX
iajs-3385	90	5	partially	partially	ADV
iajs-3385	90	6	supported	support	VERB
iajs-3385	90	7	by	by	ADP
iajs-3385	90	8	the	the	DET
iajs-3385	90	9	department	department	NOUN
iajs-3385	90	10	of	of	ADP
iajs-3385	90	11	chemistry/	chemistry/	NUM
iajs-3385	90	12	college	college	NOUN
iajs-3385	90	13	of	of	ADP
iajs-3385	90	14	education	education	NOUN
iajs-3385	90	15	for	for	ADP
iajs-3385	90	16	pure	pure	ADJ
iajs-3385	90	17	science	science	NOUN
iajs-3385	90	18	(	(	PUNCT
iajs-3385	90	19	ibn	ibn	PROPN
iajs-3385	90	20	alhaitham)/	alhaitham)/	PROPN
iajs-3385	90	21	university	university	PROPN
iajs-3385	90	22	of	of	ADP
iajs-3385	90	23	baghdad	baghdad	PROPN
iajs-3385	90	24	.	.	PUNCT
iajs-3385	91	1	conflict	conflict	NOUN
iajs-3385	91	2	of	of	ADP
iajs-3385	91	3	interest	interest	NOUN
iajs-3385	91	4	the	the	DET
iajs-3385	91	5	authors	author	NOUN
iajs-3385	91	6	declare	declare	VERB
iajs-3385	91	7	that	that	SCONJ
iajs-3385	91	8	they	they	PRON
iajs-3385	91	9	have	have	VERB
iajs-3385	91	10	no	no	DET
iajs-3385	91	11	conflicts	conflict	NOUN
iajs-3385	91	12	of	of	ADP
iajs-3385	91	13	interest	interest	NOUN
iajs-3385	91	14	.	.	PUNCT
iajs-3385	92	1	funding	fund	VERB
iajs-3385	92	2	no	no	DET
iajs-3385	92	3	financial	financial	ADJ
iajs-3385	92	4	support	support	NOUN
iajs-3385	92	5	was	be	AUX
iajs-3385	92	6	found	find	VERB
iajs-3385	92	7	.	.	PUNCT
iajs-3385	93	1	ethical	ethical	ADJ
iajs-3385	93	2	clearance	clearance	NOUN
iajs-3385	93	3	the	the	DET
iajs-3385	93	4	study	study	NOUN
iajs-3385	93	5	has	have	AUX
iajs-3385	93	6	been	be	AUX
iajs-3385	93	7	approved	approve	VERB
iajs-3385	93	8	by	by	ADP
iajs-3385	93	9	the	the	DET
iajs-3385	93	10	committee	committee	NOUN
iajs-3385	93	11	of	of	ADP
iajs-3385	93	12	the	the	DET
iajs-3385	93	13	university	university	NOUN
iajs-3385	93	14	of	of	ADP
iajs-3385	93	15	baghdad/	baghdad/	NUM
iajs-3385	93	16	college	college	NOUN
iajs-3385	93	17	of	of	ADP
iajs-3385	93	18	education	education	NOUN
iajs-3385	93	19	for	for	ADP
iajs-3385	93	20	pure	pure	ADJ
iajs-3385	93	21	science	science	NOUN
iajs-3385	93	22	(	(	PUNCT
iajs-3385	93	23	ibn	ibn	PROPN
iajs-3385	93	24	al	al	PROPN
iajs-3385	93	25	-	-	PUNCT
iajs-3385	93	26	haitham	haitham	PROPN
iajs-3385	93	27	)	)	PUNCT
iajs-3385	93	28	.	.	PUNCT
iajs-3385	94	1	references	reference	NOUN
iajs-3385	94	2	1	1	NUM
iajs-3385	94	3	.	.	PUNCT
iajs-3385	94	4	kresge	kresge	PROPN
iajs-3385	94	5	n	n	SYM
iajs-3385	94	6	,	,	PUNCT
iajs-3385	94	7	simoni	simoni	PROPN
iajs-3385	94	8	rd	rd	PROPN
iajs-3385	94	9	,	,	PUNCT
iajs-3385	94	10	hill	hill	PROPN
iajs-3385	94	11	rl	rl	PROPN
iajs-3385	94	12	.	.	PUNCT
iajs-3385	95	1	selman	selman	PROPN
iajs-3385	95	2	waksman	waksman	PROPN
iajs-3385	95	3	:	:	PUNCT
iajs-3385	95	4	the	the	DET
iajs-3385	95	5	father	father	NOUN
iajs-3385	95	6	of	of	ADP
iajs-3385	95	7	antibiotics	antibiotic	NOUN
iajs-3385	95	8	.	.	PUNCT
iajs-3385	96	1	j	j	PROPN
iajs-3385	96	2	biol	biol	PROPN
iajs-3385	96	3	chem	chem	NOUN
iajs-3385	96	4	.	.	PUNCT
iajs-3385	97	1	2004	2004	NUM
iajs-3385	97	2	;	;	PUNCT
iajs-3385	97	3	279(48):e7	279(48):e7	NUM
iajs-3385	97	4	.	.	X
iajs-3385	97	5	https://doi.org/10.1016/s0021-9258(20)67861-9	https://doi.org/10.1016/s0021-9258(20)67861-9	NOUN
iajs-3385	97	6	.	.	PUNCT
iajs-3385	98	1	2	2	NUM
iajs-3385	98	2	.	.	X
iajs-3385	98	3	li	li	PROPN
iajs-3385	98	4	d	d	PROPN
iajs-3385	98	5	,	,	PUNCT
iajs-3385	98	6	zhou	zhou	PROPN
iajs-3385	98	7	b	b	PROPN
iajs-3385	98	8	,	,	PUNCT
iajs-3385	98	9	lv	lv	PROPN
iajs-3385	98	10	b.	b.	PROPN
iajs-3385	98	11	antibacterial	antibacterial	ADJ
iajs-3385	98	12	therapeutic	therapeutic	ADJ
iajs-3385	98	13	agents	agent	NOUN
iajs-3385	98	14	composed	compose	VERB
iajs-3385	98	15	of	of	ADP
iajs-3385	98	16	functional	functional	ADJ
iajs-3385	98	17	biological	biological	ADJ
iajs-3385	98	18	molecules	molecule	NOUN
iajs-3385	98	19	.	.	PUNCT
iajs-3385	99	1	j	j	PROPN
iajs-3385	99	2	chem	chem	NOUN
iajs-3385	99	3	.	.	PUNCT
iajs-3385	100	1	2020	2020	NUM
iajs-3385	100	2	;	;	PUNCT
iajs-3385	100	3	2020(6578579):1	2020(6578579):1	NUM
iajs-3385	100	4	-	-	SYM
iajs-3385	100	5	13	13	NUM
iajs-3385	100	6	.	.	PUNCT
iajs-3385	101	1	https://doi.org/10.1155/2020/6578579	https://doi.org/10.1155/2020/6578579	PROPN
iajs-3385	101	2	3	3	X
iajs-3385	101	3	.	.	PUNCT
iajs-3385	102	1	mikhael	mikhael	PROPN
iajs-3385	102	2	em	em	PRON
iajs-3385	102	3	,	,	PUNCT
iajs-3385	102	4	hasan	hasan	PROPN
iajs-3385	102	5	mk	mk	PROPN
iajs-3385	102	6	,	,	PUNCT
iajs-3385	102	7	abdulridha	abdulridha	PROPN
iajs-3385	102	8	sz	sz	PROPN
iajs-3385	102	9	.	.	PROPN
iajs-3385	102	10	assessment	assessment	NOUN
iajs-3385	102	11	of	of	ADP
iajs-3385	102	12	antibiotic	antibiotic	ADJ
iajs-3385	102	13	knowledge	knowledge	NOUN
iajs-3385	102	14	among	among	ADP
iajs-3385	102	15	final	final	ADJ
iajs-3385	102	16	year	year	NOUN
iajs-3385	102	17	pharmacy	pharmacy	NOUN
iajs-3385	102	18	students	student	NOUN
iajs-3385	102	19	at	at	ADP
iajs-3385	102	20	baghdad	baghdad	PROPN
iajs-3385	102	21	university	university	PROPN
iajs-3385	102	22	.	.	PUNCT
iajs-3385	103	1	tophj	tophj	PROPN
iajs-3385	103	2	.	.	PUNCT
iajs-3385	104	1	2019	2019	NUM
iajs-3385	104	2	;	;	PUNCT
iajs-3385	104	3	12(1):379	12(1):379	NUM
iajs-3385	104	4	-	-	SYM
iajs-3385	104	5	383	383	NUM
iajs-3385	104	6	.	.	PUNCT
iajs-3385	105	1	https://doi.org/10.2174/1874944501912010379	https://doi.org/10.2174/1874944501912010379	X
iajs-3385	105	2	4	4	NUM
iajs-3385	105	3	.	.	PUNCT
iajs-3385	105	4	miry	miry	PROPN
iajs-3385	105	5	sm	sm	PROPN
iajs-3385	105	6	,	,	PUNCT
iajs-3385	105	7	al	al	PROPN
iajs-3385	105	8	-	-	PUNCT
iajs-3385	105	9	hayann	hayann	PROPN
iajs-3385	105	10	hs	hs	PROPN
iajs-3385	105	11	.	.	PROPN
iajs-3385	105	12	antibacterial	antibacterial	ADJ
iajs-3385	105	13	and	and	CCONJ
iajs-3385	105	14	anti	anti	ADJ
iajs-3385	105	15	-	-	ADJ
iajs-3385	105	16	biofilm	biofilm	ADJ
iajs-3385	105	17	activities	activity	NOUN
iajs-3385	105	18	of	of	ADP
iajs-3385	105	19	iraqi	iraqi	ADJ
iajs-3385	105	20	propolis	propolis	NOUN
iajs-3385	105	21	extracts	extract	NOUN
iajs-3385	105	22	against	against	ADP
iajs-3385	105	23	some	some	DET
iajs-3385	105	24	antibiotic	antibiotic	ADJ
iajs-3385	105	25	-	-	PUNCT
iajs-3385	105	26	resistant	resistant	ADJ
iajs-3385	105	27	pathogenic	pathogenic	ADJ
iajs-3385	105	28	bacteria	bacteria	NOUN
iajs-3385	105	29	.	.	PUNCT
iajs-3385	106	1	iraqi	iraqi	ADJ
iajs-3385	106	2	j	j	PROPN
iajs-3385	106	3	biotechnol	biotechnol	NOUN
iajs-3385	106	4	.	.	PUNCT
iajs-3385	107	1	2022	2022	NUM
iajs-3385	107	2	;	;	PUNCT
iajs-3385	108	1	21(2):511	21(2):511	PROPN
iajs-3385	108	2	-	-	SYM
iajs-3385	108	3	521	521	NUM
iajs-3385	108	4	.	.	NOUN
iajs-3385	108	5	5	5	NUM
iajs-3385	108	6	.	.	PUNCT
iajs-3385	108	7	etebu	etebu	NOUN
iajs-3385	108	8	e	e	NOUN
iajs-3385	108	9	,	,	PUNCT
iajs-3385	108	10	arikekpar	arikekpar	PROPN
iajs-3385	108	11	i.	i.	NOUN
iajs-3385	108	12	antibiotics	antibiotic	NOUN
iajs-3385	108	13	:	:	PUNCT
iajs-3385	108	14	classification	classification	NOUN
iajs-3385	108	15	and	and	CCONJ
iajs-3385	108	16	mechanisms	mechanism	NOUN
iajs-3385	108	17	of	of	ADP
iajs-3385	108	18	action	action	NOUN
iajs-3385	108	19	with	with	ADP
iajs-3385	108	20	emphasis	emphasis	NOUN
iajs-3385	108	21	on	on	ADP
iajs-3385	108	22	molecular	molecular	ADJ
iajs-3385	108	23	perspectives	perspective	NOUN
iajs-3385	108	24	.	.	PUNCT
iajs-3385	109	1	int	int	PROPN
iajs-3385	109	2	j	j	PROPN
iajs-3385	109	3	appl	appl	PROPN
iajs-3385	109	4	microbiol	microbiol	PROPN
iajs-3385	109	5	biotechnol	biotechnol	PROPN
iajs-3385	109	6	res	re	NOUN
iajs-3385	109	7	.	.	PROPN
iajs-3385	109	8	2016	2016	NUM
iajs-3385	109	9	;	;	PUNCT
iajs-3385	109	10	4(2016):90	4(2016):90	NUM
iajs-3385	109	11	-	-	SYM
iajs-3385	109	12	101	101	NUM
iajs-3385	109	13	.	.	NOUN
iajs-3385	110	1	6	6	NUM
iajs-3385	110	2	.	.	X
iajs-3385	110	3	aminov	aminov	PROPN
iajs-3385	110	4	ri	ri	PROPN
iajs-3385	110	5	.	.	PUNCT
iajs-3385	111	1	a	a	DET
iajs-3385	111	2	brief	brief	ADJ
iajs-3385	111	3	history	history	NOUN
iajs-3385	111	4	of	of	ADP
iajs-3385	111	5	the	the	DET
iajs-3385	111	6	antibiotic	antibiotic	ADJ
iajs-3385	111	7	era	era	NOUN
iajs-3385	111	8	:	:	PUNCT
iajs-3385	111	9	lessons	lesson	NOUN
iajs-3385	111	10	learned	learn	VERB
iajs-3385	111	11	and	and	CCONJ
iajs-3385	111	12	challenges	challenge	NOUN
iajs-3385	111	13	for	for	ADP
iajs-3385	111	14	the	the	DET
iajs-3385	111	15	future	future	NOUN
iajs-3385	111	16	.	.	PUNCT
iajs-3385	112	1	front	front	ADJ
iajs-3385	112	2	microbiol	microbiol	PROPN
iajs-3385	112	3	.	.	PUNCT
iajs-3385	113	1	2010	2010	NUM
iajs-3385	113	2	;	;	PUNCT
iajs-3385	113	3	1:134	1:134	NUM
iajs-3385	113	4	.	.	PUNCT
iajs-3385	114	1	https://doi.org/10.3389/fmicb.2010.00134	https://doi.org/10.3389/fmicb.2010.00134	PROPN
iajs-3385	114	2	.	.	PROPN
iajs-3385	114	3	7	7	X
iajs-3385	114	4	.	.	X
iajs-3385	114	5	oloke	oloke	PROPN
iajs-3385	114	6	jk	jk	PROPN
iajs-3385	114	7	.	.	PUNCT
iajs-3385	114	8	activity	activity	NOUN
iajs-3385	114	9	pattern	pattern	NOUN
iajs-3385	114	10	of	of	ADP
iajs-3385	114	11	natural	natural	ADJ
iajs-3385	114	12	and	and	CCONJ
iajs-3385	114	13	synthetic	synthetic	ADJ
iajs-3385	114	14	antibacterial	antibacterial	ADJ
iajs-3385	114	15	agents	agent	NOUN
iajs-3385	114	16	among	among	ADP
iajs-3385	114	17	hospital	hospital	NOUN
iajs-3385	114	18	isolates	isolate	NOUN
iajs-3385	114	19	.	.	PUNCT
iajs-3385	115	1	microbios	microbio	NOUN
iajs-3385	115	2	.	.	PUNCT
iajs-3385	116	1	2000	2000	NUM
iajs-3385	116	2	;	;	PUNCT
iajs-3385	116	3	102(403):175	102(403):175	NUM
iajs-3385	116	4	-	-	SYM
iajs-3385	116	5	181	181	NUM
iajs-3385	116	6	.	.	NOUN
iajs-3385	116	7	8	8	NUM
iajs-3385	116	8	.	.	PUNCT
iajs-3385	117	1	carbon	carbon	NOUN
iajs-3385	117	2	c	c	NOUN
iajs-3385	117	3	,	,	PUNCT
iajs-3385	117	4	isturiz	isturiz	PROPN
iajs-3385	117	5	r.	r.	PROPN
iajs-3385	117	6	narrow	narrow	PROPN
iajs-3385	117	7	versus	versus	ADP
iajs-3385	117	8	broad	broad	ADJ
iajs-3385	117	9	spectrum	spectrum	NOUN
iajs-3385	117	10	antibacterials	antibacterial	NOUN
iajs-3385	117	11	:	:	PUNCT
iajs-3385	117	12	factors	factor	NOUN
iajs-3385	117	13	in	in	ADP
iajs-3385	117	14	the	the	DET
iajs-3385	117	15	selection	selection	NOUN
iajs-3385	117	16	of	of	ADP
iajs-3385	117	17	pneumococcal	pneumococcal	ADJ
iajs-3385	117	18	resistance	resistance	NOUN
iajs-3385	117	19	to	to	ADP
iajs-3385	117	20	beta‐lactams	beta‐lactam	NOUN
iajs-3385	117	21	.	.	PUNCT
iajs-3385	118	1	drugs	drug	NOUN
iajs-3385	118	2	.	.	PUNCT
iajs-3385	119	1	2002	2002	NUM
iajs-3385	119	2	;	;	PUNCT
iajs-3385	119	3	62(9):1289‐1294	62(9):1289‐1294	NUM
iajs-3385	119	4	.	.	PUNCT
iajs-3385	120	1	https://doi.org/10.2165/00003495-200262090-00001	https://doi.org/10.2165/00003495-200262090-00001	X
iajs-3385	120	2	.	.	PUNCT
iajs-3385	121	1	9	9	X
iajs-3385	121	2	.	.	X
iajs-3385	121	3	newton	newton	PROPN
iajs-3385	121	4	ba	ba	PROPN
iajs-3385	121	5	.	.	PUNCT
iajs-3385	122	1	mechanisms	mechanism	NOUN
iajs-3385	122	2	of	of	ADP
iajs-3385	122	3	antibiotic	antibiotic	ADJ
iajs-3385	122	4	action	action	NOUN
iajs-3385	122	5	.	.	PUNCT
iajs-3385	123	1	annu	annu	PROPN
iajs-3385	123	2	rev	rev	VERB
iajs-3385	123	3	microbiol	microbiol	PROPN
iajs-3385	123	4	.	.	PUNCT
iajs-3385	124	1	1965	1965	NUM
iajs-3385	124	2	;	;	PUNCT
iajs-3385	124	3	19(1):209	19(1):209	NUM
iajs-3385	124	4	-	-	SYM
iajs-3385	124	5	240	240	NUM
iajs-3385	124	6	.	.	PUNCT
iajs-3385	125	1	https://doi.org/10.1146/annurev.mi.19.100165.001233	https://doi.org/10.1146/annurev.mi.19.100165.001233	NOUN
iajs-3385	125	2	.	.	PUNCT
iajs-3385	126	1	10	10	NUM
iajs-3385	126	2	.	.	PUNCT
iajs-3385	127	1	u.s	u.s	PROPN
iajs-3385	127	2	.	.	PROPN
iajs-3385	127	3	pharmacopeia	pharmacopeia	PROPN
iajs-3385	127	4	national	national	PROPN
iajs-3385	127	5	formulary	formulary	PROPN
iajs-3385	127	6	(	(	PUNCT
iajs-3385	127	7	usp44	usp44	PROPN
iajs-3385	127	8	-	-	PROPN
iajs-3385	127	9	nf39	nf39	PROPN
iajs-3385	127	10	)	)	PUNCT
iajs-3385	127	11	,	,	PUNCT
iajs-3385	127	12	2021	2021	NUM
iajs-3385	127	13	.	.	PUNCT
iajs-3385	128	1	11	11	NUM
iajs-3385	128	2	.	.	PUNCT
iajs-3385	129	1	bush	bush	PROPN
iajs-3385	129	2	lm	lm	PROPN
iajs-3385	129	3	,	,	PUNCT
iajs-3385	129	4	chaparro	chaparro	PROPN
iajs-3385	129	5	-	-	PUNCT
iajs-3385	129	6	rojas	rojas	PROPN
iajs-3385	129	7	f	f	PROPN
iajs-3385	129	8	,	,	PUNCT
iajs-3385	129	9	okeh	okeh	PROPN
iajs-3385	129	10	v	v	NOUN
iajs-3385	129	11	,	,	PUNCT
iajs-3385	129	12	etienne	etienne	PROPN
iajs-3385	129	13	j.	j.	PROPN
iajs-3385	129	14	cumulative	cumulative	VERB
iajs-3385	129	15	clinical	clinical	ADJ
iajs-3385	129	16	experience	experience	NOUN
iajs-3385	129	17	from	from	ADP
iajs-3385	129	18	over	over	ADP
iajs-3385	129	19	a	a	PRON
iajs-3385	129	20	decade	decade	NOUN
iajs-3385	129	21	of	of	ADP
iajs-3385	129	22	use	use	NOUN
iajs-3385	129	23	of	of	ADP
iajs-3385	129	24	levofloxacin	levofloxacin	NOUN
iajs-3385	129	25	in	in	ADP
iajs-3385	129	26	urinary	urinary	ADJ
iajs-3385	129	27	tract	tract	NOUN
iajs-3385	129	28	infections	infection	NOUN
iajs-3385	129	29	:	:	PUNCT
iajs-3385	129	30	critical	critical	ADJ
iajs-3385	129	31	appraisal	appraisal	NOUN
iajs-3385	129	32	and	and	CCONJ
iajs-3385	129	33	role	role	NOUN
iajs-3385	129	34	in	in	ADP
iajs-3385	129	35	therapy	therapy	NOUN
iajs-3385	129	36	.	.	PUNCT
iajs-3385	130	1	infect	infect	VERB
iajs-3385	130	2	drug	drug	NOUN
iajs-3385	130	3	resist	resist	NOUN
iajs-3385	130	4	.	.	PUNCT
iajs-3385	131	1	2011	2011	NUM
iajs-3385	131	2	;	;	PUNCT
iajs-3385	131	3	4:177	4:177	NUM
iajs-3385	131	4	-	-	SYM
iajs-3385	131	5	189	189	NUM
iajs-3385	131	6	.	.	PUNCT
iajs-3385	132	1	https://doi.org/10.2147/idr.s15610	https://doi.org/10.2147/idr.s15610	X
iajs-3385	132	2	.	.	PUNCT
iajs-3385	133	1	https://doi.org/10.1016/s0021-9258(20)67861-9	https://doi.org/10.1016/s0021-9258(20)67861-9	NOUN
iajs-3385	133	2	https://doi.org/10.1007/s12108-016-9307-z	https://doi.org/10.1007/s12108-016-9307-z	VERB
iajs-3385	133	3	https://doi.org/10.2165/00003495-200262090-00001	https://doi.org/10.2165/00003495-200262090-00001	NOUN
iajs-3385	133	4	https://doi.org/10.1146/annurev.mi.19.100165.001233	https://doi.org/10.1146/annurev.mi.19.100165.001233	NOUN
iajs-3385	133	5	https://doi.org/10.2147/idr.s15610	https://doi.org/10.2147/idr.s15610	PRON
iajs-3385	133	6	ihjpas	ihjpa	VERB
iajs-3385	133	7	.	.	PUNCT
iajs-3385	134	1	2025	2025	NUM
iajs-3385	134	2	,	,	PUNCT
iajs-3385	134	3	38(2	38(2	NUM
iajs-3385	134	4	)	)	PUNCT
iajs-3385	134	5	212	212	NUM
iajs-3385	134	6	12	12	NUM
iajs-3385	134	7	.	.	PUNCT
iajs-3385	135	1	anderson	anderson	PROPN
iajs-3385	135	2	vr	vr	PROPN
iajs-3385	135	3	,	,	PUNCT
iajs-3385	135	4	perry	perry	PROPN
iajs-3385	135	5	cm	cm	PROPN
iajs-3385	135	6	.	.	PUNCT
iajs-3385	136	1	levofloxacin	levofloxacin	PROPN
iajs-3385	136	2	:	:	PUNCT
iajs-3385	136	3	a	a	DET
iajs-3385	136	4	review	review	NOUN
iajs-3385	136	5	of	of	ADP
iajs-3385	136	6	its	its	PRON
iajs-3385	136	7	use	use	NOUN
iajs-3385	136	8	as	as	ADP
iajs-3385	136	9	a	a	DET
iajs-3385	136	10	high	high	ADJ
iajs-3385	136	11	-	-	PUNCT
iajs-3385	136	12	dose	dose	NOUN
iajs-3385	136	13	,	,	PUNCT
iajs-3385	136	14	short	short	ADJ
iajs-3385	136	15	-	-	PUNCT
iajs-3385	136	16	course	course	NOUN
iajs-3385	136	17	treatment	treatment	NOUN
iajs-3385	136	18	for	for	ADP
iajs-3385	136	19	bacterial	bacterial	ADJ
iajs-3385	136	20	infection	infection	NOUN
iajs-3385	136	21	.	.	PUNCT
iajs-3385	137	1	drugs	drug	NOUN
iajs-3385	137	2	.	.	PUNCT
iajs-3385	137	3	2008	2008	NUM
iajs-3385	137	4	;	;	PUNCT
iajs-3385	137	5	68(4):535	68(4):535	NUM
iajs-3385	137	6	-	-	SYM
iajs-3385	137	7	565	565	NUM
iajs-3385	137	8	.	.	PUNCT
iajs-3385	138	1	https://doi.org/10.2165/00003495-200868040-00011	https://doi.org/10.2165/00003495-200868040-00011	NOUN
iajs-3385	138	2	.	.	PROPN
iajs-3385	138	3	13	13	NUM
iajs-3385	138	4	.	.	PUNCT
iajs-3385	138	5	british	british	ADJ
iajs-3385	138	6	pharmacopoeia	pharmacopoeia	PROPN
iajs-3385	138	7	.	.	PUNCT
iajs-3385	139	1	british	british	ADJ
iajs-3385	139	2	pharmacopoeia	pharmacopoeia	PROPN
iajs-3385	139	3	.	.	PUNCT
iajs-3385	140	1	2022	2022	NUM
iajs-3385	140	2	;	;	PUNCT
iajs-3385	140	3	vol	vol	NOUN
iajs-3385	140	4	.	.	NOUN
iajs-3385	140	5	2	2	NUM
iajs-3385	140	6	,	,	PUNCT
iajs-3385	140	7	p.	p.	NOUN
iajs-3385	140	8	302	302	NUM
iajs-3385	140	9	,	,	PUNCT
iajs-3385	140	10	820	820	NUM
iajs-3385	140	11	,	,	PUNCT
iajs-3385	140	12	1042	1042	NUM
iajs-3385	140	13	.	.	PUNCT
iajs-3385	141	1	14	14	NUM
iajs-3385	141	2	.	.	PUNCT
iajs-3385	142	1	anjana	anjana	PROPN
iajs-3385	142	2	gv	gv	PROPN
iajs-3385	142	3	.	.	PUNCT
iajs-3385	142	4	synthesis	synthesis	NOUN
iajs-3385	142	5	and	and	CCONJ
iajs-3385	142	6	antimicrobial	antimicrobial	ADJ
iajs-3385	142	7	evaluation	evaluation	NOUN
iajs-3385	142	8	of	of	ADP
iajs-3385	142	9	deuterated	deuterate	VERB
iajs-3385	142	10	analogues	analogue	NOUN
iajs-3385	142	11	of	of	ADP
iajs-3385	142	12	metronidazole	metronidazole	NOUN
iajs-3385	142	13	.	.	PUNCT
iajs-3385	143	1	iraqi	iraqi	PROPN
iajs-3385	143	2	j	j	PROPN
iajs-3385	143	3	pharm	pharm	PROPN
iajs-3385	143	4	sci	sci	PROPN
iajs-3385	143	5	.	.	PROPN
iajs-3385	143	6	2022	2022	NUM
iajs-3385	143	7	;	;	PUNCT
iajs-3385	143	8	31(2):297	31(2):297	NUM
iajs-3385	143	9	-	-	PUNCT
iajs-3385	143	10	303	303	NUM
iajs-3385	143	11	.	.	PUNCT
iajs-3385	143	12	https://doi.org/10.31351/vol31iss2pp297-303	https://doi.org/10.31351/vol31iss2pp297-303	X
iajs-3385	143	13	.	.	PUNCT
iajs-3385	144	1	15	15	NUM
iajs-3385	144	2	.	.	PUNCT
iajs-3385	144	3	mcdonald	mcdonald	PROPN
iajs-3385	144	4	lc	lc	PROPN
iajs-3385	144	5	,	,	PUNCT
iajs-3385	144	6	gerding	gerde	VERB
iajs-3385	144	7	dn	dn	PROPN
iajs-3385	144	8	,	,	PUNCT
iajs-3385	144	9	johnson	johnson	PROPN
iajs-3385	144	10	s	s	PROPN
iajs-3385	144	11	,	,	PUNCT
iajs-3385	144	12	bakken	bakken	PROPN
iajs-3385	144	13	js	js	PROPN
iajs-3385	144	14	,	,	PUNCT
iajs-3385	144	15	carroll	carroll	PROPN
iajs-3385	144	16	kc	kc	PROPN
iajs-3385	144	17	,	,	PUNCT
iajs-3385	144	18	coffin	coffin	NOUN
iajs-3385	144	19	se	se	ADV
iajs-3385	144	20	,	,	PUNCT
iajs-3385	144	21	dubberke	dubberke	VERB
iajs-3385	144	22	er	er	INTJ
iajs-3385	144	23	,	,	PUNCT
iajs-3385	144	24	garey	garey	PROPN
iajs-3385	144	25	k	k	PROPN
iajs-3385	144	26	w	w	PROPN
iajs-3385	144	27	,	,	PUNCT
iajs-3385	144	28	gould	gould	PROPN
iajs-3385	144	29	cv	cv	PROPN
iajs-3385	144	30	,	,	PUNCT
iajs-3385	144	31	kelly	kelly	PROPN
iajs-3385	144	32	c	c	AUX
iajs-3385	144	33	,	,	PUNCT
iajs-3385	144	34	loo	loo	NOUN
iajs-3385	144	35	v	v	NOUN
iajs-3385	144	36	,	,	PUNCT
iajs-3385	144	37	sammons	sammon	NOUN
iajs-3385	144	38	js	js	PROPN
iajs-3385	144	39	,	,	PUNCT
iajs-3385	144	40	sandora	sandora	PROPN
iajs-3385	144	41	tj	tj	PROPN
iajs-3385	144	42	,	,	PUNCT
iajs-3385	144	43	wilcox	wilcox	PROPN
iajs-3385	144	44	mh	mh	PROPN
iajs-3385	144	45	.	.	PUNCT
iajs-3385	145	1	clinical	clinical	ADJ
iajs-3385	145	2	practice	practice	NOUN
iajs-3385	145	3	guidelines	guideline	NOUN
iajs-3385	145	4	for	for	ADP
iajs-3385	145	5	clostridium	clostridium	NOUN
iajs-3385	145	6	difficile	difficile	ADJ
iajs-3385	145	7	infection	infection	NOUN
iajs-3385	145	8	in	in	ADP
iajs-3385	145	9	adults	adult	NOUN
iajs-3385	145	10	and	and	CCONJ
iajs-3385	145	11	children	child	NOUN
iajs-3385	145	12	:	:	PUNCT
iajs-3385	145	13	2017	2017	NUM
iajs-3385	145	14	update	update	NOUN
iajs-3385	145	15	by	by	ADP
iajs-3385	145	16	the	the	DET
iajs-3385	145	17	infectious	infectious	ADJ
iajs-3385	145	18	diseases	disease	NOUN
iajs-3385	145	19	society	society	NOUN
iajs-3385	145	20	of	of	ADP
iajs-3385	145	21	america	america	PROPN
iajs-3385	145	22	(	(	PUNCT
iajs-3385	145	23	idsa	idsa	PROPN
iajs-3385	145	24	)	)	PUNCT
iajs-3385	145	25	and	and	CCONJ
iajs-3385	145	26	society	society	NOUN
iajs-3385	145	27	for	for	ADP
iajs-3385	145	28	healthcare	healthcare	PROPN
iajs-3385	145	29	epidemiology	epidemiology	PROPN
iajs-3385	145	30	of	of	ADP
iajs-3385	145	31	america	america	PROPN
iajs-3385	145	32	(	(	PUNCT
iajs-3385	145	33	shea	shea	PROPN
iajs-3385	145	34	)	)	PUNCT
iajs-3385	145	35	.	.	PUNCT
iajs-3385	146	1	clin	clin	PROPN
iajs-3385	146	2	infect	infect	PROPN
iajs-3385	146	3	dis	dis	PROPN
iajs-3385	146	4	.	.	PUNCT
iajs-3385	147	1	2018	2018	NUM
iajs-3385	147	2	;	;	PUNCT
iajs-3385	147	3	66(7):e1	66(7):e1	NOUN
iajs-3385	147	4	-	-	PUNCT
iajs-3385	147	5	e48	e48	NOUN
iajs-3385	147	6	.	.	PUNCT
iajs-3385	148	1	https://doi.org/10.1093/cid/cix1085	https://doi.org/10.1093/cid/cix1085	X
iajs-3385	148	2	.	.	PROPN
iajs-3385	149	1	16	16	NUM
iajs-3385	149	2	.	.	PUNCT
iajs-3385	150	1	dingsdag	dingsdag	PROPN
iajs-3385	150	2	sa	sa	PROPN
iajs-3385	150	3	,	,	PUNCT
iajs-3385	150	4	neil	neil	PROPN
iajs-3385	150	5	hunter	hunter	PROPN
iajs-3385	150	6	n.	n.	PROPN
iajs-3385	150	7	metronidazole	metronidazole	PROPN
iajs-3385	150	8	:	:	PUNCT
iajs-3385	150	9	an	an	DET
iajs-3385	150	10	update	update	NOUN
iajs-3385	150	11	on	on	ADP
iajs-3385	150	12	metabolism	metabolism	NOUN
iajs-3385	150	13	,	,	PUNCT
iajs-3385	150	14	structure	structure	NOUN
iajs-3385	150	15	–	–	PUNCT
iajs-3385	150	16	cytotoxicity	cytotoxicity	NOUN
iajs-3385	150	17	and	and	CCONJ
iajs-3385	150	18	resistance	resistance	NOUN
iajs-3385	150	19	mechanisms	mechanism	NOUN
iajs-3385	150	20	.	.	PUNCT
iajs-3385	151	1	j	j	PROPN
iajs-3385	151	2	antimicrob	antimicrob	PROPN
iajs-3385	151	3	chemother	chemother	PROPN
iajs-3385	151	4	.	.	PUNCT
iajs-3385	152	1	2018	2018	NUM
iajs-3385	152	2	;	;	PUNCT
iajs-3385	153	1	73(2):265	73(2):265	NOUN
iajs-3385	153	2	-	-	SYM
iajs-3385	153	3	279	279	NUM
iajs-3385	153	4	.	.	PUNCT
iajs-3385	154	1	https://doi.org/10.1093/jac/dkx351	https://doi.org/10.1093/jac/dkx351	PROPN
iajs-3385	154	2	.	.	PUNCT
iajs-3385	155	1	17	17	NUM
iajs-3385	155	2	.	.	PUNCT
iajs-3385	156	1	tawgozy	tawgozy	PROPN
iajs-3385	156	2	f	f	X
iajs-3385	156	3	,	,	PUNCT
iajs-3385	156	4	qarasnji	qarasnji	PROPN
iajs-3385	156	5	bk	bk	VERB
iajs-3385	156	6	.	.	PUNCT
iajs-3385	157	1	molecular	molecular	ADJ
iajs-3385	157	2	analysis	analysis	NOUN
iajs-3385	157	3	of	of	ADP
iajs-3385	157	4	rifampicin	rifampicin	VERB
iajs-3385	157	5	resistance	resistance	NOUN
iajs-3385	157	6	conferring	confer	VERB
iajs-3385	157	7	mutations	mutation	NOUN
iajs-3385	157	8	in	in	ADP
iajs-3385	157	9	mycobacterium	mycobacterium	NOUN
iajs-3385	157	10	tuberculosis	tuberculosis	NOUN
iajs-3385	157	11	.	.	PUNCT
iajs-3385	158	1	baghdad	baghdad	PROPN
iajs-3385	158	2	sci	sci	PROPN
iajs-3385	158	3	j.	j.	PROPN
iajs-3385	158	4	2020	2020	NUM
iajs-3385	158	5	;	;	PUNCT
iajs-3385	158	6	17(2):444	17(2):444	NUM
iajs-3385	158	7	-	-	SYM
iajs-3385	158	8	451	451	NUM
iajs-3385	158	9	.	.	PUNCT
iajs-3385	159	1	https://doi.org/10.21123/bsj.2020.17.2.0444	https://doi.org/10.21123/bsj.2020.17.2.0444	X
iajs-3385	159	2	.	.	PROPN
iajs-3385	160	1	18	18	NUM
iajs-3385	160	2	.	.	PUNCT
iajs-3385	161	1	al	al	PROPN
iajs-3385	161	2	-	-	PUNCT
iajs-3385	161	3	rubaye	rubaye	NOUN
iajs-3385	161	4	ds	ds	ADJ
iajs-3385	161	5	,	,	PUNCT
iajs-3385	161	6	henihan	henihan	ADV
iajs-3385	161	7	g	g	PROPN
iajs-3385	161	8	,	,	PUNCT
iajs-3385	161	9	al	al	PROPN
iajs-3385	161	10	-	-	PUNCT
iajs-3385	161	11	abasly	abasly	ADV
iajs-3385	161	12	aka	aka	ADV
iajs-3385	161	13	,	,	PUNCT
iajs-3385	161	14	seagar	seagar	PROPN
iajs-3385	161	15	al	al	PROPN
iajs-3385	161	16	,	,	PUNCT
iajs-3385	161	17	al	al	PROPN
iajs-3385	161	18	-	-	PUNCT
iajs-3385	161	19	attraqchi	attraqchi	PROPN
iajs-3385	161	20	aaf	aaf	PROPN
iajs-3385	161	21	,	,	PUNCT
iajs-3385	161	22	schulze	schulze	NOUN
iajs-3385	161	23	h	h	PROPN
iajs-3385	161	24	,	,	PUNCT
iajs-3385	161	25	hashim	hashim	PROPN
iajs-3385	161	26	ds	ds	PROPN
iajs-3385	161	27	,	,	PUNCT
iajs-3385	161	28	kamil	kamil	PROPN
iajs-3385	161	29	jk	jk	PROPN
iajs-3385	161	30	,	,	PUNCT
iajs-3385	161	31	laurenson	laurenson	NOUN
iajs-3385	161	32	if	if	SCONJ
iajs-3385	161	33	,	,	PUNCT
iajs-3385	161	34	bachmann	bachmann	PROPN
iajs-3385	161	35	tt	tt	PROPN
iajs-3385	161	36	.	.	PROPN
iajs-3385	161	37	genotypic	genotypic	ADJ
iajs-3385	161	38	assessment	assessment	NOUN
iajs-3385	161	39	of	of	ADP
iajs-3385	161	40	drug	drug	NOUN
iajs-3385	161	41	-	-	PUNCT
iajs-3385	161	42	resistant	resistant	ADJ
iajs-3385	161	43	tuberculosis	tuberculosis	NOUN
iajs-3385	161	44	in	in	ADP
iajs-3385	161	45	baghdad	baghdad	PROPN
iajs-3385	161	46	and	and	CCONJ
iajs-3385	161	47	other	other	ADJ
iajs-3385	161	48	iraqi	iraqi	ADJ
iajs-3385	161	49	provinces	province	NOUN
iajs-3385	161	50	using	use	VERB
iajs-3385	161	51	low	low	ADJ
iajs-3385	161	52	-	-	PUNCT
iajs-3385	161	53	cost	cost	NOUN
iajs-3385	161	54	and	and	CCONJ
iajs-3385	161	55	low	low	ADJ
iajs-3385	161	56	-	-	PUNCT
iajs-3385	161	57	density	density	NOUN
iajs-3385	161	58	dna	dna	NOUN
iajs-3385	161	59	microarrays	microarray	NOUN
iajs-3385	161	60	.	.	PUNCT
iajs-3385	162	1	j	j	PROPN
iajs-3385	162	2	med	med	PROPN
iajs-3385	162	3	microbiol	microbiol	PROPN
iajs-3385	162	4	.	.	PUNCT
iajs-3385	163	1	2016	2016	NUM
iajs-3385	163	2	;	;	PUNCT
iajs-3385	163	3	65(2):114	65(2):114	PROPN
iajs-3385	163	4	-	-	SYM
iajs-3385	163	5	122	122	NUM
iajs-3385	163	6	.	.	PUNCT
iajs-3385	164	1	https://doi.org/10.1099/jmm.0.000203	https://doi.org/10.1099/jmm.0.000203	PROPN
iajs-3385	164	2	.	.	PUNCT
iajs-3385	165	1	19	19	NUM
iajs-3385	165	2	.	.	X
iajs-3385	165	3	khalil	khalil	PROPN
iajs-3385	166	1	i	i	PROPN
iajs-3385	166	2	,	,	PUNCT
iajs-3385	166	3	ronn	ronn	PROPN
iajs-3385	166	4	am	am	PROPN
iajs-3385	166	5	,	,	PUNCT
iajs-3385	166	6	alifrangis	alifrangis	PROPN
iajs-3385	166	7	m	m	PRON
iajs-3385	166	8	,	,	PUNCT
iajs-3385	166	9	gabar	gabar	PROPN
iajs-3385	166	10	ha	ha	INTJ
iajs-3385	166	11	,	,	PUNCT
iajs-3385	166	12	satti	satti	PROPN
iajs-3385	166	13	gm	gm	PROPN
iajs-3385	166	14	,	,	PUNCT
iajs-3385	166	15	bygbjerg	bygbjerg	PROPN
iajs-3385	166	16	ic	ic	PROPN
iajs-3385	166	17	.	.	PUNCT
iajs-3385	166	18	dihydrofolate	dihydrofolate	PROPN
iajs-3385	166	19	reductase	reductase	NOUN
iajs-3385	166	20	and	and	CCONJ
iajs-3385	166	21	dihydropteroate	dihydropteroate	VERB
iajs-3385	166	22	synthase	synthase	NOUN
iajs-3385	166	23	genotypes	genotype	NOUN
iajs-3385	166	24	associated	associate	VERB
iajs-3385	166	25	with	with	ADP
iajs-3385	166	26	in	in	ADP
iajs-3385	166	27	vitro	vitro	X
iajs-3385	166	28	resistance	resistance	NOUN
iajs-3385	166	29	of	of	ADP
iajs-3385	166	30	plasmodium	plasmodium	NOUN
iajs-3385	166	31	falciparum	falciparum	NOUN
iajs-3385	166	32	to	to	PART
iajs-3385	166	33	pyrimethamine	pyrimethamine	VERB
iajs-3385	166	34	,	,	PUNCT
iajs-3385	166	35	trimethoprim	trimethoprim	ADJ
iajs-3385	166	36	,	,	PUNCT
iajs-3385	166	37	sulfadoxine	sulfadoxine	NOUN
iajs-3385	166	38	,	,	PUNCT
iajs-3385	166	39	and	and	CCONJ
iajs-3385	166	40	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	166	41	.	.	PUNCT
iajs-3385	167	1	am	be	AUX
iajs-3385	167	2	j	j	PROPN
iajs-3385	167	3	trop	trop	X
iajs-3385	167	4	med	med	PROPN
iajs-3385	167	5	hyg	hyg	PROPN
iajs-3385	167	6	.	.	PROPN
iajs-3385	167	7	2003	2003	NUM
iajs-3385	167	8	;	;	PUNCT
iajs-3385	167	9	68(5	68(5	NUM
iajs-3385	167	10	):	):	PUNCT
iajs-3385	167	11	586	586	NUM
iajs-3385	167	12	-	-	SYM
iajs-3385	167	13	589	589	NUM
iajs-3385	167	14	.	.	PUNCT
iajs-3385	168	1	https://doi.org/10.4269/ajtmh.2003.68.586	https://doi.org/10.4269/ajtmh.2003.68.586	PROPN
iajs-3385	168	2	.	.	PUNCT
iajs-3385	169	1	20	20	NUM
iajs-3385	169	2	.	.	PUNCT
iajs-3385	170	1	khalaf	khalaf	PROPN
iajs-3385	170	2	hs	hs	PROPN
iajs-3385	170	3	,	,	PUNCT
iajs-3385	170	4	al	al	PROPN
iajs-3385	170	5	-	-	PUNCT
iajs-3385	170	6	haidari	haidari	PROPN
iajs-3385	170	7	am	am	NOUN
iajs-3385	170	8	,	,	PUNCT
iajs-3385	170	9	dikran	dikran	PROPN
iajs-3385	170	10	sb	sb	PROPN
iajs-3385	170	11	,	,	PUNCT
iajs-3385	170	12	mohammed	mohammed	PROPN
iajs-3385	170	13	ak	ak	PROPN
iajs-3385	170	14	.	.	PROPN
iajs-3385	170	15	spectrophotometric	spectrophotometric	ADJ
iajs-3385	170	16	determination	determination	NOUN
iajs-3385	170	17	of	of	ADP
iajs-3385	170	18	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	170	19	in	in	ADP
iajs-3385	170	20	pure	pure	ADJ
iajs-3385	170	21	and	and	CCONJ
iajs-3385	170	22	pharmaceutical	pharmaceutical	ADJ
iajs-3385	170	23	preparations	preparation	NOUN
iajs-3385	170	24	based	base	VERB
iajs-3385	170	25	on	on	ADP
iajs-3385	170	26	condensation	condensation	NOUN
iajs-3385	170	27	reaction	reaction	NOUN
iajs-3385	170	28	method	method	NOUN
iajs-3385	170	29	.	.	PUNCT
iajs-3385	171	1	jubpas	jubpas	PROPN
iajs-3385	171	2	.	.	PUNCT
iajs-3385	172	1	2017	2017	NUM
iajs-3385	172	2	;	;	PUNCT
iajs-3385	172	3	25(2):515	25(2):515	NOUN
iajs-3385	172	4	-	-	SYM
iajs-3385	172	5	524	524	NUM
iajs-3385	172	6	.	.	PUNCT
iajs-3385	172	7	21	21	NUM
iajs-3385	172	8	.	.	PUNCT
iajs-3385	172	9	abrahem	abrahem	PROPN
iajs-3385	172	10	s	s	PROPN
iajs-3385	172	11	,	,	PUNCT
iajs-3385	172	12	abdul	abdul	PROPN
iajs-3385	172	13	kader	kader	PROPN
iajs-3385	172	14	s	s	PROPN
iajs-3385	172	15	,	,	PUNCT
iajs-3385	172	16	ibrahim	ibrahim	PROPN
iajs-3385	172	17	s.	s.	PROPN
iajs-3385	173	1	different	different	ADJ
iajs-3385	173	2	analytical	analytical	ADJ
iajs-3385	173	3	methods	method	NOUN
iajs-3385	173	4	for	for	ADP
iajs-3385	173	5	the	the	DET
iajs-3385	173	6	determination	determination	NOUN
iajs-3385	173	7	of	of	ADP
iajs-3385	173	8	metronidazole	metronidazole	NOUN
iajs-3385	173	9	–	–	PUNCT
iajs-3385	173	10	a	a	DET
iajs-3385	173	11	review	review	NOUN
iajs-3385	173	12	.	.	PUNCT
iajs-3385	174	1	int	int	PROPN
iajs-3385	174	2	j	j	PROPN
iajs-3385	174	3	res	re	VERB
iajs-3385	174	4	eng	eng	PROPN
iajs-3385	174	5	innov	innov	NOUN
iajs-3385	174	6	.	.	PUNCT
iajs-3385	175	1	2020	2020	NUM
iajs-3385	175	2	;	;	PUNCT
iajs-3385	175	3	4(2):86	4(2):86	NOUN
iajs-3385	175	4	-	-	SYM
iajs-3385	175	5	90	90	NUM
iajs-3385	175	6	.	.	PUNCT
iajs-3385	176	1	https://doi.org/10.36037/ijrei.2020.4202	https://doi.org/10.36037/ijrei.2020.4202	PROPN
iajs-3385	176	2	.	.	PUNCT
iajs-3385	177	1	22	22	NUM
iajs-3385	177	2	.	.	PUNCT
iajs-3385	177	3	kotadiya	kotadiya	PROPN
iajs-3385	177	4	rm	rm	PROPN
iajs-3385	177	5	,	,	PUNCT
iajs-3385	177	6	patel	patel	PROPN
iajs-3385	177	7	fn	fn	PROPN
iajs-3385	177	8	.	.	PUNCT
iajs-3385	178	1	analytical	analytical	ADJ
iajs-3385	178	2	methods	method	NOUN
iajs-3385	178	3	practiced	practice	VERB
iajs-3385	178	4	to	to	ADP
iajs-3385	178	5	quantitation	quantitation	NOUN
iajs-3385	178	6	of	of	ADP
iajs-3385	178	7	rifampicin	rifampicin	NOUN
iajs-3385	178	8	:	:	PUNCT
iajs-3385	178	9	a	a	DET
iajs-3385	178	10	captious	captious	ADJ
iajs-3385	178	11	survey	survey	NOUN
iajs-3385	178	12	.	.	PUNCT
iajs-3385	179	1	curr	curr	PROPN
iajs-3385	179	2	pharm	pharm	PROPN
iajs-3385	179	3	anal	anal	PROPN
iajs-3385	179	4	.	.	PUNCT
iajs-3385	179	5	2021	2021	NUM
iajs-3385	179	6	;	;	PUNCT
iajs-3385	179	7	17(8):983	17(8):983	NUM
iajs-3385	179	8	-	-	SYM
iajs-3385	179	9	999	999	NUM
iajs-3385	179	10	.	.	PUNCT
iajs-3385	180	1	https://doi.org/10.2174/1573412916999200704144231	https://doi.org/10.2174/1573412916999200704144231	ADJ
iajs-3385	180	2	.	.	NOUN
iajs-3385	181	1	23	23	NUM
iajs-3385	181	2	.	.	PUNCT
iajs-3385	182	1	biancolillo	biancolillo	PROPN
iajs-3385	182	2	a	a	PRON
iajs-3385	182	3	,	,	PUNCT
iajs-3385	182	4	marini	marini	PROPN
iajs-3385	182	5	f.	f.	PROPN
iajs-3385	182	6	chemometric	chemometric	PROPN
iajs-3385	182	7	methods	method	NOUN
iajs-3385	182	8	for	for	ADP
iajs-3385	182	9	spectroscopy	spectroscopy	NOUN
iajs-3385	182	10	-	-	PUNCT
iajs-3385	182	11	based	base	VERB
iajs-3385	182	12	pharmaceutical	pharmaceutical	ADJ
iajs-3385	182	13	analysis	analysis	NOUN
iajs-3385	182	14	.	.	PUNCT
iajs-3385	183	1	front	front	ADJ
iajs-3385	183	2	chem	chem	NOUN
iajs-3385	183	3	.	.	PUNCT
iajs-3385	184	1	2018	2018	NUM
iajs-3385	184	2	;	;	PUNCT
iajs-3385	184	3	6:576	6:576	NUM
iajs-3385	184	4	.	.	PUNCT
iajs-3385	185	1	https://doi.org/10.3389/fchem.2018.00576	https://doi.org/10.3389/fchem.2018.00576	PROPN
iajs-3385	185	2	.	.	PROPN
iajs-3385	186	1	24	24	NUM
iajs-3385	186	2	.	.	PUNCT
iajs-3385	187	1	gupta	gupta	PROPN
iajs-3385	187	2	d	d	PROPN
iajs-3385	187	3	,	,	PUNCT
iajs-3385	187	4	bhardwaj	bhardwaj	PROPN
iajs-3385	187	5	s	s	PROPN
iajs-3385	187	6	,	,	PUNCT
iajs-3385	187	7	sethi	sethi	PROPN
iajs-3385	187	8	s	s	PROPN
iajs-3385	187	9	,	,	PUNCT
iajs-3385	187	10	pramanik	pramanik	X
iajs-3385	187	11	s	s	PROPN
iajs-3385	187	12	,	,	PUNCT
iajs-3385	187	13	kumar	kumar	PROPN
iajs-3385	187	14	das	das	PROPN
iajs-3385	187	15	d	d	PROPN
iajs-3385	187	16	,	,	PUNCT
iajs-3385	187	17	kumar	kumar	PROPN
iajs-3385	187	18	r	r	PROPN
iajs-3385	187	19	,	,	PUNCT
iajs-3385	187	20	pratap	pratap	PROPN
iajs-3385	187	21	singh	singh	PROPN
iajs-3385	187	22	p	p	PROPN
iajs-3385	187	23	,	,	PUNCT
iajs-3385	187	24	kumar	kumar	PROPN
iajs-3385	187	25	vashistha	vashistha	PROPN
iajs-3385	187	26	v.	v.	ADP
iajs-3385	187	27	simultaneous	simultaneous	ADJ
iajs-3385	187	28	spectrophotometric	spectrophotometric	ADJ
iajs-3385	187	29	determination	determination	NOUN
iajs-3385	187	30	of	of	ADP
iajs-3385	187	31	drug	drug	NOUN
iajs-3385	187	32	components	component	NOUN
iajs-3385	187	33	from	from	ADP
iajs-3385	187	34	their	their	PRON
iajs-3385	187	35	dosage	dosage	NOUN
iajs-3385	187	36	formulations	formulation	NOUN
iajs-3385	187	37	.	.	PUNCT
iajs-3385	188	1	spectrochim	spectrochim	PROPN
iajs-3385	188	2	acta	acta	VERB
iajs-3385	188	3	a	a	DET
iajs-3385	188	4	mol	mol	PROPN
iajs-3385	188	5	biomol	biomol	PROPN
iajs-3385	188	6	spectrosc	spectrosc	PROPN
iajs-3385	188	7	.	.	PUNCT
iajs-3385	189	1	2022	2022	NUM
iajs-3385	189	2	;	;	PUNCT
iajs-3385	189	3	270:120819	270:120819	NUM
iajs-3385	189	4	.	.	PUNCT
iajs-3385	190	1	https://doi.org/10.1016/j.saa.2021.120819	https://doi.org/10.1016/j.saa.2021.120819	PROPN
iajs-3385	190	2	.	.	PUNCT
iajs-3385	191	1	25	25	NUM
iajs-3385	191	2	.	.	PUNCT
iajs-3385	191	3	skoog	skoog	PROPN
iajs-3385	191	4	da	da	PROPN
iajs-3385	191	5	,	,	PUNCT
iajs-3385	191	6	holler	holler	VERB
iajs-3385	191	7	fj	fj	PROPN
iajs-3385	191	8	,	,	PUNCT
iajs-3385	191	9	crouch	crouch	PROPN
iajs-3385	191	10	sr	sr	PROPN
iajs-3385	191	11	.	.	PUNCT
iajs-3385	192	1	principles	principle	NOUN
iajs-3385	192	2	of	of	ADP
iajs-3385	192	3	instrumental	instrumental	ADJ
iajs-3385	192	4	analysis	analysis	NOUN
iajs-3385	192	5	;	;	PUNCT
iajs-3385	192	6	7th	7th	ADJ
iajs-3385	192	7	ed	ed	NOUN
iajs-3385	192	8	.	.	PROPN
iajs-3385	192	9	,	,	PUNCT
iajs-3385	192	10	cengage	cengage	PROPN
iajs-3385	192	11	learning	learning	PROPN
iajs-3385	192	12	,	,	PUNCT
iajs-3385	192	13	u.s	u.s	PROPN
iajs-3385	192	14	,	,	PUNCT
iajs-3385	192	15	2018	2018	NUM
iajs-3385	192	16	.	.	PUNCT
iajs-3385	193	1	26	26	NUM
iajs-3385	193	2	.	.	PUNCT
iajs-3385	194	1	sowjanya	sowjanya	PROPN
iajs-3385	194	2	g	g	PROPN
iajs-3385	194	3	,	,	PUNCT
iajs-3385	194	4	chandaka	chandaka	PROPN
iajs-3385	194	5	pk	pk	PROPN
iajs-3385	194	6	.	.	PROPN
iajs-3385	194	7	chemometrics	chemometric	NOUN
iajs-3385	194	8	approach	approach	VERB
iajs-3385	194	9	to	to	ADP
iajs-3385	194	10	drug	drug	NOUN
iajs-3385	194	11	analysis	analysis	NOUN
iajs-3385	194	12	–	–	PUNCT
iajs-3385	194	13	an	an	DET
iajs-3385	194	14	overview	overview	NOUN
iajs-3385	194	15	.	.	PUNCT
iajs-3385	195	1	a	a	DET
iajs-3385	195	2	j	j	PROPN
iajs-3385	195	3	pharm	pharm	PROPN
iajs-3385	195	4	tech	tech	NOUN
iajs-3385	195	5	res	re	NOUN
iajs-3385	195	6	.	.	PROPN
iajs-3385	195	7	2019	2019	NUM
iajs-3385	195	8	;	;	PUNCT
iajs-3385	195	9	9(1):1	9(1):1	X
iajs-3385	195	10	-	-	SYM
iajs-3385	195	11	13	13	NUM
iajs-3385	195	12	.	.	PUNCT
iajs-3385	196	1	https://doi.org/10.46624/ajptr.2019.v9.i1.001	https://doi.org/10.46624/ajptr.2019.v9.i1.001	PROPN
iajs-3385	196	2	.	.	PUNCT
iajs-3385	197	1	27	27	NUM
iajs-3385	197	2	.	.	PUNCT
iajs-3385	198	1	vittal	vittal	PROPN
iajs-3385	198	2	ss	ss	PROPN
iajs-3385	198	3	,	,	PUNCT
iajs-3385	198	4	veeraiah	veeraiah	PROPN
iajs-3385	198	5	t	t	PROPN
iajs-3385	198	6	,	,	PUNCT
iajs-3385	198	7	reddy	reddy	PROPN
iajs-3385	198	8	chvr	chvr	PROPN
iajs-3385	198	9	.	.	PUNCT
iajs-3385	199	1	simultaneous	simultaneous	ADJ
iajs-3385	199	2	spectrophotometric	spectrophotometric	ADJ
iajs-3385	199	3	determination	determination	NOUN
iajs-3385	199	4	of	of	ADP
iajs-3385	199	5	levofloxacin	levofloxacin	PROPN
iajs-3385	199	6	and	and	CCONJ
iajs-3385	199	7	azithromycin	azithromycin	PROPN
iajs-3385	199	8	using	use	VERB
iajs-3385	199	9	π	π	NOUN
iajs-3385	199	10	-	-	NOUN
iajs-3385	199	11	acceptors	acceptor	NOUN
iajs-3385	199	12	as	as	ADP
iajs-3385	199	13	analytical	analytical	ADJ
iajs-3385	199	14	reagents	reagent	NOUN
iajs-3385	199	15	.	.	PUNCT
iajs-3385	200	1	iosr	iosr	ADJ
iajs-3385	200	2	j	j	PROPN
iajs-3385	200	3	pharm	pharm	PROPN
iajs-3385	200	4	.	.	PUNCT
iajs-3385	201	1	2019	2019	NUM
iajs-3385	201	2	;	;	PUNCT
iajs-3385	201	3	9(1):50	9(1):50	NUM
iajs-3385	201	4	-	-	SYM
iajs-3385	201	5	61	61	NUM
iajs-3385	201	6	.	.	PUNCT
iajs-3385	202	1	https://doi.org/10.37285/ijpsn.2020.13.5.5	https://doi.org/10.37285/ijpsn.2020.13.5.5	X
iajs-3385	202	2	.	.	PUNCT
iajs-3385	202	3	https://doi.org/10.2165/00003495-200868040-00011	https://doi.org/10.2165/00003495-200868040-00011	PROPN
iajs-3385	202	4	https://doi.org/10.31351/vol31iss2pp297-303	https://doi.org/10.31351/vol31iss2pp297-303	X
iajs-3385	202	5	https://doi.org/10.21123/bsj.2020.17.2.0444	https://doi.org/10.21123/bsj.2020.17.2.0444	PROPN
iajs-3385	202	6	https://doi.org/10.1099/jmm.0.000203	https://doi.org/10.1099/jmm.0.000203	PROPN
iajs-3385	202	7	https://doi.org/10.4269/ajtmh.2003.68.586	https://doi.org/10.4269/ajtmh.2003.68.586	NOUN
iajs-3385	202	8	https://doi.org/10.36037/ijrei.2020.4202	https://doi.org/10.36037/ijrei.2020.4202	PROPN
iajs-3385	203	1	https://doi.org/10.2174/1573412916999200704144231	https://doi.org/10.2174/1573412916999200704144231	PROPN
iajs-3385	203	2	https://doi.org/10.3389/fchem.2018.00576	https://doi.org/10.3389/fchem.2018.00576	PROPN
iajs-3385	203	3	https://doi.org/10.1016/j.saa.2021.120819	https://doi.org/10.1016/j.saa.2021.120819	PUNCT
iajs-3385	203	4	https://doi.org/10.46624/ajptr.2019.v9.i1.001	https://doi.org/10.46624/ajptr.2019.v9.i1.001	NOUN
iajs-3385	203	5	https://doi.org/10.37285/ijpsn.2020.13.5.5	https://doi.org/10.37285/ijpsn.2020.13.5.5	NUM
iajs-3385	203	6	ihjpas	ihjpa	NOUN
iajs-3385	203	7	.	.	PUNCT
iajs-3385	204	1	2025	2025	NUM
iajs-3385	204	2	,	,	PUNCT
iajs-3385	204	3	38(2	38(2	NUM
iajs-3385	204	4	)	)	PUNCT
iajs-3385	204	5	213	213	NUM
iajs-3385	204	6	28	28	NUM
iajs-3385	204	7	.	.	PUNCT
iajs-3385	205	1	el	el	PROPN
iajs-3385	205	2	-	-	PUNCT
iajs-3385	205	3	yazbi	yazbi	PROPN
iajs-3385	205	4	af	af	PROPN
iajs-3385	205	5	,	,	PUNCT
iajs-3385	205	6	khamis	khamis	PROPN
iajs-3385	205	7	ef	ef	PROPN
iajs-3385	205	8	,	,	PUNCT
iajs-3385	205	9	youssef	youssef	PROPN
iajs-3385	205	10	rm	rm	PROPN
iajs-3385	205	11	,	,	PUNCT
iajs-3385	205	12	el	el	PROPN
iajs-3385	205	13	-	-	PUNCT
iajs-3385	205	14	sayed	say	VERB
iajs-3385	205	15	ma	ma	PROPN
iajs-3385	205	16	,	,	PUNCT
iajs-3385	205	17	aboukhalil	aboukhalil	PROPN
iajs-3385	205	18	fm	fm	PROPN
iajs-3385	205	19	.	.	PROPN
iajs-3385	205	20	green	green	ADJ
iajs-3385	205	21	analytical	analytical	ADJ
iajs-3385	205	22	methods	method	NOUN
iajs-3385	205	23	for	for	ADP
iajs-3385	205	24	simultaneous	simultaneous	ADJ
iajs-3385	205	25	determination	determination	NOUN
iajs-3385	205	26	of	of	ADP
iajs-3385	205	27	compounds	compound	NOUN
iajs-3385	205	28	having	have	VERB
iajs-3385	205	29	relatively	relatively	ADV
iajs-3385	205	30	disparate	disparate	ADJ
iajs-3385	205	31	absorbance	absorbance	NOUN
iajs-3385	205	32	;	;	PUNCT
iajs-3385	205	33	application	application	NOUN
iajs-3385	205	34	to	to	ADP
iajs-3385	205	35	antibiotic	antibiotic	ADJ
iajs-3385	205	36	formulation	formulation	NOUN
iajs-3385	205	37	of	of	ADP
iajs-3385	205	38	azithromycin	azithromycin	PROPN
iajs-3385	205	39	and	and	CCONJ
iajs-3385	205	40	levofloxacin	levofloxacin	PROPN
iajs-3385	205	41	.	.	PUNCT
iajs-3385	206	1	heliyon	heliyon	NOUN
iajs-3385	206	2	.	.	PUNCT
iajs-3385	207	1	2020	2020	NUM
iajs-3385	207	2	;	;	PUNCT
iajs-3385	207	3	6(9):e04819	6(9):e04819	X
iajs-3385	207	4	.	.	PUNCT
iajs-3385	208	1	https://doi.org/10.1016/j.heliyon.2020.e04819	https://doi.org/10.1016/j.heliyon.2020.e04819	NOUN
iajs-3385	208	2	.	.	PUNCT
iajs-3385	209	1	29	29	NUM
iajs-3385	209	2	.	.	PUNCT
iajs-3385	209	3	mostafa	mostafa	PROPN
iajs-3385	209	4	a.	a.	PROPN
iajs-3385	209	5	spectrophotometric	spectrophotometric	PROPN
iajs-3385	209	6	and	and	CCONJ
iajs-3385	209	7	multivariate	multivariate	VERB
iajs-3385	209	8	calibration	calibration	NOUN
iajs-3385	209	9	techniques	technique	NOUN
iajs-3385	209	10	for	for	ADP
iajs-3385	209	11	simultaneous	simultaneous	ADJ
iajs-3385	209	12	determination	determination	NOUN
iajs-3385	209	13	of	of	ADP
iajs-3385	209	14	different	different	ADJ
iajs-3385	209	15	drugs	drug	NOUN
iajs-3385	209	16	in	in	ADP
iajs-3385	209	17	pharmaceutical	pharmaceutical	NOUN
iajs-3385	209	18	formulations	formulation	NOUN
iajs-3385	209	19	and	and	CCONJ
iajs-3385	209	20	human	human	ADJ
iajs-3385	209	21	urine	urine	NOUN
iajs-3385	209	22	:	:	PUNCT
iajs-3385	209	23	evaluation	evaluation	NOUN
iajs-3385	209	24	of	of	ADP
iajs-3385	209	25	greenness	greenness	NOUN
iajs-3385	209	26	profile	profile	NOUN
iajs-3385	209	27	.	.	PUNCT
iajs-3385	210	1	j	j	PROPN
iajs-3385	210	2	anal	anal	ADJ
iajs-3385	210	3	methods	method	NOUN
iajs-3385	210	4	chem	chem	NOUN
iajs-3385	210	5	.	.	PUNCT
iajs-3385	211	1	2020	2020	NUM
iajs-3385	211	2	;	;	PUNCT
iajs-3385	211	3	2020(1):8873003	2020(1):8873003	NUM
iajs-3385	211	4	.	.	PUNCT
iajs-3385	212	1	https://doi.org/10.1155/2020/8873003	https://doi.org/10.1155/2020/8873003	PROPN
iajs-3385	212	2	.	.	PROPN
iajs-3385	213	1	30	30	NUM
iajs-3385	213	2	.	.	PUNCT
iajs-3385	214	1	bodhankar	bodhankar	PROPN
iajs-3385	214	2	v	v	PROPN
iajs-3385	214	3	,	,	PUNCT
iajs-3385	214	4	thoke	thoke	PROPN
iajs-3385	214	5	st	st	PROPN
iajs-3385	214	6	,	,	PUNCT
iajs-3385	214	7	kouthekar	kouthekar	PROPN
iajs-3385	214	8	vr	vr	PROPN
iajs-3385	214	9	,	,	PUNCT
iajs-3385	214	10	deshmukh	deshmukh	PROPN
iajs-3385	214	11	sm	sm	PROPN
iajs-3385	214	12	,	,	PUNCT
iajs-3385	214	13	jadhao	jadhao	PROPN
iajs-3385	214	14	ut	ut	PROPN
iajs-3385	214	15	.	.	PROPN
iajs-3385	214	16	simultaneous	simultaneous	ADJ
iajs-3385	214	17	estimation	estimation	NOUN
iajs-3385	214	18	of	of	ADP
iajs-3385	214	19	ambroxol	ambroxol	NOUN
iajs-3385	214	20	hydrochloride	hydrochloride	NOUN
iajs-3385	214	21	and	and	CCONJ
iajs-3385	214	22	levofloxacin	levofloxacin	NOUN
iajs-3385	214	23	hemihydrate	hemihydrate	NOUN
iajs-3385	214	24	using	use	VERB
iajs-3385	214	25	absorbance	absorbance	NOUN
iajs-3385	214	26	ratio	ratio	NOUN
iajs-3385	214	27	method	method	NOUN
iajs-3385	214	28	.	.	PUNCT
iajs-3385	215	1	eur	eur	PROPN
iajs-3385	215	2	j	j	PROPN
iajs-3385	215	3	pharm	pharm	PROPN
iajs-3385	215	4	med	med	PROPN
iajs-3385	215	5	res	re	NOUN
iajs-3385	215	6	.	.	PUNCT
iajs-3385	215	7	2021	2021	NUM
iajs-3385	215	8	;	;	PUNCT
iajs-3385	215	9	8(3):640	8(3):640	NUM
iajs-3385	215	10	-	-	SYM
iajs-3385	215	11	645	645	NUM
iajs-3385	215	12	.	.	PUNCT
iajs-3385	216	1	31	31	NUM
iajs-3385	216	2	.	.	PUNCT
iajs-3385	217	1	gholse	gholse	PROPN
iajs-3385	217	2	yn	yn	PROPN
iajs-3385	217	3	,	,	PUNCT
iajs-3385	217	4	chaple	chaple	PROPN
iajs-3385	217	5	dr	dr	PROPN
iajs-3385	217	6	,	,	PUNCT
iajs-3385	217	7	kasliwal	kasliwal	PROPN
iajs-3385	217	8	rh	rh	PROPN
iajs-3385	217	9	.	.	PROPN
iajs-3385	217	10	development	development	PROPN
iajs-3385	217	11	and	and	CCONJ
iajs-3385	217	12	validation	validation	NOUN
iajs-3385	217	13	of	of	ADP
iajs-3385	217	14	novel	novel	ADJ
iajs-3385	217	15	analytical	analytical	ADJ
iajs-3385	217	16	simultaneous	simultaneous	ADJ
iajs-3385	217	17	estimation	estimation	NOUN
iajs-3385	217	18	based	base	VERB
iajs-3385	217	19	uv	uv	NOUN
iajs-3385	217	20	spectrophotometric	spectrophotometric	ADJ
iajs-3385	217	21	method	method	NOUN
iajs-3385	217	22	for	for	ADP
iajs-3385	217	23	doxycycline	doxycycline	NOUN
iajs-3385	217	24	and	and	CCONJ
iajs-3385	217	25	levofloxacin	levofloxacin	NOUN
iajs-3385	217	26	determination	determination	NOUN
iajs-3385	217	27	.	.	PUNCT
iajs-3385	218	1	briac	briac	NOUN
iajs-3385	218	2	.	.	PUNCT
iajs-3385	219	1	2022	2022	NUM
iajs-3385	219	2	;	;	PUNCT
iajs-3385	219	3	12(4):5458	12(4):5458	NUM
iajs-3385	219	4	-	-	SYM
iajs-3385	219	5	5478	5478	NUM
iajs-3385	219	6	.	.	PUNCT
iajs-3385	220	1	https://doi.org/10.33263/briac124.54585478	https://doi.org/10.33263/briac124.54585478	X
iajs-3385	220	2	.	.	PUNCT
iajs-3385	221	1	32	32	NUM
iajs-3385	221	2	.	.	PUNCT
iajs-3385	222	1	ravi	ravi	PROPN
iajs-3385	222	2	m	m	PROPN
iajs-3385	222	3	,	,	PUNCT
iajs-3385	222	4	veeraiah	veeraiah	PROPN
iajs-3385	222	5	t	t	PROPN
iajs-3385	222	6	,	,	PUNCT
iajs-3385	222	7	venkata	venkata	PROPN
iajs-3385	222	8	rrch	rrch	NOUN
iajs-3385	222	9	.	.	PUNCT
iajs-3385	223	1	simultaneous	simultaneous	ADJ
iajs-3385	223	2	spectrophotometric	spectrophotometric	ADJ
iajs-3385	223	3	estimation	estimation	NOUN
iajs-3385	223	4	of	of	ADP
iajs-3385	223	5	levofloxacin	levofloxacin	NOUN
iajs-3385	223	6	and	and	CCONJ
iajs-3385	223	7	ornidazole	ornidazole	NOUN
iajs-3385	223	8	using	use	VERB
iajs-3385	223	9	ddq	ddq	PROPN
iajs-3385	223	10	and	and	CCONJ
iajs-3385	223	11	p	p	X
iajs-3385	223	12	-	-	PUNCT
iajs-3385	223	13	ca	ca	NOUN
iajs-3385	223	14	as	as	ADP
iajs-3385	223	15	analytical	analytical	ADJ
iajs-3385	223	16	reagents	reagent	NOUN
iajs-3385	223	17	.	.	PUNCT
iajs-3385	224	1	j	j	PROPN
iajs-3385	224	2	pharm	pharm	PROPN
iajs-3385	224	3	sci	sci	PROPN
iajs-3385	224	4	&	&	CCONJ
iajs-3385	224	5	res	re	NOUN
iajs-3385	224	6	.	.	PUNCT
iajs-3385	224	7	2022	2022	NUM
iajs-3385	224	8	;	;	PUNCT
iajs-3385	224	9	14(9):901907	14(9):901907	NUM
iajs-3385	224	10	.	.	PUNCT
iajs-3385	225	1	33	33	NUM
iajs-3385	225	2	.	.	PUNCT
iajs-3385	226	1	khattab	khattab	PROPN
iajs-3385	226	2	fi	fi	PROPN
iajs-3385	226	3	,	,	PUNCT
iajs-3385	226	4	ramadan	ramadan	PROPN
iajs-3385	226	5	nk	nk	PROPN
iajs-3385	226	6	,	,	PUNCT
iajs-3385	226	7	hegazy	hegazy	PROPN
iajs-3385	226	8	ma	ma	PROPN
iajs-3385	226	9	,	,	PUNCT
iajs-3385	226	10	ghoniem	ghoniem	ADJ
iajs-3385	226	11	ns	ns	ADJ
iajs-3385	226	12	.	.	PUNCT
iajs-3385	226	13	simultaneous	simultaneous	ADJ
iajs-3385	226	14	determination	determination	NOUN
iajs-3385	226	15	of	of	ADP
iajs-3385	226	16	metronidazole	metronidazole	NOUN
iajs-3385	226	17	and	and	CCONJ
iajs-3385	226	18	spiramycin	spiramycin	NOUN
iajs-3385	226	19	in	in	ADP
iajs-3385	226	20	bulk	bulk	ADJ
iajs-3385	226	21	powder	powder	NOUN
iajs-3385	226	22	and	and	CCONJ
iajs-3385	226	23	in	in	ADP
iajs-3385	226	24	tablets	tablet	NOUN
iajs-3385	226	25	using	use	VERB
iajs-3385	226	26	different	different	ADJ
iajs-3385	226	27	spectrophotometric	spectrophotometric	ADJ
iajs-3385	226	28	techniques	technique	NOUN
iajs-3385	226	29	.	.	PUNCT
iajs-3385	227	1	drug	drug	NOUN
iajs-3385	227	2	test	test	NOUN
iajs-3385	227	3	anal	anal	NOUN
iajs-3385	227	4	.	.	PUNCT
iajs-3385	228	1	2010	2010	NUM
iajs-3385	228	2	;	;	PUNCT
iajs-3385	228	3	2(1):37	2(1):37	NUM
iajs-3385	228	4	-	-	SYM
iajs-3385	228	5	44	44	NUM
iajs-3385	228	6	.	.	PUNCT
iajs-3385	229	1	https://doi.org/10.1002/dta.83	https://doi.org/10.1002/dta.83	ADJ
iajs-3385	229	2	.	.	PUNCT
iajs-3385	230	1	34	34	NUM
iajs-3385	230	2	.	.	PUNCT
iajs-3385	230	3	alphonse	alphonse	PROPN
iajs-3385	230	4	m.	m.	PROPN
iajs-3385	230	5	development	development	PROPN
iajs-3385	230	6	and	and	CCONJ
iajs-3385	230	7	validation	validation	NOUN
iajs-3385	230	8	of	of	ADP
iajs-3385	230	9	a	a	DET
iajs-3385	230	10	uv	uv	NOUN
iajs-3385	230	11	spectrophotometric	spectrophotometric	ADJ
iajs-3385	230	12	method	method	NOUN
iajs-3385	230	13	for	for	ADP
iajs-3385	230	14	the	the	DET
iajs-3385	230	15	simultaneous	simultaneous	ADJ
iajs-3385	230	16	determination	determination	NOUN
iajs-3385	230	17	of	of	ADP
iajs-3385	230	18	ciprofloxacin	ciprofloxacin	NOUN
iajs-3385	230	19	hydrochloride	hydrochloride	NOUN
iajs-3385	230	20	and	and	CCONJ
iajs-3385	230	21	metronidazole	metronidazole	NOUN
iajs-3385	230	22	in	in	ADP
iajs-3385	230	23	binary	binary	ADJ
iajs-3385	230	24	mixture	mixture	NOUN
iajs-3385	230	25	.	.	PUNCT
iajs-3385	231	1	j	j	PROPN
iajs-3385	231	2	chem	chem	PROPN
iajs-3385	231	3	pharm	pharm	NOUN
iajs-3385	231	4	res	re	NOUN
iajs-3385	231	5	.	.	PUNCT
iajs-3385	231	6	2012	2012	NUM
iajs-3385	231	7	;	;	PUNCT
iajs-3385	231	8	4(11):4710	4(11):4710	PROPN
iajs-3385	231	9	-	-	PUNCT
iajs-3385	231	10	4715	4715	NUM
iajs-3385	231	11	.	.	PUNCT
iajs-3385	232	1	35	35	NUM
iajs-3385	232	2	.	.	PUNCT
iajs-3385	233	1	ertokuş	ertokuş	PROPN
iajs-3385	233	2	gp	gp	PROPN
iajs-3385	233	3	,	,	PUNCT
iajs-3385	233	4	çelik	çelik	PROPN
iajs-3385	233	5	um	um	INTJ
iajs-3385	233	6	.	.	PUNCT
iajs-3385	234	1	chemometric	chemometric	ADJ
iajs-3385	234	2	analysis	analysis	NOUN
iajs-3385	234	3	of	of	ADP
iajs-3385	234	4	moxifloxacin	moxifloxacin	NOUN
iajs-3385	234	5	and	and	CCONJ
iajs-3385	234	6	metronidazole	metronidazole	NOUN
iajs-3385	234	7	in	in	ADP
iajs-3385	234	8	binary	binary	ADJ
iajs-3385	234	9	drug	drug	NOUN
iajs-3385	234	10	combinations	combination	NOUN
iajs-3385	234	11	with	with	ADP
iajs-3385	234	12	spectrophotometric	spectrophotometric	ADJ
iajs-3385	234	13	method	method	NOUN
iajs-3385	234	14	.	.	PUNCT
iajs-3385	235	1	eajs	eajs	NOUN
iajs-3385	235	2	.	.	PUNCT
iajs-3385	235	3	2017	2017	NUM
iajs-3385	235	4	;	;	PUNCT
iajs-3385	235	5	3(2):30	3(2):30	NUM
iajs-3385	235	6	-	-	SYM
iajs-3385	235	7	37	37	NUM
iajs-3385	235	8	.	.	PUNCT
iajs-3385	235	9	36	36	NUM
iajs-3385	235	10	.	.	PUNCT
iajs-3385	236	1	alsamarrai	alsamarrai	PROPN
iajs-3385	236	2	haj	haj	PROPN
iajs-3385	236	3	,	,	PUNCT
iajs-3385	236	4	alsamarrai	alsamarrai	NOUN
iajs-3385	236	5	kf	kf	PROPN
iajs-3385	236	6	.	.	PROPN
iajs-3385	236	7	spectrophotometric	spectrophotometric	ADJ
iajs-3385	236	8	determination	determination	NOUN
iajs-3385	236	9	of	of	ADP
iajs-3385	236	10	metronidazole	metronidazole	NOUN
iajs-3385	236	11	and	and	CCONJ
iajs-3385	236	12	metronidazole	metronidazole	NOUN
iajs-3385	236	13	benzoate	benzoate	NOUN
iajs-3385	236	14	via	via	ADP
iajs-3385	236	15	first	first	ADJ
iajs-3385	236	16	and	and	CCONJ
iajs-3385	236	17	second	second	ADJ
iajs-3385	236	18	derivative	derivative	ADJ
iajs-3385	236	19	order	order	NOUN
iajs-3385	236	20	spectroscopy	spectroscopy	NOUN
iajs-3385	236	21	.	.	PUNCT
iajs-3385	237	1	baghdad	baghdad	PROPN
iajs-3385	237	2	sci	sci	PROPN
iajs-3385	237	3	j.	j.	PROPN
iajs-3385	237	4	2017	2017	NUM
iajs-3385	237	5	;	;	PUNCT
iajs-3385	237	6	14(2):320	14(2):320	X
iajs-3385	237	7	-	-	SYM
iajs-3385	237	8	327	327	NUM
iajs-3385	237	9	.	.	PUNCT
iajs-3385	238	1	https://doi.org/10.21123/bsj.2017.14.2.0320	https://doi.org/10.21123/bsj.2017.14.2.0320	NOUN
iajs-3385	238	2	.	.	PROPN
iajs-3385	239	1	37	37	NUM
iajs-3385	239	2	.	.	PUNCT
iajs-3385	240	1	hendawy	hendawy	PROPN
iajs-3385	240	2	h	h	PROPN
iajs-3385	240	3	,	,	PUNCT
iajs-3385	240	4	amin	amin	NOUN
iajs-3385	240	5	as	as	ADP
iajs-3385	240	6	,	,	PUNCT
iajs-3385	240	7	moalla	moalla	PROPN
iajs-3385	240	8	sm	sm	PROPN
iajs-3385	240	9	,	,	PUNCT
iajs-3385	240	10	aish	aish	PROPN
iajs-3385	240	11	mm	mm	PROPN
iajs-3385	240	12	.	.	PUNCT
iajs-3385	241	1	artificial	artificial	ADJ
iajs-3385	241	2	neural	neural	ADJ
iajs-3385	241	3	networks	network	NOUN
iajs-3385	241	4	for	for	ADP
iajs-3385	241	5	the	the	DET
iajs-3385	241	6	simultaneous	simultaneous	ADJ
iajs-3385	241	7	spectrophotometric	spectrophotometric	ADJ
iajs-3385	241	8	determination	determination	NOUN
iajs-3385	241	9	of	of	ADP
iajs-3385	241	10	amoxicillin	amoxicillin	PROPN
iajs-3385	241	11	trihydrate	trihydrate	NOUN
iajs-3385	241	12	,	,	PUNCT
iajs-3385	241	13	metronidazole	metronidazole	NOUN
iajs-3385	241	14	and	and	CCONJ
iajs-3385	241	15	pantoprazole	pantoprazole	NOUN
iajs-3385	241	16	in	in	ADP
iajs-3385	241	17	pharmaceutical	pharmaceutical	NOUN
iajs-3385	241	18	formulations	formulation	NOUN
iajs-3385	241	19	.	.	PUNCT
iajs-3385	242	1	egypt	egypt	PROPN
iajs-3385	242	2	j	j	PROPN
iajs-3385	242	3	chem	chem	PROPN
iajs-3385	242	4	.	.	PUNCT
iajs-3385	243	1	2023	2023	NUM
iajs-3385	243	2	;	;	PUNCT
iajs-3385	243	3	66(6):119	66(6):119	PROPN
iajs-3385	243	4	-	-	SYM
iajs-3385	243	5	127	127	NUM
iajs-3385	243	6	.	.	PUNCT
iajs-3385	244	1	https://doi.org/10.21608/ejchem.2022.151776.6582	https://doi.org/10.21608/ejchem.2022.151776.6582	NUM
iajs-3385	244	2	.	.	NOUN
iajs-3385	244	3	38	38	NUM
iajs-3385	244	4	.	.	PUNCT
iajs-3385	245	1	khamar	khamar	PROPN
iajs-3385	245	2	jc	jc	PROPN
iajs-3385	245	3	,	,	PUNCT
iajs-3385	245	4	patel	patel	PROPN
iajs-3385	245	5	sa	sa	PROPN
iajs-3385	245	6	.	.	PUNCT
iajs-3385	246	1	q	q	ADJ
iajs-3385	246	2	-	-	PUNCT
iajs-3385	246	3	absorbance	absorbance	NOUN
iajs-3385	246	4	ratio	ratio	NOUN
iajs-3385	246	5	spectrophotometric	spectrophotometric	VERB
iajs-3385	246	6	method	method	NOUN
iajs-3385	246	7	for	for	ADP
iajs-3385	246	8	the	the	DET
iajs-3385	246	9	simultaneous	simultaneous	ADJ
iajs-3385	246	10	estimation	estimation	NOUN
iajs-3385	246	11	of	of	ADP
iajs-3385	246	12	rifampicin	rifampicin	NOUN
iajs-3385	246	13	and	and	CCONJ
iajs-3385	246	14	piperine	piperine	NOUN
iajs-3385	246	15	in	in	ADP
iajs-3385	246	16	their	their	PRON
iajs-3385	246	17	combined	combine	VERB
iajs-3385	246	18	capsule	capsule	NOUN
iajs-3385	246	19	dosage	dosage	NOUN
iajs-3385	246	20	.	.	PUNCT
iajs-3385	247	1	j	j	PROPN
iajs-3385	247	2	appl	appl	PROPN
iajs-3385	247	3	pharm	pharm	PROPN
iajs-3385	247	4	sci	sci	PROPN
iajs-3385	247	5	.	.	PROPN
iajs-3385	247	6	2012	2012	NUM
iajs-3385	247	7	;	;	PUNCT
iajs-3385	247	8	2(4):137	2(4):137	NUM
iajs-3385	247	9	-	-	SYM
iajs-3385	247	10	141	141	NUM
iajs-3385	247	11	.	.	PUNCT
iajs-3385	248	1	https://doi.org/10.7324/japs.2012.2416	https://doi.org/10.7324/japs.2012.2416	NOUN
iajs-3385	248	2	.	.	PROPN
iajs-3385	248	3	39	39	NUM
iajs-3385	248	4	.	.	PUNCT
iajs-3385	249	1	stets	stet	NOUN
iajs-3385	249	2	s	s	PART
iajs-3385	249	3	,	,	PUNCT
iajs-3385	249	4	tavares	tavares	PROPN
iajs-3385	249	5	tm	tm	PROPN
iajs-3385	249	6	,	,	PUNCT
iajs-3385	249	7	peralta	peralta	PROPN
iajs-3385	249	8	-	-	PUNCT
iajs-3385	249	9	zamora	zamora	PROPN
iajs-3385	249	10	pg	pg	PROPN
iajs-3385	249	11	,	,	PUNCT
iajs-3385	249	12	pessoab	pessoab	PROPN
iajs-3385	249	13	ca	can	AUX
iajs-3385	249	14	,	,	PUNCT
iajs-3385	249	15	nagata	nagata	PROPN
iajs-3385	249	16	n.	n.	PROPN
iajs-3385	249	17	simultaneous	simultaneous	ADJ
iajs-3385	249	18	determination	determination	NOUN
iajs-3385	249	19	of	of	ADP
iajs-3385	249	20	rifampicin	rifampicin	VERB
iajs-3385	249	21	and	and	CCONJ
iajs-3385	249	22	isoniazid	isoniazid	NOUN
iajs-3385	249	23	in	in	ADP
iajs-3385	249	24	urine	urine	NOUN
iajs-3385	249	25	and	and	CCONJ
iajs-3385	249	26	pharmaceutical	pharmaceutical	NOUN
iajs-3385	249	27	formulations	formulation	NOUN
iajs-3385	249	28	by	by	ADP
iajs-3385	249	29	multivariate	multivariate	NOUN
iajs-3385	249	30	visible	visible	ADJ
iajs-3385	249	31	spectrophotometry	spectrophotometry	NOUN
iajs-3385	249	32	.	.	PUNCT
iajs-3385	250	1	j	j	PROPN
iajs-3385	250	2	braz	braz	PROPN
iajs-3385	250	3	chem	chem	PROPN
iajs-3385	250	4	soc	soc	NOUN
iajs-3385	250	5	.	.	PUNCT
iajs-3385	251	1	2013	2013	NUM
iajs-3385	251	2	;	;	PUNCT
iajs-3385	251	3	24(7):1198	24(7):1198	PROPN
iajs-3385	251	4	-	-	PUNCT
iajs-3385	251	5	1205	1205	NUM
iajs-3385	251	6	.	.	PUNCT
iajs-3385	252	1	http://dx.doi.org/10.5935/0103-5053.20130154	http://dx.doi.org/10.5935/0103-5053.20130154	PROPN
iajs-3385	252	2	.	.	PROPN
iajs-3385	253	1	40	40	NUM
iajs-3385	253	2	.	.	PUNCT
iajs-3385	254	1	tilinca	tilinca	PROPN
iajs-3385	254	2	m	m	PROPN
iajs-3385	254	3	,	,	PUNCT
iajs-3385	254	4	hancu	hancu	X
iajs-3385	254	5	g	g	NOUN
iajs-3385	254	6	,	,	PUNCT
iajs-3385	254	7	mircia	mircia	PROPN
iajs-3385	254	8	e	e	NOUN
iajs-3385	254	9	,	,	PUNCT
iajs-3385	254	10	iriminescu	iriminescu	PROPN
iajs-3385	254	11	d	d	PROPN
iajs-3385	254	12	,	,	PUNCT
iajs-3385	254	13	rusu	rusu	PROPN
iajs-3385	254	14	a	a	PRON
iajs-3385	254	15	,	,	PUNCT
iajs-3385	254	16	vlad	vlad	VERB
iajs-3385	254	17	ra	ra	PROPN
iajs-3385	254	18	,	,	PUNCT
iajs-3385	254	19	barabás	barabás	PROPN
iajs-3385	254	20	e.	e.	PROPN
iajs-3385	254	21	simultaneous	simultaneous	ADJ
iajs-3385	254	22	determination	determination	NOUN
iajs-3385	254	23	of	of	ADP
iajs-3385	254	24	isoniazid	isoniazid	NOUN
iajs-3385	254	25	and	and	CCONJ
iajs-3385	254	26	rifampicin	rifampicin	VERB
iajs-3385	254	27	by	by	ADP
iajs-3385	254	28	uv	uv	NOUN
iajs-3385	254	29	spectrophotometry	spectrophotometry	NOUN
iajs-3385	254	30	.	.	PUNCT
iajs-3385	255	1	farmacia	farmacia	PROPN
iajs-3385	255	2	.	.	PUNCT
iajs-3385	255	3	2017	2017	NUM
iajs-3385	255	4	;	;	PUNCT
iajs-3385	255	5	65(2):219	65(2):219	NOUN
iajs-3385	255	6	-	-	SYM
iajs-3385	255	7	224	224	NUM
iajs-3385	255	8	.	.	PUNCT
iajs-3385	256	1	41	41	NUM
iajs-3385	256	2	.	.	PUNCT
iajs-3385	257	1	khawas	khawas	PROPN
iajs-3385	257	2	s	s	PROPN
iajs-3385	257	3	,	,	PUNCT
iajs-3385	257	4	parui	parui	PROPN
iajs-3385	257	5	s	s	PART
iajs-3385	257	6	,	,	PUNCT
iajs-3385	257	7	dey	dey	PROPN
iajs-3385	257	8	s	s	PART
iajs-3385	257	9	,	,	PUNCT
iajs-3385	257	10	mondal	mondal	PROPN
iajs-3385	257	11	sk	sk	PROPN
iajs-3385	257	12	,	,	PUNCT
iajs-3385	257	13	sarkar	sarkar	PROPN
iajs-3385	257	14	s.	s.	PROPN
iajs-3385	257	15	simultaneous	simultaneous	PROPN
iajs-3385	257	16	spectrophotometric	spectrophotometric	ADJ
iajs-3385	257	17	estimation	estimation	NOUN
iajs-3385	257	18	of	of	ADP
iajs-3385	257	19	rifampicin	rifampicin	NOUN
iajs-3385	257	20	,	,	PUNCT
iajs-3385	257	21	isoniazid	isoniazid	NOUN
iajs-3385	257	22	and	and	CCONJ
iajs-3385	257	23	pyrazinamide	pyrazinamide	VERB
iajs-3385	257	24	in	in	ADP
iajs-3385	257	25	their	their	PRON
iajs-3385	257	26	pharmaceutical	pharmaceutical	ADJ
iajs-3385	257	27	dosage	dosage	NOUN
iajs-3385	257	28	form	form	NOUN
iajs-3385	257	29	.	.	PUNCT
iajs-3385	258	1	asian	asian	PROPN
iajs-3385	258	2	j	j	PROPN
iajs-3385	258	3	research	research	NOUN
iajs-3385	258	4	chem	chem	NOUN
iajs-3385	258	5	.	.	PUNCT
iajs-3385	259	1	2020	2020	NUM
iajs-3385	259	2	;	;	PUNCT
iajs-3385	259	3	13(2):117	13(2):117	NUM
iajs-3385	259	4	-	-	SYM
iajs-3385	259	5	122	122	NUM
iajs-3385	259	6	.	.	PUNCT
iajs-3385	260	1	https://doi.org/10.5958/0974-4150.2020.00024.3	https://doi.org/10.5958/0974-4150.2020.00024.3	AUX
iajs-3385	260	2	.	.	PUNCT
iajs-3385	260	3	https://doi.org/10.1016/j.heliyon.2020.e04819	https://doi.org/10.1016/j.heliyon.2020.e04819	PROPN
iajs-3385	260	4	https://doi.org/10.1155/2020/8873003	https://doi.org/10.1155/2020/8873003	PROPN
iajs-3385	260	5	https://doi.org/10.33263/briac124.54585478	https://doi.org/10.33263/briac124.54585478	NUM
iajs-3385	260	6	https://doi.org/10.1002/dta.83	https://doi.org/10.1002/dta.83	PROPN
iajs-3385	260	7	https://doi.org/10.21123/bsj.2017.14.2.0320	https://doi.org/10.21123/bsj.2017.14.2.0320	PROPN
iajs-3385	260	8	https://doi.org/10.21608/ejchem.2022.151776.6582	https://doi.org/10.21608/ejchem.2022.151776.6582	PROPN
iajs-3385	260	9	https://doi.org/10.7324/japs.2012.2416	https://doi.org/10.7324/japs.2012.2416	PROPN
iajs-3385	260	10	https://jbcs.sbq.org.br/audiencia_pdf.asp?aid2=3706&nomearquivo=v24n7a14.pdf	https://jbcs.sbq.org.br/audiencia_pdf.asp?aid2=3706&nomearquivo=v24n7a14.pdf	NOUN
iajs-3385	260	11	https://jbcs.sbq.org.br/audiencia_pdf.asp?aid2=3706&nomearquivo=v24n7a14.pdf	https://jbcs.sbq.org.br/audiencia_pdf.asp?aid2=3706&nomearquivo=v24n7a14.pdf	NOUN
iajs-3385	260	12	https://jbcs.sbq.org.br/audiencia_pdf.asp?aid2=3706&nomearquivo=v24n7a14.pdf	https://jbcs.sbq.org.br/audiencia_pdf.asp?aid2=3706&nomearquivo=v24n7a14.pdf	NOUN
iajs-3385	260	13	http://dx.doi.org/10.5935/0103-5053.20130154	http://dx.doi.org/10.5935/0103-5053.20130154	NOUN
iajs-3385	260	14	https://doi.org/10.5958/0974-4150.2020.00024.3	https://doi.org/10.5958/0974-4150.2020.00024.3	PROPN
iajs-3385	260	15	ihjpas	ihjpa	NOUN
iajs-3385	260	16	.	.	PUNCT
iajs-3385	261	1	2025	2025	NUM
iajs-3385	261	2	,	,	PUNCT
iajs-3385	261	3	38(2	38(2	NUM
iajs-3385	261	4	)	)	PUNCT
iajs-3385	261	5	214	214	NUM
iajs-3385	261	6	42	42	NUM
iajs-3385	261	7	.	.	PUNCT
iajs-3385	262	1	bhoyar	bhoyar	PROPN
iajs-3385	262	2	v	v	PROPN
iajs-3385	262	3	,	,	PUNCT
iajs-3385	262	4	belgamwar	belgamwar	NOUN
iajs-3385	262	5	vs	vs	ADP
iajs-3385	262	6	,	,	PUNCT
iajs-3385	262	7	trivedi	trivedi	PROPN
iajs-3385	262	8	s.	s.	PROPN
iajs-3385	262	9	simultaneous	simultaneous	ADJ
iajs-3385	262	10	determination	determination	NOUN
iajs-3385	262	11	and	and	CCONJ
iajs-3385	262	12	validation	validation	NOUN
iajs-3385	262	13	of	of	ADP
iajs-3385	262	14	anti	anti	ADJ
iajs-3385	262	15	-	-	ADJ
iajs-3385	262	16	tubercular	tubercular	ADJ
iajs-3385	262	17	drugs	drug	NOUN
iajs-3385	262	18	in	in	ADP
iajs-3385	262	19	simulated	simulated	ADJ
iajs-3385	262	20	lungs	lung	NOUN
iajs-3385	262	21	alveolar	alveolar	ADJ
iajs-3385	262	22	macrophages	macrophage	NOUN
iajs-3385	262	23	fluid	fluid	NOUN
iajs-3385	262	24	by	by	ADP
iajs-3385	262	25	ultraviolet	ultraviolet	NOUN
iajs-3385	262	26	-	-	PUNCT
iajs-3385	262	27	visible	visible	ADJ
iajs-3385	262	28	spectrophotometric	spectrophotometric	ADJ
iajs-3385	262	29	method	method	NOUN
iajs-3385	262	30	.	.	PUNCT
iajs-3385	263	1	j	j	PROPN
iajs-3385	263	2	appl	appl	PROPN
iajs-3385	263	3	spectrosc	spectrosc	PROPN
iajs-3385	263	4	.	.	PUNCT
iajs-3385	264	1	2022	2022	NUM
iajs-3385	264	2	;	;	PUNCT
iajs-3385	264	3	89(5):892	89(5):892	NUM
iajs-3385	264	4	-	-	SYM
iajs-3385	264	5	897	897	NUM
iajs-3385	264	6	.	.	PUNCT
iajs-3385	265	1	https://doi.org/10.1007/s10812-022-01444-z	https://doi.org/10.1007/s10812-022-01444-z	PROPN
iajs-3385	265	2	.	.	PUNCT
iajs-3385	266	1	43	43	NUM
iajs-3385	266	2	.	.	PUNCT
iajs-3385	266	3	mohamed	mohame	VERB
iajs-3385	266	4	em	em	PRON
iajs-3385	266	5	.	.	PUNCT
iajs-3385	267	1	simultaneous	simultaneous	ADJ
iajs-3385	267	2	spectrophotometric	spectrophotometric	ADJ
iajs-3385	267	3	determination	determination	NOUN
iajs-3385	267	4	of	of	ADP
iajs-3385	267	5	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	267	6	and	and	CCONJ
iajs-3385	267	7	trimethoprim	trimethoprim	NOUN
iajs-3385	267	8	in	in	ADP
iajs-3385	267	9	drugs	drug	NOUN
iajs-3385	267	10	.	.	PUNCT
iajs-3385	268	1	anal	anal	ADJ
iajs-3385	268	2	lett	lett	PROPN
iajs-3385	268	3	.	.	PUNCT
iajs-3385	269	1	1997	1997	NUM
iajs-3385	269	2	;	;	PUNCT
iajs-3385	269	3	30(13):2341	30(13):2341	NUM
iajs-3385	269	4	-	-	SYM
iajs-3385	269	5	2352	2352	NUM
iajs-3385	269	6	.	.	PUNCT
iajs-3385	270	1	https://doi.org/10.1080/00032719708001746	https://doi.org/10.1080/00032719708001746	ADV
iajs-3385	270	2	.	.	PUNCT
iajs-3385	271	1	44	44	NUM
iajs-3385	271	2	.	.	PUNCT
iajs-3385	272	1	samar	samar	PROPN
iajs-3385	272	2	a.	a.	NOUN
iajs-3385	272	3	development	development	PROPN
iajs-3385	272	4	and	and	CCONJ
iajs-3385	272	5	validation	validation	NOUN
iajs-3385	272	6	of	of	ADP
iajs-3385	272	7	new	new	ADJ
iajs-3385	272	8	methods	method	NOUN
iajs-3385	272	9	for	for	ADP
iajs-3385	272	10	simultaneous	simultaneous	ADJ
iajs-3385	272	11	spectrophotometric	spectrophotometric	ADJ
iajs-3385	272	12	determination	determination	NOUN
iajs-3385	272	13	of	of	ADP
iajs-3385	272	14	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	272	15	and	and	CCONJ
iajs-3385	272	16	sulfacetamide	sulfacetamide	ADJ
iajs-3385	272	17	drugs	drug	NOUN
iajs-3385	272	18	in	in	ADP
iajs-3385	272	19	their	their	PRON
iajs-3385	272	20	pure	pure	ADJ
iajs-3385	272	21	forms	form	NOUN
iajs-3385	272	22	,	,	PUNCT
iajs-3385	272	23	synthetic	synthetic	ADJ
iajs-3385	272	24	samples	sample	NOUN
iajs-3385	272	25	and	and	CCONJ
iajs-3385	272	26	urine	urine	NOUN
iajs-3385	272	27	,	,	PUNCT
iajs-3385	272	28	doctoral	doctoral	ADJ
iajs-3385	272	29	dissertation	dissertation	NOUN
iajs-3385	272	30	,	,	PUNCT
iajs-3385	272	31	university	university	NOUN
iajs-3385	272	32	of	of	ADP
iajs-3385	272	33	baghdad	baghdad	PROPN
iajs-3385	272	34	,	,	PUNCT
iajs-3385	272	35	baghdad	baghdad	PROPN
iajs-3385	272	36	,	,	PUNCT
iajs-3385	272	37	2014	2014	NUM
iajs-3385	272	38	.	.	PUNCT
iajs-3385	273	1	45	45	NUM
iajs-3385	273	2	.	.	PUNCT
iajs-3385	273	3	rohman	rohman	PROPN
iajs-3385	273	4	a	a	PRON
iajs-3385	273	5	,	,	PUNCT
iajs-3385	273	6	silawati	silawati	NOUN
iajs-3385	273	7	d	d	NOUN
iajs-3385	273	8	,	,	PUNCT
iajs-3385	273	9	sudjadi	sudjadi	NOUN
iajs-3385	273	10	,	,	PUNCT
iajs-3385	273	11	riyanto	riyanto	ADP
iajs-3385	273	12	s.	s.	PROPN
iajs-3385	273	13	simultaneous	simultaneous	ADJ
iajs-3385	273	14	determination	determination	NOUN
iajs-3385	273	15	of	of	ADP
iajs-3385	273	16	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	273	17	and	and	CCONJ
iajs-3385	273	18	trimethoprim	trimethoprim	NOUN
iajs-3385	273	19	using	use	VERB
iajs-3385	273	20	uv	uv	NOUN
iajs-3385	273	21	spectroscopy	spectroscopy	NOUN
iajs-3385	273	22	in	in	ADP
iajs-3385	273	23	combination	combination	NOUN
iajs-3385	273	24	with	with	ADP
iajs-3385	273	25	multivariate	multivariate	NOUN
iajs-3385	273	26	calibration	calibration	NOUN
iajs-3385	273	27	.	.	PUNCT
iajs-3385	274	1	j	j	PROPN
iajs-3385	274	2	med	med	PROPN
iajs-3385	274	3	sci	sci	PROPN
iajs-3385	274	4	.	.	PROPN
iajs-3385	274	5	2015	2015	NUM
iajs-3385	274	6	;	;	PUNCT
iajs-3385	274	7	15(4):178	15(4):178	NUM
iajs-3385	274	8	-	-	SYM
iajs-3385	274	9	184	184	NUM
iajs-3385	274	10	.	.	PUNCT
iajs-3385	275	1	https://doi.org/10.3923/jms.2015.178.184	https://doi.org/10.3923/jms.2015.178.184	VERB
iajs-3385	275	2	.	.	PROPN
iajs-3385	275	3	46	46	NUM
iajs-3385	275	4	.	.	PUNCT
iajs-3385	276	1	muchlisyam	muchlisyam	NOUN
iajs-3385	276	2	,	,	PUNCT
iajs-3385	276	3	pardede	pardede	NOUN
iajs-3385	276	4	tr	tr	VERB
iajs-3385	276	5	,	,	PUNCT
iajs-3385	276	6	satiawan	satiawan	PROPN
iajs-3385	276	7	r.	r.	PROPN
iajs-3385	276	8	determination	determination	NOUN
iajs-3385	276	9	of	of	ADP
iajs-3385	276	10	simultaneous	simultaneous	ADJ
iajs-3385	276	11	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	276	12	and	and	CCONJ
iajs-3385	276	13	trimethoprim	trimethoprim	NOUN
iajs-3385	276	14	by	by	ADP
iajs-3385	276	15	ultraviolet	ultraviolet	ADJ
iajs-3385	276	16	spectrophotometry	spectrophotometry	NOUN
iajs-3385	276	17	with	with	ADP
iajs-3385	276	18	mean	mean	ADJ
iajs-3385	276	19	centering	centering	NOUN
iajs-3385	276	20	of	of	ADP
iajs-3385	276	21	ratio	ratio	NOUN
iajs-3385	276	22	spectra	spectra	PROPN
iajs-3385	276	23	.	.	PROPN
iajs-3385	277	1	asian	asian	PROPN
iajs-3385	277	2	j	j	PROPN
iajs-3385	277	3	pharm	pharm	PROPN
iajs-3385	277	4	clin	clin	PROPN
iajs-3385	277	5	res	re	NOUN
iajs-3385	277	6	.	.	PROPN
iajs-3385	277	7	2018	2018	NUM
iajs-3385	277	8	;	;	PUNCT
iajs-3385	278	1	11(1):61	11(1):61	NUM
iajs-3385	278	2	.	.	PUNCT
iajs-3385	279	1	https://doi.org/10.22159/ajpcr.2018.v11s1.26569	https://doi.org/10.22159/ajpcr.2018.v11s1.26569	X
iajs-3385	279	2	.	.	PUNCT
iajs-3385	280	1	47	47	NUM
iajs-3385	280	2	.	.	PUNCT
iajs-3385	281	1	nesmerak	nesmerak	PROPN
iajs-3385	281	2	k	k	PROPN
iajs-3385	281	3	,	,	PUNCT
iajs-3385	281	4	kroiherova	kroiherova	VERB
iajs-3385	281	5	a	a	PRON
iajs-3385	281	6	,	,	PUNCT
iajs-3385	281	7	baptistova	baptistova	X
iajs-3385	281	8	a	a	PRON
iajs-3385	281	9	,	,	PUNCT
iajs-3385	281	10	hranicek	hranicek	CCONJ
iajs-3385	281	11	j.	j.	PROPN
iajs-3385	281	12	spectrometric	spectrometric	PROPN
iajs-3385	281	13	determination	determination	NOUN
iajs-3385	281	14	of	of	ADP
iajs-3385	281	15	trimethoprim	trimethoprim	NOUN
iajs-3385	281	16	and	and	CCONJ
iajs-3385	281	17	sulfamethoxazole	sulfamethoxazole	NOUN
iajs-3385	281	18	in	in	ADP
iajs-3385	281	19	tablets	tablet	NOUN
iajs-3385	281	20	by	by	ADP
iajs-3385	281	21	automated	automate	VERB
iajs-3385	281	22	sequential	sequential	ADJ
iajs-3385	281	23	injection	injection	NOUN
iajs-3385	281	24	technique	technique	NOUN
iajs-3385	281	25	.	.	PUNCT
iajs-3385	282	1	monatsh	monatsh	ADJ
iajs-3385	282	2	chem	chem	NOUN
iajs-3385	282	3	.	.	PUNCT
iajs-3385	283	1	2020	2020	NUM
iajs-3385	283	2	;	;	PUNCT
iajs-3385	284	1	151(8):1311	151(8):1311	NUM
iajs-3385	284	2	-	-	SYM
iajs-3385	284	3	1316	1316	NUM
iajs-3385	284	4	.	.	PUNCT
iajs-3385	285	1	https://doi.org/10.1007/s00706-020-02631-4	https://doi.org/10.1007/s00706-020-02631-4	NUM
iajs-3385	285	2	.	.	PUNCT
iajs-3385	286	1	https://doi.org/10.1007/s10812-022-01444-z	https://doi.org/10.1007/s10812-022-01444-z	PROPN
iajs-3385	286	2	https://doi.org/10.1080/00032719708001746	https://doi.org/10.1080/00032719708001746	PROPN
iajs-3385	286	3	https://ascidatabase.com/author.php?author=sugeng&mid=&last=riyanto	https://ascidatabase.com/author.php?author=sugeng&mid=&last=riyanto	ADP
iajs-3385	286	4	https://doi.org/10.3923/jms.2015.178.184	https://doi.org/10.3923/jms.2015.178.184	VERB
iajs-3385	286	5	https://doi.org/10.22159/ajpcr.2018.v11s1.26569	https://doi.org/10.22159/ajpcr.2018.v11s1.26569	X
iajs-3385	286	6	https://doi.org/10.1007/s00706-020-02631-4	https://doi.org/10.1007/s00706-020-02631-4	PRON